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The experience of mental disorders while part of humanity, reveal inequities that are 
inhumane due to a lack of quality clinical service provisions  globally. In Haiti, a formalized mental 
healthcare infrastructure developed after the 2010 earthquake where emerging dissemination and 
implementation studies demonstrated the potential for treatment utilization within recently 
established primary care. Partners in Health (PIH) and Zanmi Lasante (ZL) the frontline healthcare 
team have coordinated with the Haitian Ministry of Health to lead this initiative. A community-
based mental healthcare system has proven to be sustainable through a task-sharing model, which 
delivers mental healthcare for common mental disorders (CMDs), severe mental disorders 
(SMDs), and neurological conditions (NCs)–with specific care pathways for major depression, 
psychotic disorders, and epilepsy. The extent to which patient mental healthcare are evaluated in 
lower-middle income countries (LMICs) like Haiti, however, have been limited. The primary aim 
of this study was to therefore evaluate patterns of mental disorders and to assess current patient 
care priorities in Haiti. The present study, builds upon previous literature by examining the 
continuum of mental disorders. A latent class analysis provides a data-driven approach to examine 




and ZL were obtained from patients (N=914) who met criterion for a primary diagnosis and had 
completed mental health evaluations that were assessed at 13 sites in Haiti from 2016-2018. 
Known characteristics of mental disorders include the patient’s primary diagnosis, mood 
symptoms such as depression and suicidality, and the level of functional impairment. Accordingly, 
each were included as an LCA model indicator. Post-hoc multinomial logistic regression (MLR) 
models predicted mental health class selection and correlates based on the descriptive and clinical 
symptom variables. Results suggested there are six distinct mental health subgroups, that were 
distinguished by functional impairment: class 1a “common mental disorders–none to low 
functional impairment” (11.5%), class 2a “severe mental disorders–none to low functional 
impairment” (4.9%), class 3a “neurological conditions–none to low functional impairment” 
(11.1%), class 4b “common mental disorders–high functional impairment” (38.62%), class 5b 
“severe mental disorders–high functional impairment” (13.02%), and class 6b “neurological 
conditions–high functional impairment” (20.9%). MLR model 1 revealed CMDs were 2–3 times 
more likely female and received psychosocial interventions more often, and by comparison SMDs 
and NCs typically received psychiatric medication. MLR model 2 included patient’s clinical 
symptoms, that suggested severe CMDs with high functional impairment were somewhat more 
likely depressed when compared to other LCA subgroups. Although, in all likelihood this finding 
was probably attributed to CMDs including mild to severe forms of major depression, whereas 
SMDs were mostly psychotic disorder and bipolar disorder. Taken together, the most frequent 
primary diagnosis included: 1) major depressive disorder (60.3%) and generalized anxiety disorder 
(27.2%) for CMDs, 2) psychotic spectrum disorders (47.6%) and bipolar disorder (23.7%) for 




psychological disorders. The varied mental health disorder subgroups that participated in 
psychotherapy and psychiatric medication management, demonstrate such mental health 
treatments for Haitian’s are feasible and acceptable. While the present analysis was exploratory, 
LCA provides potential tools for treatment specification and best practices. The WHODAS a 
measure of functional impairment may be useful as a screening tool for triage, and primary 
outcome to determine patient improvement. Mental healthcare pathways based on results should 
expand to include women’s mental health and bipolar disorder. These findings are generalizable 
due to the data being from a community sample and directly from EHRs with inclusion criterion 
that was not limited by diagnostic specification, symptom severity, or co–occurring disorders. 
Overall, there is a vast need for mental health services that are broadly accessible for CMDs, 
SMDs, and NCs. This study highlights, specific clinical training and supervision needs, and the 
necessity for increased nursing, psychiatry, and neurology collaboration in Haiti. There is hope 
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    Chapter 1: Introduction 
 
Purpose of the Study  
The overall purpose of the study is to identify characteristics of mental disorders in a lower-
middle income country (LMICs), and more specifically to understand the mental healthcare 
priorities in Haiti. This population has been underserved, and had chronic disparity with regard to 
environmental, sociocultural, and economic problems that are a continuation of the Independence 
Debt that was paid to France in exchange for freedom following the slave revolt. The present study, 
was possible thanks to Zanmi Lasante (ZL) the frontline healthcare team, Partners in Health (PIH), 
and the Global Mental Health (GMH) Lab at Teachers College, Columbia University. Together, 
the mentioned teams alongside the Haitian Ministry of Health established a mental healthcare 
infrastructure after the devastating 2010 earthquake. Capacity building was possible due to a task–
sharing model, that includes community providers and specialized care pathways for major 
depression, psychotic disorders, and epilepsy. The patients were seen at 13 ZL hospital and clinic 
sites whom more broadly, have common mental disorders (CMDs), severe mental disorders 
(SMDs), and neurological conditions (NCs). A latent class analysis provides a data-driven 
approach to examine features of such mental disorders to potentially inform mental health 
treatment and best practices. Previous LCA studies have been modeled for a specific diagnosis 
with symptoms examined individually or based on severity, and certain LCA studies have had low 
methodological quality. Based on prior LCA findings researchers have recommended to move 




The present study, builds upon previous literature by examining the continuum of mental disorders. 
The first study aim, was to better understand mental health needs and treatment utilization of an 
understudied population. The second study aim, was to examine mental health subgroups with a 
latent class analysis (LCA) based on known characteristics of mental disorders such as the patient’s 
primary diagnosis, mood symptoms such as depression and suicidality, and the level of functional 
impairment. The third study aim, examined post–hoc multinomial logistic regression (MLR) 
models to predict mental health classes and correlates based on predictor variables that included 
descriptive and clinical symptoms. We anticipate the study will contribute to the growing body of 
global mental health literature in LMICs and allow us to better understand the presence of 
debilitating problems such as functional impairment, depression symptoms, and suicide that 
frequently co-occur with mental disorders. Further we hope this research improves our 
understanding of healthcare practices for CMDs, SMDs, and NCs. Overall, the study aligns with 
the United Nations Sustainable Development Goals and initiatives led by the World Health 
Organization. 
Global Burden of Disease and Mental Health Treatment Gap  
One in five people are estimated to experience a common mental disorder at some point in 
their lifetime (Steel, et al., 2014), and the prevalence estimate may increase when severe mental 
disorders and neurological conditions are considered. Such elevated figures contribute to the 
overall disease burden and years lost of life, and increase the risk of functional impairment globally 
(Whiteford, et al., 2015). Although 80% of the world's population live in LMICs (Saxena, 




these regions with the remaining 90% located in high-income countries (WHO, 2005).  
Taken together, the 90% mental health treatment gap in LMICs should be seen as a global failure 
(Chisholm et al. 2016; Kohn, Saxena., Levav, & Saraceno, 2004; Patel et al. 2016). Other estimates 
in LMICs reveal 76.3–85.4% of people received no treatment for their mental health conditions 
(Demyttenaere, et al., 2004), and these disparities persist even in relatively well–resourced 
countries such as India and China.  
One must highlight, that large treatment gaps further vary by country and mental disorder. 
For example, according to Kohn and Colleagues (2004) the treatment gap for non-affective 
psychoses and schizophrenia was reported at 32.2%, whereas in rural Ethiopia surveys collected 
around the same time-period showed rates that exceeded 90% for people who have never received 
pharmacological treatment (Kebede, et al., 2003). Additionally, global rates of treatable epilepsy 
are much higher at 80% in LMICs, which suggests that most people do not need to suffer but have 
significant barriers to treatment access (Meyer, et al., 2010). Both severe mental disorders and 
neurological conditions require higher levels of care that include medication management and 
ongoing monitoring for treatable conditions. Many emerging countries only have 1–2 psychiatrists 
per 100,000 people (Rathod, et al., 2017), therefore, severe mental disorders and neurological 
conditions have the unjust consequence of lower mental health coverage. In 2008, WHO developed 
the Mental Health Treatment Gap Action Programme (mhGAP) to address these limits by scaling–
up mental healthcare in 90 countries (WHO, 2010). A systematic review of 33 studies that followed 
the mhGAP guidelines showed an impact on clinical treatment outcomes with minimal training 




For example, traditional faith healers were able to diagnose depression with 86% specificity and 
46% sensitivity (Keynejad, Dua, Barbui,& Thornicroft, 2017). Therefore, research suggests 
feasibility with task-sharing models with mental health services delivered by community mental 
healthcare providers.  
A Solution to Scaling-Up Mental Health Treatment: Task–Sharing Models  
“Task-sharing”, “task-shifting”, “collaborative-care”, or “stepped-care models” are 
variable terms in the global health literature that provides a framework to close the mhGAP by 
including community providers in mental health service delivery. Task-sharing models are based 
on “care pathways” that consider the identification of clinical groups through screening to 
determine and prioritize the appropriate level of care (Belkin, et al., 2011). Task-sharing therefore 
aims to reduce the cost of mental health treatment and increase healthcare access. Task-sharing in 
mental health engages locals (e.g., teachers, pastoral care) to become community providers and 
deliver quality services that have been culturally adapted under the supervision of expert 
professionals (Belkin, et al., 2011; Verdeli, et al., 2016). Through task-sharing, the gains include 
increased case identification and routine mental health services within primary care settings, which 
hopefully begins to normalize the process of mental health treatment engagement. Initially, task-
sharing models were implemented for depression (Araya 2003 & 2006; Coventry, et al., 2014; 
Katon, 2012; Raviola, 2020) and have since expanded to other mental health care pathways.  
Two systematic reviews and meta-analyses on depression determined task-sharing models 
outside the United States, have shown mixed clinical outcomes (Gilbody, et al., 2006; Van Straten, 




systematic review and meta-analysis had considered countries outside the United States the study 
by Gilbody and colleagues (2006) did not provide categorization by country where the results were 
reported only as “US” or “non-US.” Second, the study did not include the “non-US” countries 
socioeconomic status, which contributed to the summary of heterogenous results. This suggests, 
that collapsing variables can result in the interpretation of findings that lack detail. For example, 
the findings from Van Straten and colleagues (2015) were predominantly from high–income 
countries such as the United States (N=6) and Netherlands (N=6) where the results were not 
favorable to task-sharing models. However, the two LMICs included in the study were Chile (N=1) 
and India (N=1). At 6-month follow-up, the study in Chile showed 70% of the intervention group 
who enrolled in the task-sharing had recovered, when compared to only 30% of the usual care 
group (Araya, et al., 2006). At 12-month follow-up, the study in India showed the psychiatric 
symptom scores improved by 3.84 points (Buttorff, et al., 2012). These studies also suggest that 
task-sharing can be a cost-effective alternative (Araya, et al., 2006; Buttorff, et al., 2012 ). In a 
review of 27 randomized control trials, in LMICs for common mental disorders that included 
psychological care for depression, anxiety, and post-traumatic stress disorder the mental health 
treatments delivered by community mental healthcare providers had consistent improvement with 
a medium effect size d = .49, 95% CI [0.36–0.62] (Singla, et al., 2017). The study quality in LMICs 
could benefit from stronger research methods, however, the results have consistently shown 
statistically significant clinical improvement in psychological symptoms when services were 





There are currently limitations as to the interpretability of previous studies on task-sharing 
models for SMDs and NCs. Predominantly the focus has been on CMDs (Murray & Jordans, 
2016), and again there are current limitations for psychiatric medication delivery in LMICs. The 
task-sharing models taken together certainly deserve further consideration but require 
improvement in terms of implementation such as financial and governmental support and 
organizational integration, alongside these factors one must consider the potential for task-sharing 
models to not overlook more acute and severe patients given the limitations with diagnostic and 
clinical symptom screening tools. Nevertheless, task-sharing models benefits seem to exceed the 
current logistical barriers. Task-sharing provides an opportunity to engage the community further 
into the role of mental health care, which has the strong potential for improved access, reduced 
social stigma, quality treatment, and reduced healthcare costs.  
Limitations with Current Mental Health Screening and Diagnosis 
There are several limitations that currently exist with current mental health screening and 
diagnosis protocols. An example of mental health screening limitations has been observed for 
depression. Depression while acknowledged as the leading cause of functional impairment 
accounts for only 3% of the total global disease burden but suicide completion is 78% in LMICs, 
which suggests there are evident limits to current standardized screening tools. The reasons for the 
lower depression estimates in LMICs could include unavailable screening measures, social stigma, 
alternate descriptions for depression symptoms that are not representative of the current diagnostic 
threshold (e.g., increased somatization), traditional faith healers are sought instead, or protective 




primary care. The cultural variations of psychological phenomena with increased study would 
improve the screening identification generally in LMICs. The increased demand for mental health 
screening while apparent, has consistently presented challenges with limited early detection 
through primary care settings and scarce data from community-based samples (Abas, et al., 2003; 
WHO, 2008). A lack of screening reduces the likelihood of early intervention, and patients may 
seek treatment later when the illness is more acute. Notwithstanding, mental health treatment 
engagement is emerging in LMICs and there are many validated tools available to assess clinical 
symptoms globally. At present, the most useful screening tools were identified from a systematic 
literature review by Ali and colleagues (2016) that recommended to use the WHO Self-Reporting 
Questionnaire 20 (SRQ-20) to screen for CMDs, the General Health Questionnaire 12 (GHQ-12) 
for CMDs with a physical illness, the Hospital Anxiety and Depression Scale (HADS-D) for 
depressive disorders, and the Patient Health Questionnaire (PHQ-9) for depressive disorders in 
literate populations. The Kessler Psychological Distress Scale (K6) provides a screening tool for 
SMDs (Kessler, et al., 2010). The most comprehensive structured clinical interview would be the 
World Health Organization World Mental Health Composite International Diagnostic Interview 
(WHO WMH-CIDI) that is based on ICD-10 diagnoses, however, the administration requires more 
time, and presents a challenge for high-volume primary care hospitals and clinics.  
Limitations to the current screening and diagnostic measures, have been that they do not 
reflect the local idioms and most measures fully exclude NCs. Screening and diagnostic tools when 
culturally specific are perhaps more valuable however, and should be adapted from a measure with 




settings (Ali, Ryan, & De Silva, 2016). Further, these adapted measures should follow the WHO 
translation guidelines that include forward translation, expert panel back-translation, and pre-
testing before utilizing the final version for screening use (WHO, 2013). Following validation, the 
screening tools can be used by non-physician and community mental health care providers, and 
requires minimal training to administer (Kagee, Tsai, Lund, & Tomlinson, 2012). A locally 
validated screening measure for depression the Zanmi Lasante Depression Screening Inventory 
(ZLDSI) that follows such translation recommendations (WHO, 2013) was used for two out of the 
three care pathways in the present study (Rasmussen, et al., 2015).  
Prevalence of Psychological Symptoms After the 2010 Earthquake  
Mental healthcare globally is understated but an important consideration given the direct 
cause of medical illnesses, disability, and premature mortality (Miranda & Patel, 2005). Following 
the catastrophic 2010 earthquake nearly all Haitians, including children and adolescents, reported 
some symptoms of post-traumatic stress disorder or major depressive disorder (Cerdá, et al., 2013; 
Cénat, & Derivois, 2014; Cénat, et al., 2018). The prevalence rates 30-months after the 2010 
earthquake were estimated for depression at 36.75% and PTSD 25.98% respectively (Cénat & 
Derivois, 2014). For children and adolescents’ also years after the earthquake, symptoms of severe 
PTSD were 14.94% and depression 29.6% (Derivois, et al., 2017). In another study where the 
responses were gathered through interviews of community members in the Nazon area of Port Au 
Prince the majority of Haitians reported that at least one of their friend(s) or relative(s) was 
injured/killed (90.5%), had seen dead bodies (93%), had been displaced from their home (37.42%), 




endorsed some symptoms of post-traumatic stress disorder (PTSD) or major depressive disorder 
(MDD) (Cerdá, et al., 2013). Provided these outcomes, trauma exposure is evident for all Haitians 
including children and adolescents (Cénat, et al., 2018). Understanding the impact on mental health 
following repeated life events has been important for Haitians undergoing chronic trauma 
exposure. At the same time, it presents challenges to understand the onset and prognosis of mental 
disorders given such high levels of chronic stress.  
Brief Overview of Haitian Mental Health Delivery  
Prior to the 2010 earthquake a formalized mental healthcare system through the newly 
established primary care did not exist (elaborated in the “before mental health infrastructure” 
section below). Emerging studies on mental health in Haiti emphasized a vast mental health 
treatment need but also patient willingness to report their mental health symptoms to providers 
(Cénat, et al., 2018; Cerdá, et al., 2013; Derivois, et al., 2017). Nevertheless, in the early stages of 
mental healthcare development, one study showed that three out of four Haitians would prefer to 
seek community care (e.g., religious leaders, traditional healers) instead of clinical care 
(Wagenaar, et al., 2012). Through task-sharing Haitians’ have been more willing to engage in 
mental health treatment, which potentially increased due to the services being offered by many 
local and community providers who had established trust (Fils-Aimé, et al., 2018; Kazdin, et al., 
2013; Legha, et al., 2015; Raviola, et al., 2012, 2013, & 2020).  
To further develop the mental healthcare infrastructure in Haiti community mental health 
systems have become the proposed solution and led to the implementation of task-sharing models 




Cognitive behavioral therapy (CBT) and interpersonal psychotherapy (IPT) are evidence-based 
practices that have revealed beneficial outcomes in global mental health care and are frontline 
mental health treatment recommendations by WHO. The depression care pathway that was 
established with PIH and ZL selected IPT as the skills package for deliverables (Raviola, 2020). 
The adaptation of IPT treatment aims to reflect the local stories, idioms, and cultural practices to 
provide quality healthcare rather than impose “western” ideals that would not generalize to all 
settings (Bernal & Rodriguez, 2012). The level of access to mental health services in rural areas 
continues to be limited, where mobile clinics aim to respond to multiple mental healthcare needs 
(Fils-Aimé, et al., 2018). In this study, task-sharing models provided the framework to deliver 
mental healthcare pathways for depression, psychotic disorders, and epilepsy. 
The Case for Functional Impairment  
Functional impairment reduces years of life (DALYs), time spent away from work or 
household responsibilities, and contributes to long-standing economic and social disadvantages 
for the community (McKnight & Kashdan, 2009; Whiteford, et al., 2013). The Social Determinants 
of Mental Health according to WHO (2014) provides a framework that includes individual factors, 
social contexts, economic, and environmental factors. Poverty, unemployment, and impoverished 
social relationships both increase the risk for mental disorders, and lead to worse outcomes for 
these conditions (Patel et al., 2009). But importantly as has been shown in a recent literature 
review, some of these adverse socioeconomic outcomes can be reversed with effective mental 
health care interventions (Lund et al., 2011). Furthermore, all of the psychosocial approaches to 




determinants as targets for action, for example, by addressing livelihood skills or interpersonal 
skills and mobilizing community resources (Balaji et al., 2012; Raja et al., 2012; Verdeli et al., 
2004).  
For these reasons, there is a strong case to better understand the role of functional 
impairment in mental health. While further understanding will not eliminate social determinants, 
an individual’s ability to practice self-care and function at school, work, or interpersonally are key 
elements to subjective well-being and when functioning optimally enhance quality of life. For 
example, while scarcity of resources is evident in LMICs, improved functioning will allow 
individuals to assess options and increase motivation. Goals for improved functioning are 
treatment targets that will provide noticeable outcomes––for example, searching for a job, reaching 
out to government/NGOs/local organizations to increase food security, moving, or the pursuit of 
education when possible. CBT provided the treatment targets “thoughts” at times can seem 
culturally insensitive that one has been told “how to think” when previously implemented into 
global mental health settings, thus shifting to focus on functional impairment can provide a new 
framework that normalizes the mental health treatment process. LCA models to date, have not 
typically included functional impairment as an indicator.  
A Lack of Evaluation of Mental Health Service Delivery in LMICs  
In general, provided that many community mental health systems were recently established 
in LMICs most have not been rigorously evaluated. Studies are usually completed at a single time-
point, often do not include partnerships with local governments to provide sustained care, and are 




other LMICs has been more on building the initial mental healthcare infrastructure. Following 
assessment of feasibility, access, and acceptance of services it is important to assess best practices 
generally. Of importance will be to prioritize sustainability, continuity of services, the delivery of 
culturally adapted care, efficacy and the quality of services, safety and ethics for healthcare teams 
and patients, and to consider patient and collaborative care improvement.  
The measurement of such outcomes across sites can be challenging in LMICs, where paper 
and pen are possible for assessment but may present challenges for large data entry at-scale. A 
lack of electricity, internet, computers, or well-resourced infrastructures are common, and further 
there are issues with migration, political instability, and unstable infrastructure. High-income 
countries essentials are not necessarily available, and competing clinical tasks that take priority or 
resistance to the language of the measure itself are current challenges to completion of such 
standardized assessments. For example, computer-based EHRs in Haiti initially had limitations 
due to the scarcity of internet access that has since been resolved and engagement with completing 
standardized measures gradually increasing (Raviola, et al., 2020). The establishment of EHRs 
provide an opportunity to understand key insights about the current and ongoing mental healthcare 
structure by offering an efficient way to analyze data. Date-driven approaches that utilize big data 
from EHR provide important analytics on mental health needs and treatment quality that can be 
assessed at varied time points (vs. a single time-point). The challenges with current methodological 
evaluations of GMH research include the emphasis on treatment-studies that may have low 




the structure of mental healthcare practices that afterward will inform treatment studies in a more 























Recurrence of Natural Disasters & Displacement  
Environmental factors impacting Haiti are repetitive and devastating with regard to natural 
disasters. The most notable environmental events have included Hurricane Ivan and Jeanne, 2004; 
Fey, Gustav, Hanna, and Ike, 2008; earthquake, 2010; Hurricane Sandy, 2012; and Hurricane 
Matthew, 2016. The death toll from the 2010 earthquake alone, was 220,000-300,000 the number 
of people living in many cities (“CNN: Haiti Earthquake Fast Facts,” 2017). Hurricane Matthew 
destroyed 90% of Haiti South, and many of the already limited resources. Since Hurricane 
Matthew 140,000 people have been displaced from their homes, and even years later reside in 
displacement camps (HRW “Haiti Events of 2019,” 2019). The natural disasters have largely 
impacted transportation, electricity, commerce, and school infrastructures.  
Due to these inescapable social conditions, many Haitians try to migrate to the Dominican 
Republic, Venezuela, and United States (“United Nations High Commissioner for Refugees: 
Migration Profiles,” 2013). More recently, in the United States and Dominican Republic mass 
deportation has been common (“Dominican Republic: Amnesty International Calls the Dominican 
Republic to Stop Forcible Deportation of Haitians,” 2012; Kaiser, Keys, Foster, Kohrt, 2015; 
“Human Rights Watch: World Report 2018: Rights Trends in Haiti,” 2017; “U.S. Cancels Program 
for Recent Haitian Immigrants; They Must Leave By 2019,” 2017). For Haitian’s, there are 
multiple reports of social injustice, intolerance, and a lack of social integration when Haitian’s 




migrate and assimilate into another culture. In summary, repeated tropical storms and natural 
disasters have exacerbated  economic and social instability in Haiti.  
Current Social Problems  
Haiti is the poorest country in the Western Hemisphere, with 59% of people living below 
the national poverty line ("Partners in Health Haiti”, 2019; “The World Bank in Haiti: Overview”, 
2019). The majority of Haitian’s live off $1-2 per day, where survival sex or trading sex for food 
is not uncommon (“United Nations High Commissioner for Refugees: Driven by Desperation,” 
2011; Verner, et al., 2008). Basic sanitation, electricity, food insecurity, and minimal access to 
water are frequent concerns in rural and urban areas (“The World Bank: Living Conditions in 
Haiti’s Capital Improve, but Rural Communities Remain Very Poor,” 2014). Of the urban poor 
63% have electricity access, and 48% have improved sanitation access. The rural poor have 11% 
electricity access, and 16% have improved sanitation access. Throughout the country, food 
insecurity and a lack of water access are directly related to issues of sanitation and hygiene 
reducing the potential for survival.  
The resources to mobilize oneself out of these devastating social conditions are few, 
especially with limited access to education, which is a main indicator of future economic stability. 
It is estimated illiteracy is incredibly high (rural areas 80%; urban areas 47%) and due to the series 
of hurricanes and the major 2010 earthquake significant damage has resulted in fewer schools that 
destroyed the already limited educational resources (“WHO Culture and Mental Health in Haiti: 
A Literature Review,” 2010). The work and unemployment rates given these circumstances are 




36% in rural areas (“WHO Culture and Mental Health in Haiti: A Literature Review,” 2010). More 
recently, political unrest has turned violent after the rise of fuel prices by 50% that have led to 
power outages, road blocks, and over the past year further economic instability has resulted in 
local kidnappings-for-ransom (“Chicago Tribune: Haiti violence over fuel prices strands a number 
of U.S. volunteer groups,” 2018; “CNN: As Haiti protests continue, US citizens warned to shelter 
in place,” 2018; NYT “Haiti Braces for Unrest as a Defiant President Refuses to Step Down” 
2021). Persistent economic problems greatly burden the citizens of Haiti and likely are indicators 
of poor mental health. Mental health while important only addresses these problems at an 
individual level, therefore the major systemic issues must be resolved that contribute to cycles of 
poverty––such as the lack of access to jobs, education, housing, political corruption, and food 
insecurity.  
Colonialism in Haiti  
Haitians had a vision to take the words of oppressors and turn them into words of freedom. 
Haiti has a rich history of galvanizing their own revolution that was inspired by French 
Enlightenment thinkers (Bristow, 2017). The French Revolution lasted ten years from 1789 to 
1799. The Haitians, were informed by France’s desire to be at war for the benefit of independence, 
and therefore Haitian’s went into their own battle to end colonization and slavery from 1791 to 
1804. Noteworthy, were the successes found amongst the disenfranchised and otherwise separate 
social groups of bourgeoisies, peasants, and slaves. Perhaps the irony of these mutually timed wars, 
is a great example of the French Revolution leaders not putting one’s own belief system into 




freedom from the “philosophes” even after their victory the United States continued to uphold 
slavery until the end of the Civil War in 1865 (Wallace “American Revolution United States 
History,” 2018). The heroism of Jean-Francois Papillion, Georges Biassou, and Toussaint 
Louverture demonstrated Haiti’s willingness to be unified against racial oppression and slavery 
that was culturally embedded, and inspired the resilience and beauty of Haitian culture (Nicholson, 
2006).  
Issues related to colonialism have continued, with one example being the Independence 
Debt that was paid in exchange for freedom to France until 1947 because slave owners wanted 
reparations. The amount repaid is equivalent to 17BN euros today (BBC “France urged to repay 
Haiti’s huge independence debt”, 2010), with the current Haitian GDP equivalent to 12.8BN euros 
today. There is a discrepancy with such an unjust resolution established with France, and 
irrefutable consequence that has led to further destitution for Haitians. A painful history, that 
continues in many ways and written by the trauma of colonization makes current shifts to 
collaborate doubtful at times. The interwoven factors of current social determinants while failing 
to be continuously recognized on a global scale, reveal that equity and health have provided 
difficult conditions to uphold. Perhaps such disappointments might be considered a global 
responsibility to consider the contribution to such extreme disparities in Haiti, and yet instills a 







Further Social Injustice   
A recently proposed law equated LGBTQ orientation to the level of consideration of a child 
sex offender with unreasonable fines and prison sentences (“Human Rights Watch: World Report 
2018: Rights Trends in Haiti,” 2017). Prenatal care, early child development, and family planning 
collectively are limited (“WHO Culture and Mental Health in Haiti: A Literature Review,” 2010; 
“United Nations High Commissioner for Refugees: Migration Profiles,” 2013). Interpersonal 
violence, specifically toward Haitian women, are often considered normative relative to human 
rights standards (Rahill, et al., 2020; Verdeli, et al., 2016). For example, domestic violence, 
stalking, and sexual harassment is legal, while rape is the only illegal crime but rarely reported due 
to high social stigma (“Human Rights Watch: World Report 2018: Rights Trends in Haiti,” 2017). 
Along these lines, Restavek is a widely-accepted form of child slavery where children are highly 
vulnerable to physical and sexual violence, however, the families have little means or resources to 
support their children where servitude to a wealthy family seems like a safer option (“WHO 
Culture and Mental Health in Haiti: A Literature Review,” 2010). Lastly, while HIV related social 
stigma has improved it has remained another evident challenge to overcome (Castro & Farmer, 
2005; Farmer, 2001). 
Establishment of Primary Care in Haiti  
Routine medical care while available is not always routine. The majority of Haitians 
(90.6%) do have access to primary care within 3 miles of their home and only a limited number 
(23%) live near service delivery sites that have been rigorously evaluated as “good quality” (Gage, 




the public sector healthcare spending is amongst the lowest in the world (Gage, et al., 2016). It is 
incredible the amount of care that Haitians have for each other, otherwise the healthcare system 
would not survive without the dedication of citizens. Community level providers have been the 
cornerstone of medical and mental health for many years (Walton, et al., 2004). Common medical 
concerns in Haiti include HIV (2.1% prevalence) in particular mother to child transmission, 
cholera, tuberculosis (188 per 100,000), and lymphatic filariasis (American Medical Association, 
2015; “Haiti’s Health System — CDC,” 2013; Oscar, et al., 2014; "Partners in Health Haiti”, 
2019). With regard to family planning the resources are limited throughout the country and 
contribute to high rates of maternal and child mortality under the age of 5-years-old (67 per 1,000) 
(Gage, et al., 2016; “Haiti’s Health System — CDC,” 2013; "Partners in Health Haiti”, 2019). 
Routine infant vaccinations are not fully adopted by families, which limit the overall ability to 
control the spread of disease (American Medical Association, 2015; “Haiti’s Health System — 
CDC,” 2013). Despite current outcomes, there have been extensive efforts to rebuild the healthcare 
system following the 2010 earthquake that have not gone unnoticed. Healthcare improvements for 
Haitians have included access to HIV treatment, TB treatment, and an integrated healthcare 
infrastructure coordinated with the Haitian Ministry of Health (“Partners in Health Haiti”, 2019). 
Before Haitian Mental Health Infrastructure: The Role of Religion & Spirituality  
Before the 2010 earthquake, mental health was not part of the primary care infrastructure 
and traditional healers or religious leaders were sought instead (Grelotti, et al., 2015; Tiberi, 2016). 
In 2011, there were two psychiatric hospitals that included Défilé de Beudet Hospital with 120-




oversight (Raviola, 2020). Early mental healthcare was focused on HIV related support and severe 
mental illness. Beyond this, some NGOs and religious organizations delivered mental healthcare. 
Spirituality and religion have always been imbued in Haitian medicine, and mental health. Roman 
Catholicism, Voodoo Priests, and more recently Protestantism are upheld religions in Haitian 
culture (Auguste & Rasmussen, 2019; Blanc, et al., 2016), although for some Haitian’s there is a 
rejection of Christian beliefs and preference for Voodoo because it opposes French colonialism. 
Likewise, African-centered spirituality can at times be misunderstood by the west, and yet often 
is still practiced alongside Christian denominations such as Catholicism and Protestantism 
(Auguste & Rasmussen, 2019). The Voodoo spiritism of Haiti is widely accepted where concepts 
of self-include “pitit bon anj" (little good angel), the “gwo bon anj” (big good angel), and the “kò 
kadav” (body cadaver) that are meant to harmonize together (“WHO Culture and Mental Health 
in Haiti: A Literature Review,” 2010). Mental health is often based on such Cosmo centric values 
that spirit when aligned with the natural order of the universe will provide good health. In many 
ways, these beliefs parallel other religions and notions of spirituality (e.g., Holy Trinity, Karma, 
or Archangel Gabriel/Gavriʾel/Jibrail).  
It is widely accepted in Haiti that the root cause of mental health problems can also be due 
to a hex or curse rather than be biological in nature (Sterlin, 2006; Tiberi, 2016), especially with 
regard to epilepsy (Cavanna, Cavanna, & Cavanna, 2010; Obeid, et al., 2012). This has led to 
human rights abuses where people with psychosocial disabilities will be chained or “shackled,” 
and family support becomes the only available or understood mental healthcare for the affected 




that three out of four Haitians would prefer to seek community care instead of clinical care for 
mental distress, despite average treatment costs at $1 for hospitals, $6 herbal healers, and $120 
Voodoo Priests (Wagenaar, et al., 2012). Spiritual views of mental health persist, and lead to 
difficulty for Haitian’s to report suicidal thoughts to mental healthcare providers, despite frequent 
reports of completed suicides there has been continued preference to report such symptoms to 
religious leaders and traditional faith healers (Auguste & Rasmussen, 2019), which suggests there 
needs to be increased psychoeducation for community members and collaboration. The role of 
spirituality and religion in Haiti are therefore important considerations for mental health treatment 
















LCA and Mental Disorders  
Latent class analysis provides a novel data-driven approach to examine mental disorders 
where subgroups inform clinical treatment targets. In previous latent class analyses, the majority 
of studies have been on upper-middle or high-income samples from the United States, UK, 
Switzerland, Australia, France, Brazil, and China (Kendler, et al., 1998; Li, et al., 2014; Pignon, 
et al., 2017; Ulbricht, et al., 2018; Weich, et al., 2011). A study that used a latent transition analysis 
to examine cross-country depression prevalence included only one LMIC in Nigeria, which 
showed exceptionally low rates of depression prevalence when compared to three higher income 
countries (The United States, New Zealand, and South Africa) (Scorza, Masyn, Salomon, & 
Betancourt, 2018). Potential reasons for the lower depression rates reported in this study may have 
been attributed to differing illness presentations when compared to other cultures, or perhaps 
Nigerians are more resilient. Further, the age of onset was older for Nigerian adults, and perhaps 
there was simply a lack of endorsement to the initial screening questions that are necessary for 
further diagnostic evaluation on the WHO WMH-CIDI (Gureje, Lasebikan, Kola, & Makanjuola, 
2006; Scorza, et al., 2018).  
LCA studies have mostly focused on a single diagnosis. LCA research literature in mental 
health predominantly pertains to major depression and results have been inconsistent, which is 
likely due to the varied indicators included in the model (Li, et al., 2014; Ulbricht, et al., 2018). A 
few LCA studies exist on psychosis specifically (Kendler, et al., 1998; Pignon, et al., 2017), 




however, the results are consistent and support a psychotic continuum. LCA studies on epilepsy 
are nascent and include associations with an autism comorbidity (Cuccaro, et al., 2012). LCA 
studies that include more than a single diagnosis have supported a 2-factor model for 
internalizing/externalizing disorders that emphasize research more on psychopathological 
processes as opposed to diagnostic specificity (Krueger, et al., 1998). Building upon this research 
another study examined how bipolar disorder and psychotic disorders fit into this structure of 
internalizing/externalizing disorders and relate to each other (Vaidyanathana, Patrick, & Lacono, 
2012). The results while preliminary suggest again internalizing/externalizing disorders are 
distinct subgroups, and separately there may be more of a continuum with bipolar disorder and 
psychotic disorders (Vaidyanathana, Patrick, & Lacono, 2012). The dimensional approach has 
been adopted by global mental health research for quite a while, which emphasizes the 
categorization of CMDs, SMDs, and NCs. Internalizing/externalizing disorders would fit into the 
CMDs categorization. Substance and alcohol use disorders in global mental health literature have 
been considered separately, and in the mentioned LCA studies would be considered an 
externalizing disorder. For the present study, substance and alcohol use disorders were not a 
presenting problem.  
Other LCA studies predominantly focus on clinical symptoms only and categorize LCA 
subgroups based on severity (Ulbricht, et al., 2018), without consideration to frequently co-
occurring problems such as suicidality, psychiatric co-morbidity, and functional impairment. A 
few LCA studies on depression have included suicidality and found that suicide, guilt, and 




“moderate” to “severe” had high probabilities of suicidality (moderate=87%; severe=94%), guilt 
(moderate=66%; severe=88%), and hopelessness (moderate=87%; severe=99%) (Yi, et al., 2014). 
Another LCA study on women with post-partum depression from seven countries that were all 
high-income samples (N=17,912), showed for the “severe” latent class subgroup the total suicidal 
ideation was high at 83% with the endorsement of “sometimes” (16%) and “yes, quite often” 
(67%). Interestingly, the “moderate” subgroup rarely had endorsed suicidal ideation as 
“sometimes” (6%) or denied the statement “yes, quite often” (0%). A study from Brazil had a 4-
class solution and showed high rates of psychiatric comorbidity in the presence of high suicidality 
[(class 3: suicidality=15.8%; psychiatric comorbidity=68.2%) (class 4: suicidality=29.4%; 
psychiatric comorbidity=68.4%)] (Cotrena, et al., 2016). Another study revealed comorbidity of 
psychiatric disorders in the UK was as high as 31% (Weich, et al., 2011). This provides a brief 
review of LCA research more generally on mental disorders and the associated features like 
suicidality, psychiatric comorbidity, and again, LCA research has been limited on functional 
impairment. Other LCA limitations have included low methodological quality. For example, a 
study that examined co-occurring psychiatric disorders in Brazil, which is important to better 
understand but the sample size was not large enough for an interpretable LCA (Villalobos-
Gallegos, et al., 2017). A similar issue presented in a study on epilepsy (Spector, Cull, & Goldstein, 
2001). To our knowledge, this is the first LCA study examining the structure of mental health 
specific to an LMIC and that as recommended based on previous literature examines the 




LCA Model Indicators 
Common Mental Disorders 
Steel and colleagues (2014) completed a systematic-literature review and meta-analysis, 
which reported in 26 high-income countries and 37 LMICs, showed on average, one in five adults 
or 29.2% of the population are affected psychiatrically in their lifetime. The mental health 
treatment gap for CMDs has revealed inadequate mental healthcare coverage for those living in 
high-come countries 72%, upper-middle income 79%, lower middle-income 86%, and low-income 
93% (Chisholm, et al., 2007). The definition of CMDs according to the NICE Guidelines include 
generalized anxiety disorder, panic disorder, phobias, social anxiety disorder, obsessive-
compulsive disorder, and post-traumatic stress disorder (National Collaborating Centre for Mental 
Health UK, 2011). PTSD has been difficult to assess in a global context due to chronic stress and 
sociocultural determinants. Somatization often presents as a symptom in anxiety related disorders 
or major depression and therefore, are frequently a feature of CMDs. The comorbidity of 
depression and anxiety related disorders may lead to worse clinical outcomes (National 
Collaborating Centre for Mental Health UK, 2011), and high-income samples have shown this is 
likely an indicator of treatment resistant depression (Fava & Davidson, 1996). Issues of diagnostic 
specificity are less tenable globally due to screening and diagnostic measures that are not culturally 
adapted, and such specificity may not initially be necessary to determine care pathways. Therefore, 






Severe Mental Disorders 
 Depression has often been categorized as a CMD except when present with psychotic 
features or hypomanic/manic episodes. This would instead indicate bipolar disorder, psychotic 
related disorders, schizophrenia spectrum disorders, or major depressive disorder with psychotic 
features, which would instead be categorized as an SMD. For severe mental illnesses, such as 
schizophrenia spectrum disorders, psychotic related disorders, or major depression with psychotic 
features around 23 million people are affected worldwide, whereas bipolar disorder is 
diagnostically more common affecting around 60 million people globally (WHO “Fact Sheet 
Mental Disorders,” 2018). The research on SMDs globally while minimal deserves further 
consideration given the increased likelihood of human rights abuses. It is not rare for people with 
SMDs to be tied to poles, shackled, institutionalized for extended periods of 10 years or more, or 
left with limited to no social contact (Patel & Prince, 2010; Raviola, et al., 2020). The research to 
date has mostly focused on schizophrenia with limited knowledge on the identification and 
treatment of SMDs generally. The SMD population tends to have shortened lifespans potentially 
due to comorbid physical conditions (WHO, 2017).  
Neurological Conditions 
Importantly, CMDs and SMDs as mentioned account for the highest proportion of DALYs 
(56.7%) which is then followed by NCs (28.6%) (Whiteford, et al., 2015). Likewise, neurological 
conditions, epilepsy, and dementia are not uncommon in the presence of depression but are poorly 
understood in global contexts (Kanner, 2006; Lipton et al., 2000; Rickards, 2006). It should be 




extend beyond the focus of this brief research summary and were not presenting problems in the 
present study. First, dementia affects 47 million people and 63% of those affected live in LMICs. 
Dementia has been linked to a loss of independence where 50% of individuals become reliant on 
a caregiver with aggressive behavior, hallucinations, repetitive actions, and wandering in the later 
stages of the illness (Thakur, et al., 2016). Second, epilepsy prevalence and severity has been 
shown to be much higher (80%) in LMICs including Haiti (Collaborators, G. B. D. E., 2019; “Fact 
Sheet Epilepsy,” 2019). Epilepsy and convulsions have a range of causes that include road traffic 
accidents, infectious diseases (e.g., malaria), tumors, stroke, autoimmune diseases, genetics, and 
birth related injuries (Thakur, et al., 2016).  
These issues are exacerbated in LMICs especially with a lack of quality hospitals, 
neurologists, psychiatrists, nurses or simply the necessary medications nearby. It is estimated that 
up to 70% of individuals with epilepsy could live seizure-free with proper screening and 
medication treatment (“Fact Sheet Epilepsy,” 2019). The severity of this problem extends past 
barriers such as treatment access. Other issues of sanitation, limited water access, and food 
insecurity likely influence the onset or illness course of NCs globally. For example, in Western 
Uganda, South Sudan, and Tanzania an illness called Nodding Syndrome (NS), a rare form of 
epilepsy, though the cause is not clearly defined likely is due to an inappropriate immune response 
to parasitic worms (Friedrich, 2017). Individuals with epilepsy are another group at high-risk for 
further mistreatment that include limiting ones right to drive, work, or shackled (Collaborators, G. 
B. D. E., 2019; “Fact Sheet Epilepsy,” 2019). The experience of seizures in Haiti has often been 




access to psychiatric medication as it does not fit the cultural explanation of the illness (Cavanna, 
Cavanna, & Cavanna, 2010; Obeid, et al., 2012).  
Depression Symptoms  
The Zanmi Lasante Depression Screening Inventory (ZLDSI) provides a screening tool for 
depression and has been validated for use with school-age youth in Haiti (Legha, et al., 2020). The 
measure has been broadly used in Haiti by PIH and ZL (Fils-Aimé, et al., 2018; Legha, et al., 2020) 
and further for research on Haitian experiences as immigrants in the United States (Fanfan, et al., 
2020). ZLDSI items were mostly adapted from the PHQ-9 and followed the recommended WHO 
translation guidelines from English to Haitian Creole. For example, on item–7 for the PHQ-9 
“trouble concentrating on things, reading the newspaper or watching television” was changed to 
“listening to the radio or attending a ceremony” because of limited literacy and poverty 
(Rasmussen, et al., 2015). The other ZLDSI items use local idioms to reflect culturally adapted 
expressions of depression. The local idioms were developed by key informants that consisted of 
six Voodoo priests/priestesses (five men, or houngan, one woman, or manbo), one herbalist (doktè 
fey, a man), one sacristan (a man), one primary care doctor (a man), two teachers (both men), and 
two respected community members (both women) (Rasmussen, et al., 2015). Hougan and manbo 
are “male and female specialists in serving the spirits” (Brodwin, 1996). The key informants shared 
with researchers the problems people in the community frequently seek healing for and items were 
selected that reflected descriptions of depression. The final 13-item measure has provided a 
depression screening tool that has been well-received by healthcare providers and patients 




by the measure despite screening access. Many locals continue prefer to share suicidal ideation 
with religious leaders, traditional healers, or herbalists Doktè fey (Auguste & Rasmussen, 2019, 
which suggests the need for further integration of these local providers into the mental healthcare 
infrastructure. 
Functional Impairment  
Mental and substance use disorders are the leading cause of non-fatal disease burdens 
globally (Whiteford, et al., 2010). The World Health Organization further reports that depression 
is the leading cause of functional impairment globally (Greer, Kurian, & Trivedi, 2010; Edlund, et 
al., 2018; WHO, 2017). The illness course of major depression tends to be chronic and recurrent 
contributing to the high global disease burden (Miret, Ayuso-Mateos, Sanchez-Moreno, & Vieta, 
2013). The tremendously high burden of mental disorders is exhausted to a greater extant by the 
direct and indirect treatment costs (Miret, et al., 2013), which are further exacerbated by functional 
impairment. CMDs, SMDs, and NCs limits one’s ability to make household contributions and 
therefore drive social inequities that have the potential to become permanent without mental health 
treatment (Emerson, et al., 2011). Treatment studies to date often emphasize psychological 
symptom relief rather than improvement in role functioning, which can be problematic for many 
reasons (McKnight & Kashdan, 2009). Nevertheless, recent studies particularly in the global 
mental health literature now consider role functioning a key measure of treatment efficacy 
(Habtamu, et al., 2018; Hamdani, et al., 2017; Jordans, et al., 2019; Murphy, et al., 2017). The 




Scale (SDS), Disability Adjusted Life Years (DALYS), and World Health Organization Disability 
Assessment Schedule (WHODAS).  
Suicidality 
As described a diagnosis of major depression presents with the endorsement of suicidality 
in about 50% of cases (Ferrari, et al., 2014). To highlight, the absolute necessity for mental health 
treatment access in developing countries, 78% of completed suicides occurred in LMICs 
(Bachmann, 2018), where the most common method was self-poisoning with pesticides (WHO, 
2018). Known risk factors in global health for suicide include living in a rural area, 15-29 years of 
age, impulsivity, female gender, traumatic life events, marginalized groups (e.g., LGBTQ, 
prisoners), and history of a previous suicide attempt (WHO, “Fact Sheet Suicide,” 2018). In 
LMICs a systematic literature review by Lemmi and colleagues (2016) further assessed suicidal 
ideation and completion with the relationship between poverty, unemployment, and at the country 
level economic crisis and instability. The results, consistently showed that individual level poverty 
and unemployment increased the risk for suicidal ideation and behavior. It was unclear, whether 
economic instability for a country impacted these results, which were possibly due to confounding 
variables, and while challenging to disentangle such complexities that are likely interrelated 
factors.  
Psychiatric hospitalization in high-income samples increase the likelihood of future suicide 
attempts, particularly in the first 3-months following hospital discharge (Chung, et al., 2017). In a 
global context, psychiatric inpatient units are not usually accessible, or may have minimal human 




within primary care to reduce suicide risk. Nock and colleagues (2010), have shown that when 
controlling for psychiatric comorbidity major depression was the strongest predictor of suicide. 
However, a secondary diagnosis of anxiety showed impulse control disorders (e.g., oppositional 
defiant disorder, conduct disorder, attention deficit hyperactivity disorder, and intermittent 
explosive disorder) and substance use disorders significantly increased the likelihood of a suicide 
plan or attempt. Environmental risk factors (e.g., war, economic instability, lack of sanitation) may 
impact a sense of hopelessness and potentially increase the likelihood of suicidality. Taken 
together, screening for suicidal ideation and safety planning should become standard practice for 
CMDs, SMDs, and NCs to be effective at reducing suicide risk globally.  
Predictor Variables: Demographic Characteristics and Clinical Symptoms  
Gender and Mental Disorders  
CMDs disproportionately affect women, and for depression the risk of developing the 
disorder has been continuously found to be 1.5 to 2.5 times higher for women when compared to 
men (Kessler, 2003; National Collaborating Centre for Mental Health, 2011). In Haiti, the results 
to date show that women who are unmarried and educated are more likely to be depressed, 
however, male depression was slightly higher when there was a history of childhood maltreatment 
(Martsolf, 2004; Wagenaar, et al., 2012). Women living in rural parts of Haiti had higher scores 
on a culturally adapted version of the Beck Depression Inventory (BDI) (Wagenaar, et al., 2012). 
These symptoms worsened if they had lost a family member in the earthquake or believed spirits 
had caused their depression. Globally, the reasons for increased risk of CMDs amongst women 




potential history of childhood maltreatment, and greater likelihood of poverty (Weich, et al., 2011; 
Patel, et al., 2007). Taken together, these factors impact the prognosis of mental disorders 
especially depression, and likely worsen in the context of chronic stress environments. For SMDs 
and NCs gender differences are not notable. With consideration to severe mental illness, gender 
rates typically are consistent for men and women however, this part of the global literature often 
considers diagnoses of bipolar disorder and schizophrenia only, which affects less than 2% of the 
population worldwide (World Health Organization, 2013). Other SMDs to consider include major 
depression with psychotic features and psychotic spectrum disorders. The research globally on the 
gender differences for neurological conditions is growing, and epilepsy has shown mixed evidence 
that unprovoked seizures could be higher in men (WHO, “Fact Sheet Epilepsy,” 2019).    
Age and Mental Disorders    
There is very limited information on basic demographics and the relationship to mental 
health outcomes, especially in rural parts of Haiti (Wagenaar, et al., 2012). Other LMIC studies 
have indicated that younger age (18-25) (WHO, 2014) or in India older age (Patel, et al., 2012) 
may increase the likelihood of depression, however, generally the frequency of mood episodes 
decreases with age (Kessler & Bromet, 2013; Patten, et al., 2006; Weissman, et al., 1996). A large-
scale study from Marwaha and colleagues (2007) in the UK looked at the Adult Psychiatric 
Morbidity Survey (APMS) and found that mood instability was the highest for ages 16-24 (26%), 
and gradually decreased thereafter (ages 25-34, 19.5%; 35-44, 15.4%; and 45-54, 14.7%). The 
lowest rate of mood instability was for individuals 75 or older (3.6%). There may be a difference 




countries vs. LMICs where it appears to increase. Reasons for this might include further financial 
destitution with older age in LMICs, or seeking mental health treatment for the first time later in 
life. Overall, mental disorders affect individuals across the lifespan globally.   
Psychotherapy Received  
Over the past 15 years interpersonal psychotherapy (IPT) has expanded globally to India, 
Chile, Uganda, Lebanon, United States, Kenya, Colombia, Israel, Nepal, Kenya, and continues to 
grow (Rose-Clarke, et al., 2020; Verdeli, 2016). Research studies have shown the benefit of IPT 
for the clinical treatment of depression and other mental disorders in LMICs and economically 
developed countries (Markowitz, et al., 2015; Verdeli, 2016). IPT offers a flexible treatment that 
has been applicable to a range of countries, participants, and settings (Opiyo, et al., 2016; Verdeli, 
2016). When relevant IPT further integrates the role of family, traditional healers, community 
leaders, and spiritual beliefs into the sessions (Verdeli, 2016). IPT has been delivered individually 
and in group settings to focus on the main triggers of depression such as role transitions, grief and 
loss, interpersonal disputes, or the development of interpersonal social skills (Lewandowski, et al., 
2016; Verdeli, 2016). Provided the many research studies that have shown evidence-based support 
for IPT treatment, the present study wanted to understand the level of treatment engagement when 
adapted to provide mental healthcare for a Haitian population (Raviola, et al., 2020; Verdeli, 2016).  
Psychiatric Medication 
The WHO Mental Health Gap Action Programme (mhGAP) aims to close the mental health 
treatment gap globally. As mentioned previously one of the largest problems for delivering 




neurologists, and nurses. In many emerging countries there are only 1-2 psychiatrists per 100,000 
people, which limits mental health treatment access even when there are primary care facilities 
nearby (Rathod, et al., 2017). Further, while feasible to scale-up mental health treatment the lack 
of availability in some areas and cost of psychiatric medications has been a major treatment barrier, 
especially when many individuals live off only $1-2 per day (Chisholm, et al., 2016). As mentioned 
the task-sharing models provide a solution to expand training and to properly allocate resources 
based on illness severity. Further, when services are delivered in coordination with the government 
or NGOs this provides an opportunity to provide free mental healthcare, which has the added 
benefit of increased work productivity for the country. Research on the use of psychiatric 
medication in global mental health literature is limited, and including such research with a Haitian 
population will allow us to better understand the needs and necessary resources to target mental 
disorders.  
Number of Visits During Observation Period  
Research on task-sharing models have shown improved clinical outcomes consistently with 
an average of 10 training days prior to treatment delivery (Singla, et al., 2017). In addition, the 
number of psychotherapy sessions typically went up to 10 appointments to have observed clinical 
improvement and were held for 1-hour each over the course of 2-3 months (Singla, et al., 2017). 
IPT was the primary treatment delivered in this study and patients received the time-limited 
treatment for 12-16 weeks with 1-hour sessions (Markowitz & Weissman, 2004). An IPT brief 
(IPT-B) model has shown improved clinical outcomes after 8-sessions (Swartz, Grote, & Graham, 




maintenance sessions (Frank, et al., 1990). Global settings may present other challenges for mental 
health treatment engagement such as the cost to travel to the appointment, competing needs such 
as attending or seeking work, simply seeking food and water, social stigma, and the cost of ongoing 
























  To explore the characteristics of mental health patterns in Haiti, that to date are unknown. 
The majority of research thus far has focused on the development of a community mental 
healthcare infrastructure and validation of screening measures. Further, existing treatment studies 
are often for a specific diagnosis and since mental healthcare services in primary care are new the 
research has been nascent.  
Aim 1. To describe critical demographic factors (gender, age), clinical characteristics (depression 
symptoms, functional impairment, suicidality), and the primary and secondary ICD-10 diagnoses 
of mental health in Haiti. Treatment utilization was examined based on the primary diagnosis and 
patients were categorized as CMDs, SMDs, and NCs to look at the number of patients and 
percentage of service use for psychotherapy, psychiatric medication type/dose/frequency, 
delivered treatment location, provider type, and the number of visits during the observation period 
of an understudied population. 
Hypothesis 1a. Descriptive statistics will provide key data about the mental health 
treatment needs of clinical subgroups in Haiti.  
Hypothesis 1b. Preliminary Pearson’s correlation and chi-square tests will show 
statistically significant group differences for descriptive and clinical symptoms when 
compared to common mental disorders, severe mental disorders, and neurological 
conditions.  




Aim 2. To use an LCA to examine mental health classes based on 6 indicators: Common Mental 
Disorders, Severe Mental Disorders, Neurological Conditions, Level of Functional Impairment, 
Depression Symptom Severity, and Suicidality. 
Hypothesis 2. Based on previous research results have recommended to include 
functional impairment, more than a single diagnosis that expands upon the 2-factor model 
with CMDs, SMDs, NCs, and to move beyond symptom severity only. To our knowledge, 
this is the first LCA study specific to the structure of mental health in a LMIC and global 
mental health setting. For these reasons, the LCA analysis was considered exploratory.  
Aim 3. To use post-hoc multinomial logistic regression models to predict mental health class 
selection and correlates based on MLR model 1 demographic variables: Gender, Age, 
Psychotherapy Received, Psychiatric Medication Received, and Number of Visits During 
Observed Period.  To also use post-hoc multinomial logistic regression models to predict mental 
health class selection and correlates based on MLR model 2 clinical symptom variables: Clinically 
Depressed, Functional Impairment, and Suicidality. 
Hypothesis 3a. Post-hoc MLR model 1 descriptive predictor variables will estimate 
correlates of the unknown mental health classes with varying associations of lower or 
higher odds.  
Hypothesis 3b. Including predictor variables from model 1 in the analyses will show better 




Hypothesis 3c. Post-hoc MLR model 2 clinical symptom predictor variables will estimate 
correlates of the unknown mental health classes with varying associations of lower or 
higher odds.  
Hypothesis 3d. Including predictor variables from model 2 in the analyses will show better 























Nine-hundred fourteen patients EHR data met criterion for a primary mental health 
diagnosis (ICD-10) and completed clinical measures, such as the ZLDSI and WHODAS therefore 
were eligible for the present evaluation. Patients were seen in the mental health department of a 
hospital or clinic setting in Haiti. Patients were referred by community providers, clinical staff, 
other medical personnel, and traditional healers. The institutional review boards of participating 
sites that included Partners in Health, Zanmi Lasante, and Teachers College, Columbia University 
approved all study procedures. The data collection period was from January 2016 to August 2018. 
The EHR was recently established and patients may have been seen prior to the data collection 
period. The dataset was presented in Haitian Creole and English. To be eligible, for data inclusion 
patients had to be 18 years or older and have a primary mental health diagnosis (ICD-10) at the 
first recorded visit. Patients were excluded if they did not complete the ZLDSI or WHODAS. No 
patients were excluded based on primary mental health diagnosis or clinical symptom severity. 
Thus, 914 patients out of the 4,488 patients who were seen during the data collection period were 
included in the data analysis. 
Procedures  
Beginning in 2010 there was a collaborative response to the devastating 2010 earthquake, 
to build a mental health infrastructure by ZL the frontline healthcare team, PIH at Harvard 
University, the Global Mental Health (GMH) Lab at Teachers College, Columbia University, the 




Haitian Ministry of Health, and Grand Challenges Canada (GCC) (Legha, et al., 2013; Raviola, et 
al., 2012). PRogramme for Improving Mental healthcarE (PRIME) was a consortium that used the 
Theory of Change (ToC) (Belkin, et al., 2011; Breuer, et al., 2016) to develop integrated mental 
healthcare systems for primary care in LMICs and introduced these key strategies: (1) assess the 
context; (2) identify and map priority care pathways; (3) specify decision support tools; (4) develop 
management infrastructure and use quality improvement practices; and (5) address sustainability, 
research, and capacity-building (see figure 1). Belkin and colleagues (2011) provided a task-
sharing  framework that scales the co-created ToC for mental health services using a 5X5 model 
(see figure 2). The 5X5 model delivers skills packages that determine the appropriate level of care 
that include: (1) case finding & screening, psychoeducation, follow-up visits for individuals below 
the clinical threshold, (2) community health care and undergraduate level (e.g., psychology or 
social work) to deliver interpersonal psychotherapy, (3) psychiatric medication evaluation and 
interpersonal psychotherapy, (4) acute or severe cases with psychiatric medication management 
by a primary care physician and interpersonal psychotherapy treatment, and (5) expert mental 
health care providers to ensure treatment progress and provide quality oversight. The initial clinical 
care pathway by ZL and PIH focused on treatment for depression and later was adapted to include 
mental health care pathways for epilepsy and psychotic disorders (see figures 3-5). EHR data was 
utilized in the study, and variables included primary and secondary ICD-10 diagnoses, clinical 
measures of depression (ZLDSI), functional impairment (WHODAS), and suicidality. 




points were psychiatric medication type/dosage/frequency, provider type, number of visits during 
observation period, psychiatric medication received, and psychotherapy received.  
Procedures Study 1––Sample Characteristics and Preliminary Analyses.  
Gender was recorded as “1” for female or “0” for male and the age with month/day/year 
of birth was recorded. Age was categorized as 18-27, 28-35, 36-64, and 65 years or older. The 
ZLDSI “none or mild depression symptoms” were scores of 12 or fewer, and “moderate to severe 
depression symptoms” were scores of 13 or more. The WHODAS “no impairment” were scores 0 
to 12, and “mild to severe” functional impairment were scores of 13 or more. Suicidality was coded 
“1” for yes, or “0” as no based on the ZLDSI item-12 (see “LCA Indicator Suicide” for full 
description below). 































































































The psychotherapy received variable was coded “1” for yes, or “0” as no, and the psychiatric 
medication received variable was coded “1” for yes, or “0” as no. Diagnostic categorizations are 
described in the “LCA Indicators” section below. Delivered treatment location included 13 sites 
from urban and rural parts of Haiti. Provider type included social workers, psychologists, 
medical doctor (generalist), psychologists, and nurses. Patients that required higher levels of 
support with collaborative care team have more than one provider type. The number of visits 
during the observation period ranged from 1-26. The psychiatric medication types included: 
anxiolytics, antidepressants, anticonvulsants, and antipsychotics with the associated dosage and 
frequency.  
Procedures Study 2––LCA Indicators  
Common Mental Disorders, Severe Mental Disorders, and Neurological Conditions. 
Standardized semi-structured clinical interviews from PIH and ZL provided the information on 
psychiatric diagnoses and descriptives. The primary and secondary diagnoses were based on the 
ICD-10, and after were categorized as CMDs, SMDs, and NCs, which was aligned with previous 
literature. CMDs according to the NICE Clinical Guidelines include generalized anxiety disorder, 
panic disorder, phobias, social anxiety disorder, obsessive-compulsive disorder, and post-
traumatic stress disorder (National Collaborating Centre for Mental Health, 2011). SMDs include 
psychosis, schizophrenia, bipolar disorder, and major depression with psychosis (WHO, 2017). 
NCs include epilepsy, Alzheimer disease and other dementias, cerebrovascular diseases including 




neuroinfections, brain tumors, traumatic disorders of the nervous system due to head trauma, and 
neurological disorders as a result of malnutrition (Kanner, 2006; Lipton et al., 2000; Rickards, 
2006; WHO “Mental Health: Neurological Conditions”, 2016). Secondary diagnoses were not 
included as a model indicator but this information was included within the primary diagnosis 
category to provide further characterization of the LCA subgroups. LCA model indicators included 
CMDs, SMDs, and NCs that were binary coded as “1” for yes, or “0” as no.   
Zanmi Lasante Depression Symptom Inventory Range (ZLDSI). The ZLDSI 
depression 13-item screening tool has scores that range from 0 to 39 (Rasmussen, et al., 2015). 
The measure sensitivity score ranges, from 12 to 14 but may not have diagnostic specificity. 
Therefore, the depression total scores for “mild symptoms” were 1-12. The cutoff score of 13 was 
used and would indicate a treatment referral that followed the Depression Care Pathway and 
Epilepsy Care Pathway. Elevated symptom scores for the care pathways were “moderate” 13-17, 
“less acute” 18-27, and “acute” 28-39. The LCA indicator was based on the ZLDSI total score and 
coded as binary “1” for mild to severe depression, and “0” when the score was no to mild 
depression symptoms. Each individual item was scored on a four point 0–3 scale and intended to 
measure the frequency of distress in the past two weeks, from “not at all” (di tou), “for a few days” 
(pandan kèkjou), “more than one week” (plis pase yon semèn), to “almost every day” (preske chak 
jou). The measure was developed to reflect local idioms that describe psychological symptoms 
specific to Haiti. For example, symptoms of anxiety or depression were described as “ke” or heart 
problems and psychosis are “te” or head problems. A Haitian-American doctor fluent in French 




2013). The idioms and translation were checked to ensure the measure reflected cultural norms. 
The measure showed high internal consistency and construct validity with a Cronbach’s alpha of 
.89. The measure was validated for parts of rural Haiti, and recently validated for a school-age 
population (Legha, et al., 2020).  
Suicidality. Individuals were screened for suicidality using the ZLDSI. ZLDSI item-12 
“ou di nan tèt ou: Pito-w te mouri, oubyen ou gen lide pou fè tèt-w mal” or “you say to yourself: 
you'd rather die, or you intend to hurt yourself.” Responses of “non” or “no” were coded 0, and 
“oui” or “yes” were as coded 1. If suicidal ideation was endorsed each patient was evaluated further 
and collaboratively established a safety plan with their healthcare provider. 
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). The 
WHODAS 2.0 was developed and measures functional impairment in global settings (Üstün, 
Kostanjsek, Chatterji, & Rehm, 2010). The 12-item measure has an individual item score that 
ranges from 0–4, and total score that ranges from 0–48. Andrews and colleagues (2004) manuscript 
provide scoring cutoffs and normative data for the 12-item measure. In “simple scoring,” the scores 
assigned to each of the items include: “none” (0), “mild” (1), “moderate” (2), “severe” (3), 
“extreme” or “cannot do” (4) and are summed. There are 6 domains that include: cognition, 
mobility, self-care, getting along with others, life activities, and participation. WHODAS total 
scores 1–4 were considered “mild functional impairment.” The cutoff score of 5 or more was 
determined to be in the clinical range, and total scores of 5–9 were categorized as “moderate 
functional impairment,” and total scores of 10–48 were categorized as “severe functional 




(WHO, 2013). The LCA indicator was based on the WHODAS total score and coded as binary 
“1” for mild to severe functional impairment, which follows the simple scoring method and “0” 
when the score indicated no functional impairment.  
Procedures Study 3––Predictor Variables 
Demographic Characteristics (MLR Model 1). The predictor variables included gender 
(female/male), age (continuous), psychotherapy received (yes/no), psychiatric medication 
received (yes/no), and number of visits during the observation period (continuous). 
Clinical Symptoms (MLR Model 2). The predictor variables included clinically 
depressed (continuous), functional impairment (continuous), and suicidality (yes/no).   
Data Analysis 
Data Analysis Study 1– Sample Characteristics and Preliminary Analyses 
Descriptive statistics include gender (female/male), age (18-27; 28-35; 36-64; 65+), 
depression (ZLDSI) “none or mild depression symptoms” and “moderate to severe depression 
symptoms”, functional impairment (WHODAS 2.0) “no impairment” and “mild to severe 
functional impairment”, suicidality (yes/no), psychotherapy received (yes/no), and psychiatric 
medication received (yes/no). The primary diagnosis and secondary diagnosis are presented within 
the indicator category (CMDs, SMDs, NCs). Delivered treatment location, provider type, number 
of visits during the observation period, psychiatric medication 1 and medication 2  were presented 
within the primary diagnosis indicator category (CMDs, SMDs, NCs). Psychiatric medication and 
dosage were included. The tables included the sample size and percentiles. Pearson’s correlation 




Data Analysis Study 2–Latent Class Analysis (LCA) 
A latent class analysis identifies underlying subgroups or class membership within a large 
sample size dataset with binary or continuous outcomes (Chih-Chien, 2006; Sullivan, Prescott, & 
Kendler, 2002). Nine-hundred fourteen patients were included in the LCA analysis with indicators 
that were known characteristics of mental health. The estimates of fit will be determined using 
the Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) to compare 
models, both of which are acceptable for interpretation (Wang & Lin, 2006). There is evidence, 
however, that suggests the BIC while more complex selects the correct model most often the first 
time (Nylund, Asparouhov, & Muthén, 2007) because it has stricter criteria, and penalizes 
incorrect models more often. By comparison the AIC while interpretable may overestimate the 
model by selecting a higher number of classes. The smaller values of AIC and BIC will mean the 
more interpretable results as it provides identification of distinct latent classes (Akaike, 1973). 
While the variables included in an LCA analysis can be continuous or categorical, in these analyses 
the indicators will be binary. LCA indicators included CMDs, SMDs, NCs, Depression, 
WHODAS, and Suicidality. Interpreted in the model were the AIC, BIC, ABIC, VLMR, and 
BLRT. The LCA class membership is determined based on the response patterns of each 
participant in the study. Therefore, the model with r observed binary items, u, has a categorical 
latent variable, c, with K classes (Clark & Muthén, 2009). The Adjusted Bayesian Information 
Criterion (ABIC), Vuong Lo-Mendell-Rubin likelihood ratio test (VLMR), and Bootstrap 
Likelihood Ratio Test (BLRT) are all indices that compare the previous model. Each approach 




Rubin, 201; Nylund, Asparouhov, & Muthén, 2007). The ABIC reduces the likelihood ratio tests 
and adjusts the model based on the sample size and provides a more theoretical approach (Nylund, 
Asparouhov, & Muthén, 2007; Yang & Yang, 2007). The VLMR considers that the normal chi-
square difference test is not applicable to compare models (Chen, et al., 2017). Further, the 
Bootstrap Likelihood Ratio Test (BLRT) has been shown to be less likely to produce type I errors 
(Nylund, Asparouhov, & Muthén, 2007). The entropy describes how well the individuals were 
classified into the latent classes, where values closer to 1 indicate a better fit (Celeux & 
Soromenho, 1996). Therefore, to determine the best fitting model class size, convergence, and 
posterior probability were evaluated. As research tools diversify in biomedical research and 
biostatistics, the opportunity to analyze “big data” or large-scale projects has become readily 
available. Therefore, the present study used data-driven results that could potentially inform more 
individualized healthcare practices. The latent class analyses (LCA) was run using Mplus version 
8.2 (Muthén & Muthén, 2017) from a converted CSV file. 
Data Analysis Study 3–Multinomial Logistic Regression (MLR) Models 1 & 2 
Multinomial logistic regression (MLR) expands upon binary logistic regression, as the 
model can include independent variables that are both binary and continuous, and dependent 
variables that represent unordered categories. For the MLR models the predictor variables of 
interest were compared individually to the selected mental health subgroups. For MLR model 1 
predicator variables included gender, age, psychotherapy received, psychiatric medication 
received, and number of visits during the observation period. Continuous predictor variables 




were binary included gender “female=1” or “male=0”, and psychotherapy received or psychiatric 
medication received “yes=1” or “no=0.” For MLR model 2 predicator variables were binary 
“yes=1” or “no=0” and in the clinical range of moderate to severe, which included clinically 
depressed, functionally impaired, and suicidality. MLR model results determine the maximum log 
likelihood through parameter estimates to reduce overall model error (Long & Freeze, 2006; 
Starkweather & Moske, 2011). Sample size, outliers, and multicollinearity should be evaluated in 
the model. The likelihood ratio chi-square tests, compare the full model whereas the Pearson’s and 
Deviance chi-square tests determine the goodness of model fit. Benefits to multinomial logistic 
regression is it does not assume normality, linearity, or the same variance homoscedasticity 
(Starkweather & Moske, 2011). Parameter estimates often consider interpretation of the regression 
coefficients, odds ratios, tests of significance, standard error, and confidence intervals (Osborne, 













Study Aim 1– Sample Characteristics and Preliminary Analyses 
Table 1 provides sample characteristics for the patients (N=914). Patients were mostly 
female 66.7% and ages ranged from 18-27 (33.8%), 28-35 (17.4%), 36-64 (38.9%), to 65 years 
and older (4.6%). The ZLDSI depression symptoms included none to mild symptoms (49.8%) and 
moderate to severe (50.2%). Based on these results 50% of the total sample endorsed moderate to 
severe depression symptoms. The WHODAS functional impairment symptoms included no 
impairment (26.5%), and moderate to severe (73.5%). Nearly 75% of the total sample had mild to 
severe levels of functional impairment, which indicates increased patient debilitation. The results 
indicate difficulty completing or initiating daily tasks such as communicating, bathing, standing, 
eating, or engaging effectively in social relationships. Of the total sample, the majority of patients 
denied suicidal ideation (90%), however, rates were still elevated. Patients in the mental health 
care pathway whom received psychotherapy were 67.1%, and psychiatric medication were 60.3%. 
Psychotherapy was interpersonal psychotherapy and psychiatric medication included 4 categories: 
antidepressants, anxiolytics, anticonvulsants, and antipsychotics.  
Primary Diagnosis and Indicator Categories  
Primary diagnoses were categorized based on global mental health literature as (WHO, 
2017 & 2019) CMDs (n=456), SMDs (n=164), and NCs (n=294) (see table 2). Previous LCA 
literature (Ulbricht, et al., 2018) categorizes the primary diagnosis as the LCA model indicator. 
The CMDs indicator consisted of International Classification of Diseases 10th Revision (ICD-10)  






Note. ZLDSI “none or mild depression symptoms” were scores equal to 12 ≤ or fewer. ZLDSI “moderate to severe 
depression symptoms” were scores equal to 13 ≥ or more. WHODAS “no impairment” were scores 0 to 12 and “mild 
to severe functional impairment” were scores equal to 13 ≥ or more. The ZLDSI follows the scoring established by 
the measure, and WHODAS follows the simple scoring methods based on a sum of total positive scores that indicates 
the patient had some issue with functioning that ranges from mild to severe. Psychotherapy and psychiatric medication 
received were patients who received clinical treatment as part of the mental health care pathway. System missing 






Table 1.  Sample Characteristics (N=914) 
Measure n % 
Gender   
      Female  610 66.7 
      Male 304 33.3 
Age   
     18-27 309 33.8 
     28-35 159 17.4 
   36-64 356 38.9 
     65+ 42 4.6 
Depression (ZLDSI)   
     None or Mild Depression Symptoms 455 49.8 
     Moderate to Severe Depression Symptoms 459 50.2 
Functional Impairment (WHODAS)   
    No Impairment  242 26.5 
    Mild to Severe Functional Impairment 672 73.5 
Suicidality    
    No 823 90.0 
    Yes  91 10.0 
Psychotherapy Received   
    No 301 32.9 
    Yes 613 67.1 
Psychiatric Medication Received   
    No 363 39.7 




primary diagnoses such as major depression, mild to moderate (45.4%), generalized anxiety 
disorder (27.2%), and major depression, severe without psychotic features (14.9%). Less frequent 
were primary diagnoses of acute reaction to a stressor (4.9%), post-traumatic stress disorder 
(3.9%), adjustment disorder (1.1%), psychosomatic disorder (1.1%), mood disorder (0.9%), 
obsessive-compulsive disorder (0.2%), personality disorder, not otherwise specified (0.2%), and 
dissociative conversion disorder (0.2%). The severe mental disorders indicator mostly had primary 
diagnoses that included psychotic disorder (47.6%), major depressive disorder, with psychotic 
features (16.5%), and bipolar disorder, unspecified episode (14.6%). SMDs patients were less 
prone to have a primary diagnosis of bipolar disorder while in a current mood episode, and were 
rarely on the schizophrenia spectrum or had other psychotic disorders. The SMDs indicator 
included patients with a primary diagnosis of bipolar disorder, mania without psychotic features 
(6.1%), delusional disorder (4.9%), schizophrenia (4.9%), bipolar disorder, mania with psychotic 
features (3.0%), and acute and transient psychotic disorder (2.4%). Over 90% of the NCs indicator 
included a primary diagnosis of epilepsy (88.8%) and focal epilepsy (2.7%), whereas patients less 
frequently had migraines (3.1%), dementia (3.1%), intellectual disability (2.7%), pervasive 
developmental disorder (0.7%), and mixed language disorder (0.3%). The indicators for the LCA 
analysis therefore, represented for each primary diagnostic indicator category: CMDs (49.9%), 





Table 2. Primary Diagnosis and Indicator Categories 
 n % 
Common Mental Disorders (CMDs) (n=456)   
Acute reaction to a stressor 22 4.9 
Adjustment disorder 5 1.1 
Dissociative conversion disorder 1 0.2 
Generalized anxiety disorder 124 27.2 
Major depressive disorder, mild to moderate episode 207 45.4 
Major  depressive disorder, severe without psychotic 
features  68 14.9 
Mood disorder 4 0.9 
Obsessive compulsive disorder 1 0.2 
Personality disorder, not otherwise specified 2 0.2 
Post-traumatic stress disorder  18 3.9 
Psychosomatic disorder 5 1.1 
Severe Mental Disorders (SMDs) (n=164)   
Acute and transient psychotic disorder 4 2.4 
Bipolar disorder, unspecified episode 24 14.6 
              Bipolar disorder, mania with psychotic features  5 3.0 
Bipolar disorder, mania without psychotic features  10 6.1 
Delusional disorder 8 4.9 
Major depressive disorder, with psychotic features  27 16.5 
Psychotic disorder 78 47.6 
              Schizophrenia 8 4.9 
Neurological Conditions (NCs) (n=294)   
Dementia 9 3.1 
Epilepsy 261 88.8 
Focal epilepsy 8 2.7 
Intellectual disability  4 1.4 
Migraine  9 3.1 
Mixed language disorder 1 0.3 
Pervasive developmental disorder 2 0.7 
 
Note. Of the total sample (N=914) 49.9% were common mental disorders, 17.9% were severe mental disorders, 
and 32.2% were neurological conditions. Those with a mood disorder were on the bipolar spectrum but did not 




Secondary Diagnosis within the Primary Diagnosis Indicator Categories  
Secondary diagnoses for the total sample were infrequent (19.14%), and while not a model 
indicator, provide further characterization of the primary diagnostic indicator categories (see table 
3). The CMDs indicator, revealed patients had a secondary diagnosis that included generalized 
anxiety disorder (7.7%), major depression, mild to moderate symptoms (4.6%), epilepsy (4.4%), 
major depression, severe without psychotic features (2.0%), adjustment disorder (1.3%), migraine 
(0.9%), post-traumatic stress disorder (0.9%), psychosomatic disorder (0.9%), acute reaction to a 
stressor (0.2%), mood disorder (0.2%), and intellectual disability (0.2%). The CMDs indicator 
rarely had more acute secondary psychiatric disorders such as psychotic disorder (0.9%), bipolar 
disorder, unspecified episode (0.4%), bipolar disorder, mania with psychotic features (0.2%), 
bipolar disorder, mania without psychotic features (0.2%), and delusional disorder (0.2%). For the 
SMDs indicator, secondary diagnoses included major depression, mild to moderate episode 
(4.8%), major depression, severe without psychotic features (1.2%), generalized anxiety disorder 
(1.2%), epilepsy (1.2%), and psychosomatic disorder (0.6%). For the SMDs indicator, a secondary 
diagnosis also included major depression, severe with psychotic features (1.2%), psychotic 
disorder (1.2%), schizophrenia (1.2%), bipolar disorder, unspecified episode (0.6%), and 
delusional disorder (0.6%). For the NCs indicator, the most frequent secondary diagnoses included 
major depression, mild to moderate (5.8%), intellectual disability (1.4%), major depression, severe 
without psychotic features (1.0%), and epilepsy (1.0%). Less often (1% or fewer) for the NCs 
indicator were secondary diagnoses of generalized anxiety disorder (0.7%), acute transient 




depression, severe with psychotic features (0.3%), psychotic disorder (0.3%), mood disorder 
(0.3%), and receptive-expressive language disorder (0.3%). Again, the total sample a comorbid 
psychiatric diagnosis was less common, and the frequency of a secondary diagnosis for each 
primary diagnosis indicator category included: CMDs (12.6%), SMDs (0.03%), and NCs (0.04%). 
 
Table 3. Secondary Diagnosis within the Primary Diagnosis Indicator Categories 
 n % 
Common Mental Disorders (CMDs) (n=115)   
Acute reaction to a stressor 1 0.2 
Adjustment disorder 6 1.3 
Bipolar disorder, unspecified episode  2 0.4 
              Bipolar disorder, mania with psychotic symptoms 1 0.2 
Bipolar disorder, mania without psychotic symptoms 1 0.2 
Delusional disorder 1 0.2 
Epilepsy 20 4.4 
Generalized anxiety disorder 35 7.7 
Intellectual disability 1 0.2 
Major depressive disorder, mild to moderate episode  21 4.6 
Major depressive disorder, severe without psychotic features  9 2.0 
Migraine 4 0.9 
Mood disorder 1 0.2 
Post-traumatic stress disorder 4 0.9 
Psychotic disorder 4 0.9 
Psychosomatic disorder 4 0.9 
Severe Mental Disorders (SMDs) (n=23)   
Bipolar disorder, unspecified episode 1 0.6 
Delusional disorder 1 0.6 
Epilepsy 2 1.2 
Generalized anxiety disorder 2 1.2 
Major depressive disorder, mild to moderate episode 8 4.8 
Major depressive disorder, severe with psychotic features  2 1.2 
Major depressive disorder, severe without psychotic features  2 1.2 





Delivered Treatment Locations within the Primary Diagnosis Indicator Categories 
In terms of service utilization, mental health coverage was provided the most often to 
common mental disorders (49.78%), second to neurological conditions (32.2%), and third to 
severe mental disorders (17.94%) (see table 4). The highest proportion of patient volume was at 
Cange (17%) and Hôpital Universitaire de Mirebalais (15%) across mental disorders, and with 
exception to neurological conditions that have frequent service engagement at Hinche (22.1%). At 
Cange, mental health services were provided the most often to common mental disorders (21.7%), 
second to severe mental disorders (18.9%), and third neurological disorders (8.5%). At Hôpital 
Universitaire de Mirebalais, mental health services were provided the most often to common 
mental disorders (17.3%), second to severe mental disorders (14.6%), and third neurological 
conditions (11.6%). Additionally, for common mental disorders other sites with increased patient 
   
 n % 
Psychosomatic disorder  1  0.6 
Schizophrenia  2 1.2 
Neurological Conditions (NC) (n=35)   
Acute transient psychotic disorder 1 0.3 
Bipolar disorder, mania with psychotic features  1 0.3 
Epilepsy 3 1.0 
Generalized anxiety disorder 2 0.7 
Intellectual disability  4 1.4 
Major depressive disorder, mild to moderate episode 17 5.8 
Major depressive disorder, severe without psychotic features 3 1.0 
Major depressive disorder, severe with psychotic features 1 0.3 
Mood disorder 1 0.3 
Psychotic disorder 1 0.3 




visits were referred for mental health treatment at Saint-Marc HSN (10.7%), Verrettes (8.1%), and 
Saint-Marc SSPE (7.9%). For severe mental disorders, patients frequently visited Belladère 
(11.6%), Cerca (8.5%), Boucan-Carré (7.9%), and Saint-Marc SSPE (7.9%). For neurological  
Table 4. Delivered Treatment Location within the Primary Diagnosis Indicator Categories 
 Common Mental Disorders Severe Mental Disorders Neurological Conditions Row Totals 
 n % n % n % n % 
Delivered Treatment 
Location        
Belladère 24 5.3 19 11.6 21 7.1 64 0.7 
Boucan-Carré 23 5.0 13 7.9 15 5.1 51 0.6 
Cange 99 21.7 31 18.9 25 8.5 155 17.0 
CDI Klinik 
Ekstèn Jeneral 28 6.1 10 6.1 31 10.5 69 0.8 
Centre de Santé 
de Thomonde 9 2.0 5 3.0 27 9.2 41 0.5 
Cerca 30 6.6 14 8.5 17 5.8 61 0.7 








79 17.3 24 14.6 34 11.6 137 15.0 
Petite Rivière 8 1.8 6 3.7 11 3.7 25 0.3 
Saint-Marc HSN 49 10.7 12 7.3 6 2.0 67 0.7 
Saint-Marc 
SSPE 36 7.9 13 7.9 21 7.1 70 0.8 
Verrettes 37 8.1 5 3.0 16 5.4 58 0.6 
Column Totals  455 49.78 164 17.94 294   32.2         913 100 
 
Note. Delivered Treatment Location was the location where mental health treatment was received and not where the 





conditions, patients also visited the CDI Klinik Ekstèn Jeneral (10.5%) and Centre de Santé de  
Thomonde (9.2%). Results suggest, treatment engagement was observed across varied clinic and  
hospital outpatient settings. 
Provider Type within the Primary Diagnosis Indicator Categories 
Treatment service utilization revealed psychologists delivered the majority of services at 
83.04% for common mental disorders, severe mental disorders, and neurological conditions (see 
table 5). There was a lack of service delivery from nurses and social workers, and provisions 
accounted for less than 1% of the total sample. There were few medical doctors available, and 
generalists regularly delivered mental health services rather than psychiatrists given such 
specialists were unavailable. Psychologists and medical doctors (generalists) accounted for 
11.27% of mental health service delivery for the total sample, which aligned with the PIH and ZL 
mental health care pathway. Psychologists and medical doctors (generalists) provided the most 
mental health services to more acute or severe cases that were diagnosed with severe mental 









Table 5. Provider Type within the Primary Diagnosis Indicator Categories 




Conditions Row Totals 
           
 n % n % n % n % 
Provider Type         
   Social Worker  1 0.2 0 n/a 2 0.7 3 0.3 
   Psychologist  405 88.8 136 82.9 218 74.1 759 83.04 





Number of Visits During the Observation Period within the Primary Diagnosis Indicator 
Categories  
To further understand treatment engagement data was included on the number of visits 
during the observation period from 2016–2018. The number of mental health visits during the 
observation period ranged from 1–3 (60.5%), 4–9 (24.62%), and 10–16 (11.38%) for the total 
sample (see table 6). During the observation period 1–3 visits were typical for common mental 
disorders (72.1%). Severe mental disorders (56.1%) and neurological conditions (44.9%) 
frequently attended 1–3 visits during the observation period, which suggests these diagnostic 
groups may not have remained in treatment for a long period of time. Surprisingly, 4–9 visits 
during the observation period were similar across mental disorders: common mental disorders 
(21.3%), severe mental disorders (29.9%), and neurological conditions (26.9%). The longest 
course of mental health treatment, 10–16 visits during the observation period, were for severe 
mental disorders (11.6%) and neurological conditions (19.7%). Provided the psychological 
symptoms are less severe, the common mental disorders (11.6%) group rarely attended 10–16 
        
           
 n % n % n    % n % 
   Medical Doctor (Generalist) 
and Psychologist 33 6.8 15 9.2 55   18.7 103 11.27 
   Nurse and Psychologist  3 0.6 0 n/a 8 2.8 11 1.0 
   Nurse, Psychologist, and 
Medical Doctor (Generalist)  2 0.4 5 3.0 5 1.6 12 1.0 
Column Totals  444 48.58 159 17.4 291 31.8 894 97.81 
 
Note. The percentages for the row and column totals were calculated based on the total sample (N=914). There were 





visits during the observation period. Attending 17 or more visits during the observation period 
accounted for only 3% of the total services delivered for all mental disorders.  
Psychiatric Medication within the Primary Diagnosis Indicator Categories 
The common mental disorders group most frequently were prescribed antidepressants 
(medication 1, n=130, 28.5%; medication 2, n=5, 1.0%) and seldom received antipsychotics 
(medication 1, n=10, 2%; medication 2, n=2, 0.4%), anticonvulsants (medication 1, n=22, 5%; 
medication 2, n=2, 0.4%), and anxiolytics (medication 1, n=2, 0.4%; medication 2, not applicable) 
(see table 7). The severe mental disorders group were most frequently prescribed antipsychotics 
(medication 1, n=115, 70.12%; medication 2, n=4, 2.4%) and rarely received anticonvulsants 
(medication 1, n=7, 4%; medication 2, n=9, 5%), antidepressants (medication 1, n=5, 3%; 
medication 2, n=3, 2%), and anxiolytics (medication 1, n=4, 2.4%; medication 2, not applicable). 
The neurological conditions group were most frequently prescribed anticonvulsants (medication 
1, n=235, 80%; medication 2, n=5, 2%) and infrequently received antipsychotics (medication 1, 
n=10, 3% medication 2, n=1, 1%), and antidepressants (medication 1, n=8, 3%; medication 2, n=2, 
1%). There were no anxiolytics prescribed to the neurological conditions group. Overall, the 
psychiatric medication type comprised of four categories that included the following dosage and 
frequency: (1) antidepressants [Amitriptyline 12.5–50 mg PO, Fluoxetine 10-20 mg PO] (2) 
antipsychotics [Risperidone 0.5–3 mg PO, Haloperidol 0.5–5 mg PO], (3) anticonvulsants PO 
[Phenytoin 100 mg PO–BID; Carbamazepine 100-200 mg BID–TID; Phenobarbital 50–100 mg 
BID–TID] and (4) anxiolytics [Diazepam 5 mg PO] (see table 8). Essential psychiatric medications  





Table 7. Psychiatric Medication within the Primary Diagnosis Indicator Categories  
 Common Mental Disorders 
Severe Mental  
Disorders 
Neurological  
Conditions                Row Totals 
 
Psychiatric 
Medication        1 2 1 2 1 2 1 2 
 n % n % n % n % n % n % n % n % 
Anxiolytic                 
Diazepam 2 0.4 0 n/a 4 2.4 0 n/a 0 n/a 0 n/a 6    1.0 0 n/a 
Anxiolytic 
Columns Total 2 0.4 0 n/a 4 2.4 0 n/a 0 n/a 0 n/a 6 1.0 0 n/a 
Antidepressant                 
Amitriptyline    74 16.2 3 0.7 1 0.6 1 0.6 6 2.0 2 0.7 81 9.0 6 1.0 
Fluoxetine 56 12.3 2 0.4 4 2.4 2 1.2 2 0.7 0 n/a 62 7.0 4 0.4 
Antidepressants 
Columns Total 130 28.5 5 1.0 5 3.0 3 2.0 8 3.0 2 1.0 143 15.6 10 
  
1.0 
Table 6. Number of Visits During Observation Period within the Primary Diagnosis 
Indicator Categories 
   Common Mental     Disorders 
        Severe Mental 
        Disorders 
            Neurological 
          Conditions                   Row Totals 
           n % n % n % n % 
# of Visits During 
Observation Period         
    1-3 329 72.1 92 56.1 132 44.9 553 60.5 
    4-9 97 21.3 49 29.9 79 26.9 225 24.62 
   10-16 27 5.9 19 11.6 58 19.7 104 11.38 
   17-21 2 0.4 1 0.6 19 6.5 22 2.0 
   22-26 1 0.2 3 1.8 6 2.0 10 1.0 






                 
                 
Psychiatric 




n % n % n % n % n % n % n % n % 
 
Phenytoin 1 0.2 0 n/a 1 0.6 0 n/a 22 7.5 1 0.3 24 3.0 1 0.1 
Carbamazepine  18 3.9 2 0.4 6 3.7 3 1.8 195 66.3 3 1.0 219 24.0 8 1.0 
Phenobarbital  2 0.4 0 n/a 0 n/a 0 n/a 18 6.1 1 0.3 20 2.0 1 0.1 
Sodium 
Valproate  1 0.2 0 n/a 0 n/a 6 3.7 0 n/a 0 n/a 1 0.1 6 1.0 
Anticonvulsants 
Columns Total 22 5.0 2 0.4 7 4.0 9 5.0 235 80.0 5 2.0 264 29.0 16 2.0 
     
Antipsychotic                 
Risperidone  8 1.8 2 0.4 92 56.1 3 1.8 7 2.4 1 0.3 107 11.7 6 1.0 
 Haloperidol 2 0.4 0 n/a 23 14.0 1 0.6 3 1.0 0 n/a 28 3.0 1 0.1 
Antipsychotic 
Columns Total 10 2.0 2 0.4 115 70.12 4 2.4 10 3.0 1 1.0 135 14.8 7 1.0 
 
Note. The percentages for the column totals were calculated based on the primary diagnosis indicator: 
common mental disorders (n=456), severe mental disorders (n=164), and neurological conditions (n=294).  
The percentages for the row totals were calculated based on the total sample (N=914). 
 
Table 8. Psychiatric Medication and Dosage 
Psychiatric Medication Type Dose  
 mg Frequency 
Diazepam (anxiolytic) 5 PO 
Amitriptyline (antidepressant) 12.5-50 PO 
Fluoxetine (antidepressant) 10-20 PO 
Phenytoin (anticonvulsant) 100 PO-BID 
Carbamazepine (anticonvulsant) 100-200 BID-TID 
Phenobarbital (anticonvulsant) 50-100 BID-TID 
Risperidone (antipsychotic) 0.5-3 PO 


















Pearson’s Correlation of Descriptive Variables and Primary Diagnosis Indicator 
Categories 
There was a small negative correlation between the neurological conditions and age 
variables (r(3)= –.13, p <.01), and a small positive correlation between common mental disorders 
and age (r(3)= .08, p <.05) variables (see table 9). There was a small positive correlation between 
the neurological conditions and number of visits during observation period (r(3)= .29, p <.01), and 
a small negative correlation between common mental disorders and number of visits during 
observation period (r(3)= –.28, p <.01). There was a moderate negative correlation between 
common mental disorders and neurological conditions (r(3)= –.69, p <.01), and somewhat 
moderate negative correlation between common mental disorders and severe mental disorders 
(r(3)= –.32, p <.01). There was a moderate negative correlation between common mental disorders 
and severe mental disorders (r(3)= –.47, p <.01). The strength of the relationships overall, was 
mostly moderate, which suggest group differences, and that descriptive variables such as age and 
treatment duration had an association with the primary diagnosis that ranged from small to nearly 
moderate. The Pearson’s Correlation of CMDs, SMDs, NCs, and descriptive variables when 
compared to each primary diagnosis indicator category, suggested that further analysis with LCA 





Chi-Square Tests of Descriptive Variables and Primary Diagnosis Indicator Categories 
The present study assessed descriptive variables compared to the primary diagnosis 
indicator categories of common mental disorders, severe mental disorders, and neurological 
conditions. The common mental disorders group revealed differences on gender (χ2(1, N = 456) = 
49.95, p <.01); psychotherapy received (χ2(1, N = 456) = 17.63, p <.01); and psychiatric 
medication received (χ2(1, N = 456) = 229.71, p <.01) (see table 10). The severe mental disorders 
group revealed differences on gender (χ2(1, N = 164) = 6.06, p <.05), psychiatric medication 
received (χ2(1, N = 164) = 32.05, p <.01), and there were no observed differences for psychiatric 
medication received (see table 11).  The neurological conditions group revealed differences on 
Table 9. Pearson’s Correlation of Descriptive Variables and Primary Diagnosis Indicator 
Category 
    1 2 3 4 5 
1 Age 
     
2 Number of Visits During Observation Period 
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–.69**   





















gender (χ2(1, N = 294) = 30.83, p <.01), psychotherapy received (χ2(1, N = 294) = 21.67, p <.01), 
and psychiatric medication received (χ2(1, N = 294) = 134.42, p <.01) (see table 12). 
 
Table 10. Chi-Square Tests of Descriptive Variables and Common Mental Disorders 
Group n (%)             df χ2 
Gender 355 (77.9%) 1 49.95** 
Psychotherapy Received 335 (73.5%) 1 17.63** 
Psychiatric Medication Received 164 (36%) 1 229.71** 
Note. Common Mental Disorders (n=456). Bolded and * p <.05; ** p <.01. 
 
 
Table 11. Chi-Square Tests of Descriptive Variables and Severe Mental Disorders 
Group n (%)             df       χ2 
Gender 96 (58.5%) 1 6.06* 
Psychotherapy Received 111 (67.7%) 1 0.03 
Psychiatric Medication Received 131 (79.9%) 1 32.05** 
Note. Severe Mental Disorders (n=164). Bolded and * p <.05; ** p <.01. 
 
 
Table 12. Chi-Square Tests of Descriptive Variables and Neurological Conditions 
Group n (%)             df χ2 
Gender  159 (54.1%) 1 30.83** 
Psychotherapy Received 167 (56.8%) 1 21.67** 
Psychiatric Medication Received 256 (87.1%) 1 134.42** 





Chi-Square Tests of Clinical Symptom Variables and Primary Diagnosis Indicator 
Categories    
Further we assessed clinical symptom variables compared to the primary diagnosis 
indicator categories that included common mental disorders, severe mental disorders, and 
neurological conditions. The common mental disorders group revealed differences on patients who 
were clinically depressed (χ2(1, N = 456) = 132.45, p <.01), functionally impaired (χ2(1, N = 456) 
= 5.95, p <.05), and suicidal  (χ2(1, N = 456) = 67.04, p <.01) (see table 13). The severe mental 
disorders group revealed differences on suicidal patients (χ2(1, N = 164) = 57.87, p <.01). There 
were no statistically significant differences for severe mental disorders on clinical depression or 
functional impairment (see table 14). The neurological conditions group revealed differences on 
patients who were clinically depressed (χ2(1, N = 294) = 158.16, p <.01), functionally impaired 
(χ2(1, N = 294) = 14.51, p <.01), and suicidal (χ2(1, N = 294) = 160.76, p <.01) (see table 15). The 
chi-square tests on descriptive and clinical symptom variables when compared to each primary 
diagnosis indicator category, have suggested that analysis with LCA and MLR models would be 
appropriate to further assess these differences.  
Table 13. Chi-Square Tests of Clinical Symptoms and Common Mental Disorders 
Group n (%)             df         χ2 
Clinically Depressed   317 (69.5%) 1  132.45** 
Functionally Impaired  351 (77%) 1 5.95** 
Suicidal  10 (2.2%) 1 67.04** 






Table 14. Chi-Square Tests of Clinical Symptoms and Severe Mental Disorders 
Group n (%)             df         χ2 
Clinically Depressed   84 (51.2%) 1 0.08 
Functionally Impaired  128 (78%) 1 2.10 
Suicidal  15 (9.1%) 1 57.87** 
Note. Severe Mental Disorders (n=164). Bolded and * p <.05; ** p <.01. 
 
 
Table 15. Chi-Square Tests of Clinical Symptoms and Neurological Conditions 
Group n (%)             df         χ2 
Clinically Depressed   58 (19.7%) 1 158.16** 
Functionally Impaired  193 (65.6%) 1 14.51** 
Suicidal  66 (22.4%) 1 160.76** 
Note. Neurological Conditions (n=294). Bolded and * p <.05; ** p <.01. 
 
Study Aim 2–Latent Class Analysis (LCA) 
                  The primary aim of the latent class analysis (LCA) was to observe patterns of mental 
health in Haiti. The LCA examined associations of known mental health indicators such as the 
patient’s primary diagnosis, clinical symptoms, and functional impairment. Binary–coded 
indicators in the LCA model included categorizations based on the patient’s primary diagnosis 
such as common mental disorders, severe mental disorders, and neurological conditions. Clinical 
symptoms were binary indicators as well, and included depression severity based on the ZLDSI 
first recorded visit total score, and suicidality determined by item-12 on the ZLDSI. To assesses 
functional impairment the WHODAS first recorded visit total score was included. A series of 




provided interpretation of decreased Akaike Information Criterion (AIC), decreased Bayesian 
information criterion (BIC), and decreased sample-size adjusted BIC (SABIC) values (see table 
16). When comparing the 5-class model to the 6-class model, the 5-class model revealed larger 
AIC and BIC values and therefore was less interpretable. Further, model comparisons included the 
bootstrap methods such as Vuong Lo-Mendell Rubin (VLMR) and Bootstrap Likelihood Ratio 
Test (BLRT). Bootstrap methods were significant for each model run in the LCA series. 
Subsequently, the entropy values revealed model distinction, with further comparisons to the 7-
class model. Results showed that the 7-class model would lose 5.9% of the information criterion 
when compared to the 6-class model that held the most model information criterion. Accordingly, 
the 6-class model was the most interpretable with consideration of the information criterion (BIC, 
AIC, SABIC), bootstrap methods (VLMR, BLRT), and entropy.  
 
Table 16. Fit Indices for Conditional Latent Classes (6-Class Solution) 
Number of 
Classes AIC BIC SABIC VLMR BLRT Entropy 
1 20,232.7 20,276.05 20,247.47    
2 19,139.3 19,226.02 19,168.86 p <.01 p <.01 1.00 
3 18,208.53 18,338.61 18,252.86 p <.01 p <.01 1.00 
4 17,851.62 18,025.06 17,910.73 p <.01 p <.01 1.00 
5 17,519.8 17,736.6 17,593.68 p <.01 p <.01 1.00 
6 17,361.08 17,621.24 17,449.75 p <.01 p <.01 99.3 
7 17,294.7 17,598.22 17,398.14 p <.01 p <.01 93.4 
 
Note. AIC = Akaike Information Criterion; BIC = Bayesian Information Criterion; SABIC = Sample-Size Adjusted 
Bayesian Information Criterion; VLMR=Vuong Lo-Mendell Rubin; and BLRT = Bootstrap Likelihood Ratio Test. 
Indicators Included in the Model: Common Mental Disorders, Severe Mental Disorders, Neurological Conditions, 






The model revealed 6 distinct sub-group classes: two classes with common mental 
disorders (100%), two classes with severe mental disorders (100%), and two classes with 
neurological conditions (100%). Generally, there were two clinical pathways for common mental 
disorders, severe mental disorders, and neurological conditions: (1) patients with low clinical 
symptoms, classes 1–3a and (2) moderate to severe clinical symptoms, 4–6b. Interpretation of class 
probabilities were based on the Collins & Lanza (2010) guidelines, where values greater than or 
equal to 50% were considered high and everything else was low. A defining feature of the LCA 
subgroups were functional impairment probabilities that ranged from  “none to low impairment” 
for classes 1–3a and “high functional impairment” for classes 4–6b. The grouping name is 
subjective. Provided distinct classes of common mental disorders, severe mental disorders, and 
neurological conditions, the primary diagnosis categorizations were deemed the most appropriate 
representation for each grouping name, and further defined by the level of functional impairment. 
The characterization and class membership probabilities were as follows (see table 17, figure 6–
7): Class 1a (n=105) membership constituted 11.5% of participants total, the subgroup had a high 
probability of common mental disorders (100%)  with no functional impairment, and therefore 
were categorized as the “common mental disorders–none to low functional impairment” subgroup. 
Class 1a revealed low depression (45%) and low suicidality (1%). Class 2a (n=45) membership 
included 4.9% of participants total, the subgroup had a high probability of severe mental disorders 
(100%) with low functional impairment (19%), and were categorized as the “severe mental 




11.1%, the subgroup had a high probability of neurological conditions (100%) and no functional 
impairment. Therefore, the class was categorized as the “neurological conditions–none to low 
functional impairment” subgroup. Class 3a revealed low depression (11%) and low suicidality 
(15%). Again, LCA classes 1–3a were defined by low clinical symptoms and none to low 
functional impairment. In terms of suicidality, the neurological conditions group 3a (15%) had a 
stronger probability of being suicidal, when compared to common mental disorders 1a (1%) and 
severe mental disorders 2a (2%). Class 4b (n=353) membership constituted 38.62% of participants 
total, and the subgroup had a high probability of common mental disorders (100%) and high 
functional impairment (100%) therefore, were categorized as the “common mental disorders–high 
functional impairment” subgroup. Clinical depression for class 4b was high (77%) and suicidality 
was low (3%). Class 5b (n=119) membership constituted 13.02% of participants total, and the 
subgroup had a high probability of severe mental disorders (100%) with high functional 
impairment (100%) thus, were categorized as the “severe mental disorders–high functional 
impairment” group. Class 5b the clinical depression probability was high (60%) and suicidality 
was low (12%). Class 6b (n=191) membership constituted 20.9% of participants total, the 
subgroup had a high probability of neurological conditions (100%) with high functional 
impairment (100%), and were categorized as the “neurological conditions–high functional 
impairment” group. For class 6b, the clinical depression probability was low (25%) and suicidality 
was low (26%). Again, the suicidality for high functional impairment subgroups 4–6b, results 
showed neurological conditions (26%) had a stronger probability of suicidality, and severe mental 




Note. Description of each LCA class based on the primary diagnosis and functional impairment:   
LCA Class 1a: CMDs (100%) and no functional impairment  
LCA Class 2a: SMDs(100%) and low functional impairment (19%) 
LCA Class 3a: NCs (100%) and no functional impairment  
LCA Class 4b: CMDs (100%) and high functional impairment (100%) 
LCA Class 5b: SMDs (100%) and high functional impairment (100%) 
LCA Class 6b: NCs (100%) and high functional impairment (100%) 
LCA Classes 1–3a denotes none to low functional impairment  
LCA Classes 4–6b denotes high functional impairment  
 
(3%). The six–distinct latent classes (class 1a=11.5%; class 2a=4.9%; class 3a=11.1%; class  
4b=38.62%; class 5b=13.02%; and class 6b=20.9%) equal a total of 100%, which denotes that 




























1 1.00 0 0 0.45 0 0.01 
2 0 1.00 0 0.27 0.19 0.02 
3 0 0 1.00 0.11 0 0.15 
4 1.00 0 0 0.77 1.00 0.03 
5 0 1.00 0 0.60 1.00 0.12 




Figure 6. Probabilities for Each Indicator: None to Low Functional Impairment  
(6-Class Model) 
 
Note. Class 1a “common mental disorder–none to low functional impairment” (n=105, 11.5%); Class 2a “severe 
mental disorders– none to low functional impairment” (n=45, 4.9%); and Class 3a “neurological conditions––none 
to low functional impairment” (n= 101, 11.1%). 
 

















Note. Class 4b “common mental disorder–high functional impairment” (n=353, 38.62%); Class 5b “severe mental 
disorders–high functional impairment” (n=119, 13.02%); and Class 6b “neurological conditions––high functional 




Primary and Secondary Diagnosis Proportions within LCA Indicator Categories  
 
The primary diagnosis derived the indicator categories, whereas the secondary diagnosis 
provided further characterization of each mental health class. The primary diagnosis for class 1a 
“common mental disorders–none to low functional impairment” were most often major depressive 
disorder, mild to moderate episode (50.4%) and generalized anxiety disorder (35.2%) (see table 
18), whereas the secondary diagnosis for class 1a was most often generalized anxiety disorder 
(5.8%), major depressive disorder, mild to moderate episode (3%), and epilepsy (1.9%) (see table 
19). The primary diagnosis for class 2a “severe mental disorders–none to low functional 
impairment” was typically, psychotic disorder (57.8%), bipolar disorder, unspecified episode 
(17.8%), and major depressive disorder, severe with psychotic features (8.9%) (see table 20). The 
secondary diagnosis for 2a was most often major depressive disorder, mild to moderate episode 
(4.4%) and epilepsy (2.2%) (see table 21). The primary diagnosis for class 3a “neurological 
conditions–none to low functional impairment” was most often epilepsy (93.1%) (see table 22), 
and secondary diagnosis major depressive disorder, mild to moderate episode (3%) (see table 23). 
The primary diagnosis for class 4b “common mental disorders–high functional impairment” was 
most often major depressive disorder, mild to moderate (43.6%), generalized anxiety disorder 
(24.6%), and major depressive disorder, severe without psychotic features (18.4%) (see table 24). 
The secondary diagnosis for class 4b was most often generalized anxiety disorder (8.5%), epilepsy 
(5.1%), and major depressive disorder, mild to moderate episode (5.1%) (see table 25). The 
primary diagnosis for class 5b “severe mental disorders–high functional impairment” was most 




(19.3%), bipolar disorder, unspecified episode (13.4%), and bipolar disorder, manic episode 
without psychotic features (7.6%) (see table 26). The secondary diagnosis for class 5b, that was 
the most frequent included major depressive disorder, mild to moderate episode (5%) (see table 
27). The primary diagnosis for class 6b “neurological conditions–high functional impairment” was 
most often epilepsy (87.4%) (see table 28), and the secondary diagnosis major depressive disorder, 
mild to moderate episode (5.3%) and epilepsy (2%) (see table 29). Overall, there was consistency 
for the most frequent primary and secondary diagnoses for CMDs (major depressive disorder, mild 
to moderate episode), SMDs (psychotic disorder), and NCs (epilepsy); none to low functional 
impairment (1–3a) and high functional impairment (4–6b). Patients rarely had a secondary 
diagnosis across LCA subgroups.  
 






 N % 
Acute reaction to a stressor 5 4.8 
Dissociative conversion disorder 1 1.0 
Generalized anxiety disorder 37 35.2 
Major depressive disorder, mild to moderate episode  53 50.4 
Major depressive disorder, severe without psychotic features 3 2.9 
Mood disorder 2 1.9 





Table 19. Secondary Diagnosis Proportions within LCA Class 1a (6-Class Model) 
 
 
Table 20. Primary Diagnosis Proportions within LCA Class 2a (6-Class Model) 
 
 







 N % 
Epilepsy 2 1.9 
Generalized anxiety disorder 6 5.8 
Intellectual disability 1 1.0 
Major depressive disorder, mild to moderate episode  3 3.0 
Migraine 1 1.0 
Psychosomatic disorder 1 1.0 
Psychotic disorder 1 1.0 
 N % 
Bipolar disorder, unspecified episode 8 17.8 
Bipolar disorder, mania with psychotic features   2 4.4 
Bipolar disorder, mania without psychotic features 1 2.2 
Delusional disorder 1 2.2 
Major depressive disorder, severe with psychotic features 4 8.9 
Psychotic disorder 26 57.8 
Schizophrenia 3 6.7 
 N % 
Epilepsy 1 2.2 






Table 22. Primary Diagnosis Proportions within LCA Class 3a (6-Class Model)  
 
 
Table 23. Secondary Diagnosis Proportions within LCA Class 3a (6-Class Model) 
 
 









 N % 
Epilepsy 94 93.1 
Focal epilepsy 2 2.0 
Intellectual disability 2 2.0 
Migraine 3 3.0 
 N % 
Epilepsy 1 1.0 
Intellectual disability 1 1.0 
Major depressive disorder, mild to moderate episode 3 3.0 
 N % 
Acute reaction to a stressor 17 4.8 
Adjustment disorder 5 1.4 
Generalized anxiety disorder 87 24.6 
Major depressive disorder, mild to moderate episode 154 43.6 
Major depressive disorder, severe without psychotic features   65 18.4 
Obsessive compulsive disorder 1 0.3 
Personality disorder 1 0.3 
Pervasive developmental disorder 2 0.6 
Mood disorder 2 0.6 
Post-traumatic stress disorder 14 4.0 
Psychosomatic disorder  5 1.4 
   
   
   
   




Table 25. Secondary Diagnosis Proportions within LCA Class 4b (6-Class Model) 
 
 
Table 26. Primary Diagnosis Proportions within LCA Class 5b (6-Class Model) 
 
 
Table 27. Secondary Diagnosis Proportions within LCA Class 5b (6-Class Model)  
 N % 
Acute reaction to a stressor 1 0.3 
Adjustment disorder 6 1.7 
Bipolar disorder, unspecified episode 4 0.12 
Delusional disorder 1 0.3 
Epilepsy 18 5.1 
Generalized anxiety disorder 30 8.5 
Major depressive disorder, mild to moderate episode 18 5.1 
Major depressive disorder, severe without psychotic features   9 2.5 
Migraine  3 0.8 
Mood disorder 1 0.3 
Post-traumatic stress disorder 4 1.1 
Psychosomatic disorder  3 0.8 
Psychotic disorder 3 0.8 
 N % 
Acute and transient psychotic disorder 4 3.4 
Bipolar disorder, unspecified episode 16 13.4 
Bipolar disorder, mania with psychotic features   3 2.5 
Bipolar disorder, manic episode without psychotic features 9 7.6 
Major depressive disorder, severe with psychotic features 23 19.3 
Psychotic disorder 52 43.7 
Schizophrenia 5 4.2 
 N % 
Bipolar disorder, unspecified episode 1 0.8 
Delirium 1 0.8 
Dementia 1 0.8 
Epilepsy 1 0.8 
Generalized anxiety disorder 2 1.7 






Table 28. Primary Diagnosis Proportions within LCA Class 6b (6-Class Model)  
 
 
Table 29. Secondary Diagnosis Proportions within LCA Class 6b (6-Class Model) 
 
 
   
 N % 
Major depressive disorder, mild to moderate episode 6 5.0 
Major depressive disorder, severe with psychotic features   2 1.7 
Major depressive disorder, severe without psychotic features 2 1.7 
Psychosomatic disorder 1 0.8 
Psychotic disorder 2 1.7 
Schizophrenia 2 1.7 
 N % 
Dementia 9 4.7 
Epilepsy 167 87.4 
Focal epilepsy 6 3.1 
Intellectual disability 2 1.0 
Migraine 6 3.1 
Mixed language disorder 1 0.5 
 N % 
Acute and transient psychotic disorder 1 0.5 
Bipolar disorder, unspecified episode 1 0.5 
Epilepsy 1 2.0 
Generalized anxiety disorder 1 0.5 
Intellectual disability 3 1.6 
Major depressive disorder, mild to moderate episode 10 5.3 
Major depressive disorder, severe with psychotic features   1 0.5 
Major depressive disorder, severe without psychotic features 3 1.6 
Mood disorder 1 0.5 
Psychotic disorder 1 0.5 




Study Aim 3–Multinomial Logistic Regression (MLR) Models 1 & 2 
 
Multinomial Logistic Regression Model 1: Descriptive Predictor Variables 
 
An unordered multinomial logistic regression was used to estimate correlates of descriptive 
characteristics and treatment information by mental health class. The model included the following 
independent variables: “gender,” “age,” “psychotherapy received,” “psychiatric medication 
received,” and “number of visits during observation period.” The dependent variable was the 
categorical LCA class membership 1a–6b and the reference categories of “common mental 
disorders–none to low functional impairment,” “severe mental disorders–none to low functional 
impairment,” “neurological conditions–none to low functional impairment,” “common mental 
disorders–high functional impairment,” “severe mental disorders–high functional impairment,” 
and “neurological conditions–high functional impairment” selected. The odds ratios (OR) were 
calculated, and the 95% confidence interval (CI) for each independent variable included, with the 
significance value set to .05 (*). The goodness of fit was determined based on chi-square tests of 
Pearson’s and deviance. There was no multicollinearity of independent variables and no violations 
of assumptions met. Sample characteristics of descriptive predictor variables within the LCA class 
were included for the unordered multinomial logistic regression model 1.  
The LCA class 1a “common mental disorders–none to low functional impairment” (n=105) 
included patients that were mostly female (n=80, 76.2%) and had a mean age of 36.97 (SD=15.2) 
(see table 30–31). In terms of treatment information, LCA class 1a patients that received 
psychotherapy were 75.2% (n=79) and psychiatric medication were 25.7% (n=27), and there were 




mental disorders––none to low functional impairment” (n=45) included patients that were again, 
mostly female (n=31, 68.9%) and the average age was 38.4 years (S.D.=13.69). For treatment 
information, patients from class 2a that received psychotherapy were 60% (n=27), and received 
psychiatric medication were 84.4% (n=38). There were usually 6 patient visits (S.D.=5.42) during 
the observation period. The LCA class 3a “neurological conditions––none to low functional 
impairment” (n=101) included patients that were nearly 50% female (n=50, 49.5%) and the 
average age was 31.47 years (S.D.=11.84). LCA class 3a patients received psychotherapy less 
often at 44.6% (n=45), but received psychiatric medication more often (93.1%, n=94). There were 
usually 6 patient visits (S.D.=5.95) during the observation period. LCA class 4b “common mental 
disorders––high functional impairment” (n=353) included patients that were mostly female 
(n=276, 78.2%) and the average age was 37.41 years (S.D.=14.29). In terms of treatment 
information, patients from class 4b that received psychotherapy were 73.1% (n=258), and received 
psychiatric medication less often at 38.8% (n=137). There were usually 3 patient visits (S.D.=3.24) 
during the observation period. LCA class 5b “severe mental disorders––high functional 
impairment” (n=119) included patients that were mostly female (n=65, 54.6%) and the average 
age was 38.04 years (S.D.=14.06). In terms of treatment information, patients from class 5b 
frequently received psychotherapy at 70.6% (n=84), and also received psychiatric medication more 
at 78.2% (n=93), but were not necessarily seen for treatment longer, compared to LCA classes 1a–
4b. For LCA class 5b there were usually 4 patient visits (S.D.=4.20) during the observation period. 
The LCA class 6b “neurological conditions––high functional impairment” (n=191) included 




(S.D.=15.97). Patients for LCA class 6b that received psychotherapy at 62.8% (n=120), and more 
often received psychiatric medication at 84.8% (n=162), with usually 6 patient visits (S.D.=6.00) 
during the observation period. With consideration to the patients overall, we observed that the 
majority of LCA classes were female, except gender was equally represented for neurological 
conditions (LCA class 3a and 6b) and severe mental disorders (LCA class 5b). Patients presenting 
for mental health treatment tended to be 30 years or older. Neurological conditions generally were 
younger and the ages ranged from 31–34 years of age (LCA classes 3a and 6b). Common mental 
disorders (LCA classes 1a and 4b), and severe mental disorders (LCA classes 2a and 5b) were 
somewhat older from 36–38 years of age. For mental health treatment received, “none to low 
functional impairment” classes (1–3a) received psychotherapy less often than “high functional 
impairment” classes (4–6b). Psychiatric medication was prescribed the most often to severe mental 
disorders (LCA classes 2a and 5b) and neurological conditions classes (LCA classes 3a and 6b). 
Common mental disorders classes (classes 1a and 4b) typically received psychosocial 
interventions more often, and psychiatric medication less often when compared to the other mental 
health classes. There were usually 6 visits during the observation period. By comparison, LCA  













Table 31. Descriptive Predictor Variables within LCA Class 4–6b 
  
Class 4b (n=353) 
 
Class 5b (n=119) 
 
Class 6b (n=191) 




































137 (38.8) n/a 93 (78.2) n/a 162 (84.8) n/a 
 
# of Visits During 
Observation Period 
n/a 3.16(3.24) n/a 4.17 (4.20) n/a 6.52 (6.00) 
Table 30. Descriptive Predictor Variables within LCA Class 1–3a 
              
             Class 1a (n=105) 
 
 
        Class 2a (n=45) 
 
 
      Class 3a (n=101) 
 




































27 (25.7) n/a 38 (84.4) n/a 94 (93.1) n/a 
 
# of Visits During 
Observation Period 




Multinomial Logistic Regression Model 1: Reference Category 2a “Severe Mental 
Disorders–None to Low Functional Impairment” 
Reference category 2a “severe mental disorders–none to low functional impairment” 
when compared to the 1a “common mental disorders–none to low functional impairment” group 
and other variables in the model were held constant, the 1a “common mental disorders–none to 
low functional impairment” group were much less likely to be on psychiatric medication (OR = 
0.08; 95% CI= 0.03, 0.20; p < .01) (see table 32, figure 8). Other predictor variables in this model 
such as gender, age, psychotherapy received, and number of visits during the observation period 
were not statistically significant. Again, for reference category 2a “severe mental disorders–none 
to low functional impairment” when other variables in the model were held constant parameter 
estimates showed when compared to the 3a “neurological conditions–none to low functional 
impairment” group, patients with “neurological conditions–none to low functional impairment” 
were somewhat younger (OR = 0.96; 95% CI= 0.94, 1.00; p < .01). Other predictor variables in 
this model such as gender, psychotherapy received, psychiatric medication received, and number 
of visits during the observation period were not statistically significant. For reference category 2a 
“severe mental disorders–none to low functional impairment” when other variables in the model 
were held constant parameter estimates showed when compared to 4b “common mental disorders–
high functional impairment” group, patients with “common mental disorders–high functional 
impairment” were much less likely to be on psychiatric medication (OR = 0.15; 95% CI= 0.06, 
0.35; p < .01) and had somewhat fewer visits during the observation period (OR = 0.90; 95% CI= 




received were not statistically significant. For reference category 2a “severe mental disorders–
none to low functional impairment” when other variables in the model were held constant 
parameter estimates showed when compared to the 5b “severe mental disorders–high functional 
impairment” group, patients with “severe mental disorders–high functional impairment” had 
somewhat fewer visits during the observation period (OR = 0.93; 95% CI= 0.87, 1.00; p < .05). 
Other predictor variables in this model such as gender, age, psychotherapy received, and 
psychiatric medication received were not statistically significant. For reference category 2a 
“severe mental disorders–none to low functional impairment” when other variables in the model 
were held constant parameter estimates showed when compared to the 6b “neurological 
conditions–high functional impairment” group, none of the predictor variables were statistically 
significant. Based on model fitting information, there was significant improvement over the null 
model [X2 (25, N= 914) = 373.25, p= < .01]. The Pearson’s chi-square test indicated model fit [X2 
(4,410, N=914) =4,330.15, p=0.80] and also the deviance chi-square test indicated model fit [X2 












Table 32. Multinomial Logistic Regression for 6-Class Model: Parameter Estimates of 
Descriptive Predictor Variables for Reference Category SMDs– 
None to Low Functional Impairment (Class 2a) 









CMDs– None to Low Functional Impairment (Class 1a)    
Gender 1.31 0.41 0.58–2.93 
Age  1.00 0.01 0.97–1.02 
Psychotherapy Received   1.60 0.40 0.72–3.51 
Psychiatric Medication Received    0.08** 0.48 0.03–0.20 
Number of Visits During Observation Period    0.93 0.04 0.86–1.01 
NCs– None to Low Functional Impairment (Class 3a)    
Gender   0.48 0.38 0.23–1.02 
Age   0.96** 0.01 0.94–1.00 
Psychotherapy Received    0.57 0.38 0.27–1.21 
Psychiatric Medication Received    2.43 0.58 0.78–7.54 
Number of Visits During Observation Period    1.00 0.03 0.93–1.06 
CMDs–High Functional Impairment (Class 4b)     
   Gender 1.52 0.36 0.75–3.07 
   Age 1.00 0.01 0.98–1.02 
   Psychotherapy Received   1.38 0.35 0.70–2.74 
   Psychiatric Medication Received      0.15** 0.43 0.06–0.35 
   Number of Visits During Observation Period      0.90** 0.03 0.84–0.96 
SMDs– High Functional Impairment (Class 5b)    
     Gender 0.52 0.38 0.25–1.09 
    Age 1.00 0.01 0.98–1.02 
    Psychotherapy Received  1.44 0.38 0.69–3.02 
    Psychiatric Medication Received   0.78 0.47 0.30–1.97 
    Number of Visits During Observation Period    0.93* 0.04 0.87–1.00 
NCs– High Functional Impairment (Class 6b)    
     Gender 0.60 0.36 0.30–1.20 
    Age 0.98 0.01 0.96–1.00 






Figure 8. Multinomial Logistic Regression for 6-Class Model: Parameter Estimates of 
Descriptive Predictor Variables for Reference Category SMDs– 






    









    Psychotherapy Received  1.23 0.35 0.62–2.46 
    Psychiatric Medication Received 1.00 0.47 0.40–2.47 
    Number of Visits During Observation Period  1.01 0.03 0.95–1.08 
 
Note. Bolded and * p <.05; ** p <.01. Binary independent variables included: gender (female/male), 
psychotherapy received (yes/no), and psychiatric medication received (yes/no). Continuous independent 





Multinomial Logistic Regression Model: Reference category 3a “Neurological Conditions–
None to Low Functional Impairment” 
Reference category 3a “neurological conditions–none to low functional impairment” 
when compared to the 1a “common mental disorders–none to low functional impairment” group 
and other variables in the model were held constant, the “common mental disorders–none to low 
functional impairment” group were nearly 3 times and much more likely to be female (OR = 2.71; 
95% CI= 1.42, 5.20; p < .01) and somewhat more likely older (OR = 1.03; 95% CI= 1.01, 1.06; 
p < .01) (see table 33, figure 9). In terms of treatment predictor variables, patients with “common 
mental disorders–none to low functional impairment” were nearly 3 times and much more likely 
to receive psychotherapy (OR = 2.78; 95% CI= 1.45, 5.34; p < .01) and much less likely to receive 
psychiatric medication (OR = 0.03; 95% CI= 0.01, 0.08; p < .01). The number of visits during the 
observation period were not statistically significant. Reference category 3a “neurological 
conditions–none to low functional impairment” when compared to the 2a “severe mental 
disorders–none to low functional impairment” group and other variables in the model were held 
constant, the “severe mental disorders–none to low functional impairment” results showed none 
of the predictor variables were significant. Reference category 3a “neurological conditions–none 
to low functional impairment” when compared to 4b “common mental disorders–high functional 
impairment” group and other variables in the model were held constant, the “common mental 
disorders–high functional impairment” revealed differences for each descriptive variable. LCA 




.01) and the patients were somewhat older (OR = 1.04; 95% CI= 1.01, 1.06; p < .01). Treatment 
information revealed that psychotherapy received was 2.5 times and much more likely (OR = 2.51; 
95% CI= 1.41, 4.48; p < .01); psychiatric medication was less likely (OR = 0.32; 95% CI= 0.13, 
0.79; p < .05) for class 4b. For class 4b, there were somewhat fewer visits during the observation 
period (OR = 0.93; 95% CI= 0.88, 1.00; p < .05). Reference category 3a “neurological conditions–
none to low functional impairment” when compared to 5b “severe mental disorders–high 
functional impairment” group and other variables in the model were held constant, the “severe 
mental disorders–high functional impairment” group were somewhat older (OR = 1.04; 95% CI= 
1.02, 1.06; p < .01); 2.5 times and much more likely to receive psychotherapy (OR = 2.51; 95% 
CI= 1.41, 4.48; p < .01); less likely to receive psychiatric medication (OR = 0.32; 95% CI= 0.13, 
0.79; p < .05); had somewhat fewer visits during the observation period (OR = 0.93; 95% CI= 
0.88, 1.00; p < .05); and gender was not statistically significant. Reference category 3a 
“neurological conditions–none to low functional impairment” when compared to 6b “neurological 
conditions–high functional impairment” group and other variables in the model were held constant, 
the “neurological conditions–high functional impairment” group were 2 times and much more 
likely to receive psychotherapy (OR = 2.15; 95% CI= 1.30, 3.58; p < .01) and were less likely to 
receive psychiatric medication (OR = 0.41; 95% CI= 0.17, 0.98; p < .05). Other descriptive 
variables such as gender, age, and number of visits during the observation period were not 
statistically significant. Based on model fitting information, there was significant improvement 
over the null model [X2 (25, N= 914) = 373.25, p= < .01]. The Pearson’s chi-square test indicated 




Table 33. Multinomial Logistic Regression for 6-Class Model: Parameter Estimates of 
Descriptive Predictor Variables for Reference Category NCs– 
None to Low Functional Impairment (Class 3a) 
Reference Category “NCs– None to Low Functional Impairment” (Class 3a) Odds Ratio  Standard Error 
95% Confidence 
Interval 
CMDs– None to Low Functional Impairment (Class 1a)    
Gender      2.71** 0.33 1.42–5.20 
Age      1.03** 0.01 1.01–1.06 
Psychotherapy Received   2.78** 0.33 1.45–5.34 
Psychiatric Medication Received  0.03** 0.46 0.01–0.08 
Number of Visits During Observation Period      0.94 0.04 0.87-1.01 
SMDs– None to Low Functional Impairment (Class 2a)    
 Gender      2.07 0.38 0.98–4.39 
 Age     1.04 0.01 1.01–1.06 
 Psychotherapy Received      1.75 0.38 0.83–3.68 
 Psychiatric Medication Received     0.41 0.58 0.13–1.28 
 Number of Visits During Observation Period     1.01 0.03 0.94-1.07 
CMDs– High Functional Impairment (Class 4b)     
Gender    3.14** 0.26 1.88–5.26 
Age    1.04** 0.01 1.01–1.06 
Psychotherapy Received     2.41** 0.26 1.44–4.04 
Psychiatric Medication Received    0.06** 0.42 0.03–0.14 
Number of Visits During Observation Period    0.90** 0.03 0.86-0.95 
SMDs– High Functional Impairment (Class 5b)    
Gender    1.09 0.28 0.63–1.88 
Age    1.04** 0.01 1.02–1.06 
Psychotherapy Received     2.51** 0.30 1.41–4.48 
Psychiatric Medication Received    0.32* 0.46 0.13–0.79 
Number of Visits During Observation Period    0.93* 0.03 0.88–1.00 
NCs– High Functional Impairment (Class 6b)    
Gender    1.23 0.25 0.76–2.02 
Age    1.02 0.01 1.00–1.04 
Psychotherapy Received     2.15** 0.26 1.30–3.58 
Psychiatric Medication Received    0.41* 0.45 0.17–0.98 
Number of Visits During Observation Period 1.02 0.02 0.98-1.06 Note. Bolded and * p <.05; ** p <.01. Binary independent variables included: gender (female/male), psychotherapy 
received (yes/no), and psychiatric medication received (yes/no). Continuous independent variables included: age and 













    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 
Figure 9. Multinomial Logistic Regression for 6-Class Model: Parameter Estimates of 
Descriptive Predictor Variables for Reference Category NCs–None to Low Functional 
Impairment (Class 3a) 
 
    
 




Multinomial Logistic Regression Model 1: Reference Category 4b “Common Mental 
Disorders–High Functional Impairment” 
Reference category 4b “common mental disorders–high functional impairment” when 
compared to the 1a “common mental disorders–none to low functional impairment” group and 
other variables in the model were held constant, the “common mental disorders–none to low 
functional impairment” group were less likely to receive psychiatric medication (OR = 0.52; 95% 
CI= 0.32, 0.85; p < .05), and descriptive variables: gender, age, psychotherapy received, and the 
number of visits during observation period were not statistically significant (see table 34, figure 
10). Reference category 4b “common mental disorders–high functional impairment” when 
compared to 2a “severe mental disorders–none to low functional impairment” group and other 
variables in the model were held constant, the “severe mental disorders–none to low functional 
impairment” results showed patients were more than 6.5 times and much more likely to receive 
psychiatric medication (OR = 6.74; 95% CI= 2.88, 15.79; p < .01), and had more visits during the 
observation period (OR = 1.11; 95% CI= 1.05, 1.17; p < .01), and descriptive variables: gender, 
age, and psychotherapy received were not statistically significant. Reference category 4b 
“common mental disorders–high functional impairment” when compared to 3a “neurological 
conditions–none to low functional impairment” group and other variables in the model were held 
constant, the “neurological conditions–none to low functional impairment” revealed differences 
for each descriptive variable. LCA class 3a was much less likely to be female (OR = 0.32; 95% 
CI= 0.19, 0.53; p < .01) and patients were somewhat younger (OR = 0.97; 95% CI= 0.95, 1.00; 




received was much less likely (OR = 0.42; 95% CI= 0.25, 0.70; p < .01); psychiatric medication 
was 16 times and much more likely (OR = 0.32; 95% CI= 0.13, 0.79; p < .01); and there were 
more visits during the observation period (OR = 1.11; 95% CI= 1.05, 1.17; p < .01). Reference 
category 4b “common mental disorders–high functional impairment“ when compared to 5b 
“severe mental disorders–high functional impairment” group and other variables in the model were 
held constant, the “severe mental disorders–high functional impairment” group were much less 
likely female (OR = 0.35; 95% CI= 0.22, 0.55; p < .01), and 5 times and much more likely to 
receive psychiatric medication (OR = 5.23; 95% CI= 3.17, 8.61; p < .01). Other descriptive 
variables such as age, psychotherapy received, and the number of visits during observation period 
were not statistically significant. Reference category 4b “common mental disorders–high 
functional impairment“ when compared to 6b “neurological conditions–high functional 
impairment” group and other variables in the model were held constant, the “neurological 
conditions–high functional impairment” group were much less likely female (OR = 0.39; 95% CI= 
0.26, 0.60; p < .01); about the same age (OR = 1.00; 95% CI= 0.97, 1.00; p < .01); 6.5 times and 
much more likely to receive psychiatric medication (OR = 6.67; 95% CI= 4.18, 10.64; p < .01); 
had more visits during the observation period (OR = 1.13; 95% CI= 1.08, 1.18; p < .01); and 
psychotherapy received was not statistically significant. Based on model fitting information, there 
was significant improvement over the null model [X2 (25, N= 914) = 373.25, p= < .01]. The 
Pearson’s chi-square test indicated model fit [X2 (4,410, N=914) =4,330.15, p=0.80] and also the  




Table 34. Multinomial Logistic Regression for 6-Class Model: Parameter Estimates of 
Descriptive Predictor Variables with Reference Category CMDs–  
High Functional Impairment (Class 4b) 





CMDs– None to Low Functional Impairment (Class 1a)    
    Gender 0.86 0.27 0.51–1.45 
    Age 1.00 0.01 0.98–1.01 
    Psychotherapy Received  1.15 0.26 0.69–1.92 
    Psychiatric Medication Received   0.52* 0.26 0.32–0.85 
    Number of Visits During Observation Period 1.04 0.03 0.97-1.11 
SMDs– None to Low Functional Impairment (Class 2a)    
Gender 0.66 0.36 0.33–1.34 
Age 1.00 0.01 0.98–1.03 
Psychotherapy Received  0.73 0.35 0.37–1.44 
Psychiatric Medication Received     6.74** 0.43 2.88–15.79 
Number of Visits During Observation Period     1.11** 0.03 1.04-1.19 
NCs– None to Low Functional Impairment (Class 3a)    
Gender   0.32** 0.26 0.19–0.53 
Age   0.97** 0.01 0.95–1.00 
Psychotherapy Received    0.42** 0.26 0.25–0.70 
Psychiatric Medication Received    16.36** 0.42 7.22–37.09 
Number of Visits During Observation Period  1.11** 0.03 1.05-1.17 
SMDs– High Functional Impairment (Class 5b)    
Gender   0.35** 0.24 0.22–0.55 
Age      1.00 0.01 1.00–1.02 
Psychotherapy Received       1.04 0.25 0.64–1.71 
Psychiatric Medication Received   5.23** 0.26 3.17–8.61 
Number of Visits During Observation Period      1.03 0.03 0.97-1.09 




Note. Bolded and * p <.05; ** p <.01. Binary independent variables included: gender (female/male), psychotherapy 
received (yes/no), and psychiatric medication received (yes/no). Continuous independent variables included: age and 















    





NCs– High Functional Impairment (Class 6b)    
Gender 0.39** 0.22 0.26–0.60 
Age     1.00* 0.01 0.97–1.00 
Psychotherapy Received      0.89 0.22 0.58–1.38 
Psychiatric Medication Received  6.67** 0.24 4.18–10.64 
Number of Visits During Observation Period 1.13** 0.02 1.08-1.18 
    
Figure 10. Multinomial Logistic Regression for 6-Class Model: Parameter Estimates of 
Descriptive Predictor Variables with Reference Category CMDs– High Functional 




Multinomial Logistic Regression Model 1: Reference Category 5b “Severe Mental 
Disorders–High Functional Impairment” 
Reference category 5b “severe mental disorders–high functional impairment” when 
compared to 1a “common mental disorders–none to low functional impairment” group and other  
variables in the model were held constant, the “common mental disorders–none to low functional 
impairment” group were 2.5 times and much more likely to be female (OR = 2.50; 95% CI= 1.36, 
4.59; p < .01); much less likely to receive psychiatric medication (OR = 0.10; 95% CI= 0.05, 0.19; 
p < .01); and other descriptive variables such as age, psychotherapy received, and the number of 
visits during observation period were not statistically significant (see table 35, figure 11). 
Reference category 5b “severe mental disorders–high functional impairment” when compared to 
2a “severe mental disorders–none to low functional impairment” group and other variables in the 
model were held constant, the “severe mental disorders–none to low functional impairment” 
results showed patients had more visits during the observation period (OR = 1.08; 95% CI= 1.01, 
1.16; p < .05); and other descriptive variables: gender, age, psychotherapy received, and 
psychiatric medication received were not statistically significant. Reference category 5b “severe 
mental disorders–high functional impairment” when compared to 3a “neurological conditions–
none to low functional impairment” group and other variables in the model were held constant, the 
“neurological conditions–none to low functional impairment” results showed patients were 
somewhat younger (OR = 0.96; 95% CI= 0.94, 0.98; p < .01); much less likely to receive 
psychotherapy (OR = 0.40; 95% CI= 0.22, 0.71; p < .01); 3 times and more likely to receive 




observation period (OR = 1.07; 95% CI= 1.01, 1.14; p < .05); and gender was not statistically 
significant. Reference category 5b “severe mental disorders–high functional impairment” when 
compared to 4b “common mental disorders–high functional impairment” group and other variables 
in the model were held constant, the “common mental disorders–high functional impairment” 
results showed patients were nearly 3 times and much more likely female (OR = 2.90; 95% CI= 
1.82, 4.61; p < .01) and much less likely to receive psychiatric medication (OR = 0.19; 95% CI= 
0.12, 0.32; p < .01). Other descriptive variables such as age, psychotherapy received, and number 
of visits during the observation period were not statistically significant. Reference category 5b 
“severe mental disorders–high functional impairment” when compared to 6b “neurological 
conditions–high functional impairment” group and other variables in the model were held constant, 
the “neurological conditions–high functional impairment” results showed patients were somewhat 
younger (OR = 0.98; 95% CI= 0.97, 1.00; p < .05) and attended more visits during the observation 
period (OR = 1.09; 95% CI= 1.04, 1.15; p < .01). Other descriptive variables such as gender, 
psychotherapy received, and psychiatric medication received were not statistically significant. 
Based on model fitting information, there was significant improvement over the null model [X2 
(25, N= 914) = 373.25, p= < .01]. The Pearson’s chi-square test indicated model fit [X2 (4,410, 
N=914) =4,330.15, p=0.80] and also the deviance chi-square test indicated model fit [X2 (4,410, 






Note. Bolded and * p <.05; ** p <.01. Binary independent variables included: gender (female/male), psychotherapy 
received (yes/no), and psychiatric medication received (yes/no). Continuous independent variables included: age 






Table 35. Multinomial Logistic Regression for 6-Class Model: Parameter Estimates of 
Descriptive Predictor Variables with Reference Category SMDs– 
High Functional Impairment (Class 5b) 
Reference Category “SMDs– High Functional Impairment” (Class 5b) Odds Ratio  Standard Error 95% Confidence Interval 
CMDs– None to Low Functional Impairment (Class 1a)    
Gender     2.50** 0.31 1.36–4.59 
Age 1.00 0.01 0.98–1.01 
Psychotherapy Received  1.12 0.32 0.59–2.08 
Psychiatric Medication      0.10** 0.32 0.05–0.19 
Number of Visits During Observation Period 1.00 0.04 0.93–1.08 
SMDs– None to Low Functional Impairment (Class 2a)    
Gender  1.91 0.38 0.92–3.99 
Age  1.00 0.01 0.98–1.02 
Psychotherapy Received   0.70 0.38 0.33–1.46 
Psychiatric Medication         1.29 0.48 0.51–3.28 
Number of Visits During Observation Period   1.08* 0.04 1.01-1.16 
NCs– None to Low Functional Impairment (Class 3a)    
Gender         0.92 0.28 0.53–1.60 
Age    0.96** 0.01 0.94–0.98 
Psychotherapy Received     0.40** 0.29 0.22–0.71 
Psychiatric Medication  3.13* 0.46 1.27–7.70 
Number of Visits During Observation Period 1.07* 0.03 1.01-1.14 
CMDs– High Functional Impairment (Class 4b)    
Gender    2.90** 0.24 1.82–4.61 
Age 1.00 0.01 0.98–1.01 
Psychotherapy Received  0.96 0.25 0.59–1.57 
Psychiatric Medication    0.19** 0.26 0.12–0.32 
Number of Visits During Observation Period 0.97 0.03 0.92–1.03 
NCs– High Functional Impairment (Class 6b)    
Gender 1.14 0.24 0.71–1.82 
Age   0.98* 0.01 0.97–1.00 
Psychotherapy Received  0.86 0.26 0.51–1.43 
Psychiatric Medication 1.28 0.31 0.70–2.33 




Figure 11. Multinomial Logistic Regression for 6-Class Model: Parameter Estimates of 
Descriptive Predictor Variables with Reference Category SMDs– 
















Multinomial Logistic Regression Model 1: Reference Category 6b “Neurological 
Conditions–High Functional Impairment” 
Reference category 6b “neurological conditions–high functional impairment” when 
compared to 1a “common mental disorders–none to low functional impairment” group and other 




impairment” group were 2 times and more likely to be female (OR = 2.20; 95% CI= 1.23, 3.91; 
p < .05); much less likely to receive psychiatric medication (OR = 0.08; 95% CI= 0.04, 0.14; p < 
.01); attended fewer visits during the observation period (OR = 0.92; 95% CI= 0.86, 0.98; p < .05); 
age and psychotherapy received were not statistically significant (see table 36, figure 12). 
Reference category 6b “neurological conditions–high functional impairment” when compared to 
2a “severe mental disorders–none to low functional impairment” group and other variables in the 
model were held constant, the “severe mental disorders–none to low functional impairment” 
results showed no descriptive variables were significant. Reference category 6b “neurological 
conditions–high functional impairment” when compared to 3a “neurological conditions–none to 
low functional impairment” group and other variables in the model were held constant, the 
“neurological conditions–none to low functional impairment” results showed this subgroup was 
much less likely to receive psychotherapy (OR = 0.47; 95% CI= 0.28, 0.77; p < .01) and nearly 
2.5 times and more likely to receive psychiatric medication (OR = 2.45; 95% CI= 1.02, 5.89; p < 
.05);. Descriptive variables such as gender, age, and the number of visits during observation period 
were not statistically significant. Reference category 6b “neurological conditions–high functional 
impairment” when compared to 4b “common mental disorders–high functional impairment” group 
and other variables in the model were held constant, the “common mental disorders–high 
functional impairment”  results showed this subgroup was 2.5 times and much more likely to be 
female (OR = 2.55; 95% CI= 1.67, 3.89; p < .01) and about the same age (OR = 1.02; 95% CI= 
1.00, 1.03; p < .05). In terms of treatment information, LCA class 4b was much less likely to 




was not statistically significant, and there were fewer visits during the observation period (OR = 
0.89; 95% CI= 0.85, 0.93; p < .01). Reference category 6b “neurological conditions–high 
functional impairment” when compared to 5b “severe mental disorders–high functional 
impairment” group and other variables in the model were held constant, the “severe mental 
disorders–high functional impairment“ were about the same age (OR = 1.02; 95% CI= 1.00, 1.04; 
p < .05); had somewhat fewer visits during the observation period (OR = 0.92; 95% CI= 0.87, 
0.97; p < .01); and other descriptive variables such as gender, psychotherapy received, and 
psychiatric medication received were not statistically significant. Based on model fitting 
information, there was significant improvement over the null model [X2 (25, N= 914) = 373.25, p= 
< .01]. The Pearson’s chi-square test indicated model fit [X2 (4,410, N=914) =4,330.15, p=0.80] 
and also the deviance chi-square test indicated model fit [X2 (4,410, N=914) =2,498.30, p=1.00]. 
 
Table 36. Multinomial Logistic Regression for 6-Class Model: Parameter Estimates of 
Descriptive Predictor Variables with Reference Category NCs– 
High Functional Impairment (Class 6b) 





CMDs– None to Low Functional Impairment (Class 1a)    
Gender   2.20* 0.30 1.23–3.91 
Age 1.01 0.01 1.00–1.03 
Psychotherapy Received  1.29 0.30 0.72–2.32 
Psychiatric Medication    0.08** 0.31 0.04–0.14 
Number of Visits During Observation Period  0.92* 0.03 0.86–0.98 
    
 




Note. Bolded and * p <.05; ** p <.01. Binary independent variables included: gender (female/male), psychotherapy 
received (yes/no), and psychiatric medication received (yes/no). Continuous independent variables included: age and 
number of visits during observation period.  
 
 
    





SMDs– None to Low Functional Impairment (Class 2a)     
Gender 1.68 0.36 0.84–3.38 
Age 1.02 0.01 1.00–1.04 
Psychotherapy Received  0.81 0.35 0.41–1.62 
Psychiatric Medication 1.01 0.47 0.41–2.53 
Number of Visits During Observation Period 1.00 0.03 0.93-1.05 
NCs– None to Low Functional Impairment (Class 3a)    
Gender 0.81 0.25 0.50–1.33 
Age 0.98 0.01 0.96–1.00 
Psychotherapy Received     0.47** 0.26 0.28–0.77 
Psychiatric Medication  2.45* 0.45 1.02–5.89 
Number of Visits During Observation Period      0.98 0.02 0.94-1.03 
CMDs– High Functional Impairment (Class 4b)    
Gender   2.55** 0.22 1.67–3.89 
Age 1.02* 0.01 1.00–1.03 
Psychotherapy Received       1.12 0.22 0.73–1.72 
Psychiatric Medication    0.15** 0.24 0.09–0.24 
Number of Visits During Observation Period    0.89** 0.02 0.85–0.93 
SMDs– High Functional Impairment (Class 5b)    
Gender 0.88 0.24 0.55–1.41 
Age  1.02* 0.01 1.00–1.04 
Psychotherapy Received  1.17 0.26 0.70–1.95 
Psychiatric Medication 0.78 0.31 0.43–1.43 
Number of Visits During Observation Period     0.92** 0.03 0.87–0.97 







Figure 12. Multinomial Logistic Regression for 6-Class Model: Parameter Estimates of 
Descriptive Predictor Variables with Reference Category SMDs–High Functional 















Multinomial Logistic Regression Model 1 “None to Low Functional Impairment” and 
“High Functional Impairment”   
 LCA subgroups revealed two care pathways, and when we compare pathway one “none 




differences were observed. LCA subgroups 1a “common mental disorders–none to low functional 
impairment” were less likely to be on psychiatric medication when compared to 4b “common 
mental disorders–high functional impairment” (OR = 0.52; 95% CI= 0.32, 0.85; p < .05), and the 
other predictor variables such as gender, age, psychotherapy received, and number of visits during 
the observation period were not statistically significant. LCA subgroups 2a “severe mental 
disorders–none to low functional impairment” had a few more visits during the observation period 
when compared to 5b “severe mental disorders–high functional impairment” (OR = 1.08; 95% CI= 
1.01, 1.16; p < .05), and the other predictor variables such as gender, age, psychotherapy received, 
and psychiatric medication received were not statistically significant. LCA subgroups 3a 
“neurological conditions–none to low functional impairment” received fewer psychotherapy 
sessions (OR = 0.47; 95% CI= 0.28, 0.77; p < .01) and were more likely to receive psychiatric 
medication (OR = 2.45; 95% CI= 1.02, 5.89; p < .05) when compared to 6b “neurological 
conditions–high functional impairment,” and other predictor variables such as gender, age, and 
number of visits during the observation period were not statistically significant. Overall, the 
takeaways for clinicians would be that common mental disorders that have higher levels of 
functional impairment and will likely require psychiatric medication management. Severe mental 
disorders with none to low functional impairment may be willing to stay in treatment somewhat 
longer. Neurological conditions with none to low functional impairment were less likely to receive 
psychotherapy but did receive psychiatric medication more often. Potential reasons could be that 
patients were more likely to engage with psychiatric medication management vs. psychotherapy, 




primary care clinic or hospital. The reasons patients who have neurological conditions with high 
functional impairment received psychiatric medication less often deserves further consideration.  
Multinomial Logistic Regression Model 2: Clinical Symptom Predictor Variables  
An unordered multinomial logistic regression was used to estimate correlates of clinical 
symptoms by mental health class. The model included the following independent variables: 
“clinically depressed,” “functionally impaired,” and “suicidal.” The dependent variable was the 
categorical LCA class membership 1a–6b and the reference categories of “common mental 
disorders–none to low functional impairment,” “severe mental disorders–none to low functional 
impairment,” “neurological conditions–none to low functional impairment,” “common mental 
disorders–high functional impairment,” “severe mental disorders–high functional impairment,” 
and “neurological conditions–high functional impairment” selected. The odds ratios (OR) were 
calculated, and the 95% confidence interval (CI) for each independent variable included, with 
significance value set to .05 (*). The goodness of fit was determined based on chi-square tests of 
Pearson’s and deviance. There was no multicollinearity of independent variables and no violations 
of assumptions met. Sample characteristics of clinical symptom predictor variables within the LCA 
class were included for the unordered multinomial logistic regression model 2. 
LCA class 1a the common mental disorders–none to low functional impairment subgroup 
(n=105) included patients that were subclinical for clinical depression (M=7.5, S.D.=6.53) and 
functional impairment (M=11.76, S.D.=1.83) scores, and rarely endorsed suicidality (n=1, 2.2%) 
(see tables 37–38). LCA class 2a the severe mental disorders––none to low functional impairment 




and almost functionally impaired (M=11.13, S.D.=2.18), but infrequently were suicidal (n=1, 1%). 
LCA class 3a the neurological conditions––none to low functional impairment subgroup (n=101) 
included patients that had low clinical depression scores (M=4.43, S.D.=5.4), and were almost 
functionally impaired (M=11.36, S.D.=1.95), but had more suicidality (n=15, 14.9%). LCA class 
4b the common mental disorders––high functional impairment subgroup (n=353) included patients 
that were clinically depressed (M=19.64, S.D.=8.35), functionally impaired (M=21.74, 
S.D.=7.91), and occasionally were suicidal (n=10, 2.8%). LCA class 5b the severe mental 
disorders––high functional impairment subgroup (n=119) included patients that were again, 
clinically depressed (M=15.92, S.D.=10.12), functionally impaired (M=26.2, S.D.=9.97), and 
suicidal (n=14, 11.8%). The LCA class 6b neurological conditions––high functional impairment 
subgroup (n=191) had patients with subclinical depression (M=9.4, S.D.=7.03), but whom were 
functionally impaired (M=18.49, S.D.=6.46), and often suicidal (n=50, 26.2%). Overall, patients 
were less depressed, more functional, and rarely suicidal for LCA subgroups 1-3a, however, for 
LCA subgroups 4-6b clinical symptoms were much more severe. Differences between subgroups 
were compared in the multinomial logistic regression model 2.  
 
Table 37. Clinical Symptom Predictor Variables within LCA Class 1–3a 
  
Class 1a (n=105) 
 
Class 2a (n=45) 
 
Class 3a (n=101) 
 n (%) M(SD) n (%) M(SD) n (%) M(SD) 
Clinically Depressed  n/a 7.6 (6.53) n/a 12.29 (6.78) n/a 4.43 (5.4) 
Functional Disability  n/a 11.76 (1.83) n/a 11.13 (2.18) n/a 11.36 (1.95) 






Multinomial Logistic Regression Model 2: Reference Category 2a “Severe Mental 
Disorders–None to Low Functional Impairment” 
Reference category 2a “severe mental disorders–none to low functional impairment” 
when compared to the 1a “common mental disorders–none to low functional impairment” 
subgroup and other variables in the model were held constant, the 1a “common mental disorders–
none to low functional impairment” subgroup were somewhat more clinically depressed (OR = 
1.10; 95% CI= 1.04, 1.17; p < .01), whereas functional impairment and suicidality were not 
statistically significant (see table 39, figure 13). Again, for reference category 2a “severe mental 
disorders–none to low functional impairment” when other variables in the model were held 
constant parameter estimates showed when compared to the 3a “neurological conditions–none to 
low functional impairment” subgroup, patients with “neurological conditions–none to low 
functional impairment” were much less likely clinically depressed (OR = 0.88; 95% CI= 0.82, 
0.95; p < .01), less likely functionally impaired (OR = 0.76; 95% CI= 0.58, 1.00; p < .01), and 
Table 38. Clinical Symptom Predictor Variables within LCA Class 4–6b  
  
Class 4b (n=353) 
 
Class 5b (n=119) 
 
Class 6b (n=191) 
 n (%) M(SD) n (%) M(SD) n (%) M(SD) 
Clinically Depressed  n/a 19.64 (8.35) n/a 15.92 (10.12) n/a 9.4 (7.03) 
Functional Disability  n/a 21.74 (7.91) n/a 26.2 (9.97) n/a 18.49 (6.46) 




suicidality was not interpretable. For reference category 2a “severe mental disorders–none to low 
functional impairment” when other variables in the model were held constant parameter estimates 
showed when compared to 4b “common mental disorders–high functional impairment” subgroup, 
patients with “common mental disorders–high functional impairment” were more likely clinically 
depressed (OR = 1.17; 95% CI= 1.05, 1.29; p < .01), however, functional impairment and 
suicidality were not interpretable for this model. For reference category 2a “severe mental 
disorders–none to low functional impairment” when other variables in the model were held 
constant parameter estimates showed when compared to the 5b “severe mental disorders–high 
functional impairment” subgroup and 6b “neurological conditions–high functional impairment” 
subgroup clinical symptom variables were not statistically significant or interpretable. Based on 
model fitting information, there was significant improvement over the null model [X2 (15, N= 914) 
= 657.99, p= < .01]. The Pearson’s chi-square test indicated model fit [X2 (1,325, N=914) =695.67, 











Table 39. Multinomial Logistic Regression for 6-Class Model: Parameter Estimates of 
Clinical Symptom Predictor Variables for Reference Category SMDs– 
None to Low Functional Impairment (Class 2a) 








CMDs– None to Low Functional Impairment (Class 1a)    
Clinically Depressed     1.10** 0.03 1.04–1.17 
Functional Impairment    0.89 0.13 0.68–1.15 
Suicidality     0.34 1.45 0.02–5.74 
NCs– None to Low Functional Impairment (Class 3a)    
Clinically Depressed   0.88** 0.04 0.82–0.95 
Functional Impairment 0.76* 0.14 0.58–1.00 
Suicidality       n/a n/a n/a 
CMDs– High Functional Impairment (Class 4b)     
Clinically Depressed    1.17** 0.05 1.05–1.29 
Functional Impairment n/a n/a n/a 
Suicidality  n/a n/a n/a 
SMDs– High Functional Impairment (Class 5b)    
Clinically Depressed 1.10 0.05 1.00–1.21 
Functional Impairment n/a n/a n/a 
Suicidality  n/a n/a n/a 
NCs– High Functional Impairment (Class 6b)    
Clinically Depressed 1.00 0.05 0.91–1.11 
Functional Impairment n/a n/a n/a 
Suicidality  n/a n/a n/a 
 
Note. Bolded and * p <.05; ** p <.01. Continuous independent variables included: ZLDSI Depression Total Scores, 












Figure 13. Multinomial Logistic Regression for 6-Class Model: Clinical Predictor Variables 
































Multinomial Logistic Regression Model 2: Reference Category 3a “Neurological 
Conditions–None to Low Functional Impairment” 
 Reference category 3a “neurological conditions–none to low functional impairment” 
when compared to the 1a “common mental disorders–none to low functional impairment” 




none to low functional impairment” subgroup were much more likely to be clinically depressed 
(OR = 1.25; 95% CI= 1.17, 1.33; p < .01) and much less likely suicidal (OR = 0.04; 95% CI= 0, 
0.34; p < .01). Functional impairment was not statistically significant for this model (see table 40, 
figure 14). Reference category 3a “neurological conditions–none to low functional impairment” 
when compared to 2a “severe mental disorders–none to low functional impairment” subgroup and 
other variables in the model were held constant, the “severe mental disorders–none to low 
functional impairment” patients were more likely depressed (OR = 1.13; 95% CI= 1.06, 1.22; p < 
.01) and more likely functionally impaired (OR = 1.32; 95% CI= 1.00, 1.72; p < .05), but were less 
likely suicidal (OR = 0.11; 95% CI= 0.01, 0.90; p < .05). Reference category 3a “neurological 
conditions–none to low functional impairment” when compared to 4b “common mental disorders–
high functional impairment” subgroup and other variables in the model were held constant, the 
“common mental disorders–high functional impairment” revealed that patients were much more 
likely clinically depressed (OR = 1.32; 95% CI= 1.19, 1.47; p < .01), whereas functional 
impairment was not interpretable, and suicidality was not statistically significant. Reference 
category 3a “neurological conditions–none to low functional impairment” when compared to 5b 
“severe mental disorders–high functional impairment” subgroup and other variables in the model 
were held constant, the “severe mental disorders–high functional impairment” were much more 
likely clinically depressed (OR = 1.24; 95% CI= 1.12, 1.38; p < .01), again functional impairment 
was not interpretable and suicidality was not statistically significant. Reference category 3a 
“neurological conditions–none to low functional impairment” when compared to 6b “neurological 




constant, the “neurological conditions–high functional impairment” subgroup were more likely to 
be clinically depressed (OR = 1.14; 95% CI= 1.03, 1.26; p < .05). Functional impairment and 
suicidality were not interpretable. Based on model fitting information, there was significant 
improvement over the null model [X2 (15, N= 914) = 657.99, p= < .01]. The Pearson’s chi-square 
test indicated model fit [X2 (1,325, N=914) =695.67, p=1.00] and also the deviance chi-square test 
indicated model fit  [X2 (1,325, N=914) =376.22, p=1.00]. 
 
Table 40. Multinomial Logistic Regression for 6-Class Model: Clinical Predictor Variables 
with Reference Category NCs– None to Low Functional Impairment (Class 3a) 








CMDs– None to Low Functional Impairment (Class 1a)    
Clinically Depressed     1.25** 0.03 1.17–1.33 
Functional Impairment 1.16 0.09 0.98–1.38 
Suicidality      0.04** 1.14 0–0.34 
SMDs– None to Low Functional Impairment (Class 2a)    
Clinically Depressed    1.13** 0.04 1.06–1.22 
Functional Impairment  1.32* 0.14 1.00–1.72 
Suicidality   0.11* 1.08 0.01–0.90 
CMDs– High Functional Impairment (Class 4b)     
Clinically Depressed    1.32** 0.05 1.19–1.47 
Functional Impairment n/a n/a n/a 
Suicidality  0.17 1.13 0.02–1.60 
SMDs– High Functional Impairment (Class 5b)    
Clinically Depressed    1.24** 0.05 1.12–1.38 
Functional Impairment n/a n/a n/a 
Suicidality       0.69 1.13 0.08–6.37 




    








Clinically Depressed   1.14* 0.05 1.03–1.26 
Functional Impairment n/a n/a n/a 
Suicidality  n/a n/a n/a 
 
Note. Bolded and * p <.05; ** p <.01. Continuous independent variables included: ZLDSI Depression Total Scores, 
WHODAS Functional Impairment Total Scores. Binary independent variables included: suicidality (yes/no).  
 
 
Figure 14. Multinomial Logistic Regression for 6-Class Model: Clinical Predictor Variables 




















Multinomial Logistic Regression Model 2: Reference Category 4b “Common Mental 
Disorders–High Functional Impairment” 
Reference category 4b “common mental disorders–high functional impairment” when 
compared to the 1a “common mental disorders–none to low functional impairment” subgroup and 
other variables in the model were held constant, the “common mental disorders–none to low 
functional impairment” subgroup were much less likely to be functionally impaired (OR = 0; 95% 
CI= 0, 0.02; p < .01), and clinical symptom variables such as depression and suicidality were not 
statistically significant (see table 41, figure 15). Reference category 4b “common mental 
disorders–high functional impairment” when compared to 2a “severe mental disorders–none to 
low functional impairment” group and other variables in the model were held constant, the “severe 
mental disorders–none to low functional impairment” revealed patients were much less likely 
clinically depressed (OR = 0.86; 95% CI= 0.78, 0.95; p < .01), and much less likely functionally 
impaired (OR = 0; 95% CI= 0, 0.02; p < .01), and suicidality was not statistically significant. 
Reference category 4b “common mental disorders–high functional impairment” when compared 
to 3a “neurological conditions–none to low functional impairment” subgroup and other variables 
in the model were held constant, the “neurological conditions–none to low functional impairment” 
revealed that no clinical symptoms were statistically significant and suicidality was not 
interpretable for this model. Reference category 4b “common mental disorders–high functional 
impairment“ when compared to 5b “severe mental disorders–high functional impairment” 




functional impairment” subgroup were slightly less likely clinically depressed (OR = 0.94; 95% 
CI= 0.92, 0.96; p < .01), and somewhat more likely functionally impaired (OR = 1.07; 95% CI= 
1.04, 1.10; p < .01). Notably, LCA class 5b was 4 times and much more likely to be suicidal (OR =  
4.03; 95% CI= 1.68, 9.70; p < .01). Reference category 4b “common mental disorders–high 
functional impairment“ when compared to 6b “neurological conditions–high functional 
impairment” subgroup and other variables in the model were held constant, the “neurological 
conditions–high functional impairment” subgroup were much less likely clinically depressed 
(OR = 0.86; 95% CI= 0.84, 0.89; p < .01), and somewhat less likely functionally impaired (OR = 
0.97; 95% CI= 0.93, 1.00; p < .05). LCA class 6b, were nearly 12 times and much more likely to 
be suicidal (OR = 11.86; 95% CI= 5.42, 25.93; p < .01). Based on model fitting information, there 
was significant improvement over the null model [X2 (15, N= 914) = 657.99, p= < .01]. The 
Pearson’s chi-square test indicated model fit [X2 (1,325, N=914) =695.67, p=1.00] and also the  
Table 41. Multinomial Logistic Regression for 6-Class Model: Clinical Predictor Variables with 
Reference Category CMDs–High Functional Impairment (Class 4b) 





CMDs– None to Low Functional Impairment (Class 1a)    
     Clinically Depressed 0.95 0.05 0.86–1.04 
     Functional Impairment    0** 0.71 0–0.02 
     Suicidality  0.21 1.52 0.01–4.16 
SMDs– None to Low Functional Impairment (Class 2a)    
     Clinically Depressed     0.86** 0.05 0.78–0.95 
     Functional Impairment   0** 0.71 0–0.02 






















NCs– None to Low Functional Impairment (Class 3a)    
     Clinically Depressed 0.76 0.05 0.68–0.84 
     Functional Impairment 0 0.71 0–0.01 
     Suicidality  n/a n/a n/a 
SMDs–High Functional Impairment (Class 5b)    
     Clinically Depressed  0.94** 0.01 0.92–0.96 
     Functional Impairment  1.07** 0.01 1.04–1.10 
     Suicidality   4.03** 0.45 1.68–9.70 
NCs–High Functional Impairment (Class 6b)    
     Clinically Depressed  0.86** 0.02 0.84–0.89 
     Functional Impairment     0.97* 0.02 0.93–1.00 
     Suicidality  11.86** 0.40 5.42–25.93 
 
Note. Bolded and * p <.05; ** p <.01. Continuous independent variables included: ZLDSI Depression Total Scores, 
WHODAS Functional Impairment Total Scores. Binary independent variables included: suicidality (yes/no). 
 
Figure 15. Multinomial Logistic Regression for 6-Class Model: Clinical Predictor Variables  




Multinomial Logistic Regression Model 2: Reference Category 5b “Severe  Mental 
Disorders–High Functional Impairment” 
Reference category 5b “severe mental disorders–high functional impairment” when 
compared to 1a “common mental disorders–none to low functional impairment” subgroup and 
other variables in the model were held constant, the “common mental disorders–none to low 
functional impairment” subgroup were much less likely functionally impaired (OR = 0; 95% CI= 
0, 0.01; p < .01) and were less likely suicidal (OR = 0.05; 95% CI= 0, 1.02; p < .05), and clinical  
depression was not statistically significant (see table 42, figure 16). Reference category 5b “severe 
mental disorders–high functional impairment” when compared to 2a “severe mental disorders–
none to low functional impairment” group and other variables in the model were held constant, the 
“severe mental disorders–none to low functional impairment” patients were much less likely 
functionally impaired (OR = 0; 95% CI= 0, 0.02; p < .01) and other clinical symptoms were not 
statistically significant. Reference category 5b “severe mental disorders–high functional 
impairment” when compared to 3a “neurological conditions–none to low functional impairment” 
subgroup and other variables in the model were held constant, the “neurological conditions–none 
to low functional impairment” results showed patients were much less likely depressed (OR = 
0.81; 95% CI= 0.73, 0.89; p < .01) and much less likely functionally impaired (OR = 0; 95% CI= 
0, 0.01; p < .01). Reference category 5b “severe mental disorders–high functional impairment” 
when compared to 4b “common mental disorders–high functional impairment” subgroup and other 
variables in the model were held constant, the “common mental disorders–high functional 




CI= 1.03, 1.09; p < .01), much less functionally impaired (OR = 0.93; 95% CI= 0.91, 0.96; p < 
.01), and were much less likely to be suicidal (OR = 0.25; 95% CI= 0.10, 0.60; p < .01). Reference 
category 5b “severe mental disorders–high functional impairment” subgroup when compared to 
6b “neurological conditions–high functional impairment” subgroup and other variables in the 
model were held constant, the “neurological conditions–high functional impairment” results 
showed patients were somewhat less clinically depressed (OR = 0.92; 95% CI= 0.89, 0.95; p < 
.01), somewhat less functionally impaired (OR = 0.90; 95% CI= 0.87, 0.93; p < .01), and nearly 3 
times and much more likely to be suicidal (OR = 2.94; 95% CI= 1.43, 6.06; p < .01).  Based on 
model fitting information, there was significant improvement over the null model [X2 (15, N= 914) 
= 657.99, p= < .01]. The Pearson’s chi-square test indicated model fit [X2 (1,325, N=914) =695.67, 
p=1.00] and also the deviance chi-square test indicated model fit [X2 (1,325, N=914) =376.22, 
p=1.00]. 
 
Table 42. Multinomial Logistic Regression for 6-Class Model: Clinical Symptom Predictor 
Variables with Reference Category SMDs–High Functional Impairment (Class 5b) 
Reference Category “SMDs– High Functional Impairment” 
(Class 5b) Odds Ratio  Standard Error 
95% Confidence 
Interval 
CMDs– None to Low Functional Impairment (Class 1a)    
Clinically Depressed   1.01 0.05 0.92–1.11 
Functional Impairment    0** 0.71 0–0.01 
Suicidality      0.05* 1.52 0–1.02 
SMDs– None to Low Functional Impairment (Class 2a)    
Clinically Depressed   0.91 0.05 0.82–1.01 
Functional Impairment    0** 0.71 0–0.02 




    
     
Reference Category “SMDs– High Functional Impairment” 
(Class 5b) Odds Ratio Standard Error 
95% Confidence 
Interval 
NCs– None to Low Functional Impairment (Class 3a)    
Clinically Depressed       0.81** 0.05 0.73–0.89 
Functional Impairment    0** 0.71 0–0.01 
Suicidality          1.44 1.13 0.16–13.28 
CMDs– High Functional Impairment (Class 4b)    
Clinically Depressed         1.07** 0.01 1.03–1.09 
Functional Impairment      0.93** 0.01 0.91–0.96 
Suicidality          0.25**            0.45 0.10–0.60 
NCs– High Functional Impairment (Class 6b)    
Clinically Depressed     0.92** 0.02 0.89–0.95 
Functional Impairment         0.90** 0.02 0.87–0.93 
Suicidality          2.94** 0.37 1.43–6.06 
    
Note. Bolded and * p <.05; ** p <.01. Continuous independent variables included: ZLDSI Depression Total Scores, 
WHODAS Functional Impairment Total Scores. Binary independent variables included: suicidality (yes/no). 
 
Multinomial Logistic Regression Model 2: Reference Category 6b “Neurological Conditions–
High Functional Impairment” 
              Reference category 6b “neurological conditions–high functional impairment” when 
compared to 1a “common mental disorders–none to low functional impairment” subgroup and other 
variables in the model were held constant, the “common mental disorders–none to low functional 
impairment” subgroup were somewhat more clinically depressed (OR = 1.10; 95% CI= 1.00, 1.21; 




(OR = 0.02; 95% CI= 0, 0.32; p < .01) (see table 43, figure 17). Reference category 6b “neurological 
conditions–high functional impairment” when compared to 2a “severe mental disorders–none to low 
functional impairment” subgroup and other variables in the model were held constant, the “severe 
mental disorders–none to low functional impairment” results showed patients were much less likely 
functionally impaired (OR =0; 95% CI=0, 0.02; p < .01) and less likely suicidal (OR = 0.05; 95% CI= 
















Figure 16. Multinomial Logistic Regression for 6-Class Model: Clinical Predictor Variables  




Reference category 6b “neurological conditions–high functional impairment” when compared to 
3a “neurological conditions–none to low functional impairment” subgroup and other variables in 
the model were held constant, the “neurological conditions–none to low functional impairment” 
results showed this subgroup were less likely clinically depressed (OR = 0.88; 95% CI= 0.79, 0.97; 
p < .05) and much less likely functionally impaired (OR = 0; 95% CI= 0, 0.01; p < .01), and 
suicidality was not statistically significant. Reference category 6b “neurological conditions–high 
functional impairment” when compared to 4b “common mental disorders–high functional 
impairment” subgroup and other variables in the model were held constant, the “common mental 
disorders–high functional impairment”  results showed this subgroup were somewhat more 
clinically depressed (OR = 1.16; 95% CI=1.13, 1.20; p < .01); somewhat more functionally 
impaired (OR = 1.04; 95% CI= 1.00, 1.07; p < .05); and were much less likely suicidal (OR = 0.08; 
95% CI= 0.04, 0.18; p < .01). Reference category 6b “neurological conditions–high functional 
impairment” when compared to 5b “severe mental disorders–high functional impairment” 
subgroup and other variables in the model were held constant, the “severe mental disorders–high 
functional impairment“ were again, somewhat more clinically depressed (OR = 1.09; 95% CI= 
1.06, 1.13; p < .01); somewhat more functionally impaired (OR = 1.11; 95% CI= 1.07, 1.15; p < 
.01); and much less likely suicidal (OR = 0.34; 95% CI= 0.17, 0.70; p < .01). Based on model 
fitting information, there was significant improvement over the null model [X2 (15, N= 914) = 
657.99, p= < .01]. The Pearson’s chi-square test indicated model fit [X2 (1,325, N=914) =695.67, 






Note. Bolded and * p <.05; ** p <.01. Continuous independent variables included: ZLDSI Depression Total Scores, 








Table 43. Multinomial Logistic Regression for 6-Class Model: Clinical Symptom Predictor 
Variables with Reference Category NCs–High Functional Impairment (Class 6b) 
Reference Category “NCs– High Functional Impairment” 
(Class 6b) 
Odds 
Ratio  Standard Error 95% Confidence Interval 
CMDs– None to Low Functional Impairment (Class 1a)    
Clinically Depressed  1.10* 0.05 1.00–1.21 
Functional Impairment  0** 0.71 0–0.02 
Suicidality      0.02** 1.48 0–0.32 
SMDs– None to Low Functional Impairment (Class 2a)    
Clinically Depressed 1.00 0.05 0.90–1.10 
Functional Impairment   0** 0.71 0–0.02 
Suicidality    0.05* 1.45 0–0.90 
NCs– None to Low Functional Impairment (Class 3a)    
Clinically Depressed   0.88* 0.05 0.79–0.97 
Functional Impairment 0** 0.71 0–0.01 
Suicidality  0.49 1.08 0.06–4.09 
CMDs– High Functional Impairment (Class 4b)    
Clinically Depressed   1.16** 0.02 1.13–1.20 
Functional Impairment 1.04* 0.02 1.00–1.07 
Suicidality    0.08** 0.40 0.04–0.18 
SMDs– High Functional Impairment (Class 5b)    
Clinically Depressed 1.09** 0.42 1.06–1.13 
Functional Impairment 1.11** 0.02 1.07–1.15 




Figure 17. Multinomial Logistic Regression for 6-Class Model: Clinical Symptom Predictor 





Multinomial Logistic Regression Model 2 “None to Low Functional Impairment” and 
“High Functional Impairment”   
 LCA subgroups revealed two care pathways, and when we compare pathway one “none 
to low functional impairment” and pathway two “high functional impairment” the following 
differences were observed. LCA subgroups 1a “common mental disorders–none to low functional 
impairment” were much less likely functionally impaired when compared to 4b “common mental 




variables such as clinically depressed and suicidality were not statisticallly significant. LCA 
subgroups 2a “severe mental disorders–none to low functional impairment” were much less likely 
functionally impaired when compared to 5b “severe mental disorders–high functional impairment” 
(OR = 0; 95% CI= 0, 0.01; p < .01), and other predictor variables such as clinically depressed and 
suicidality were not statistically significant. LCA subgroups 3a “neurological conditions–none to 
low functional impairment” were less likely clinically depressed (OR = 0.88; 95% CI= 0.79, 0.97; 
p < .05) and were much less likely functionally impaired (OR = 0; 95% CI= 0, 0.01; p < .01) when 
compared to 6b “neurological conditions–high functional impairment” and suicidality was not 
statistically significant. Therefore, LCA subgroup 3a represents a clinically less severe 
neurological conditions subgroup. Altogether, the main finding for clinicians when we compare 
the severity of clinical symptoms such as depression, suicidality, and functional impairment has 













Key Results Summary  
The present study explored characteristics of unknown mental health patterns in Haiti. 
Following the 2010 earthquake a mental health infrastructure was established in a post-disaster 
setting where formalized services were not readily available. Findings provide key insights into 
current mental health priorities, the mental health infrastructure and pathways to care, and set out 
implications for clinical practice. Specifically, the results reinforce current PIH and ZL practices 
that mental health treatment has been beneficial to patients. A latent class analysis allowed us to 
identify clinical needs without previous assumptions, because the data clusters patients based on 
known indicators of mental disorders such as the patient’s diagnosis, mood symptoms like 
depression and suicidality, and functional impairment into clinical subgroups. A 6-class model 
revealed the importance of mental health treatment for common mental disorders, severe mental 
disorders, and neurological conditions. The best fitting model showed that there were two clinical 
pathways defined by the primary diagnosis indicator category, functional impairment, and the 
severity of mood symptoms.  
Implications from the study results will be useful to inform current mental health practices 
and unify task-sharing model frameworks. A strength to the present task-sharing model was the 
movement beyond common mental disorders, to further include severe mental disorders and 
neurological conditions. Additionally, the presented LCA model includes psychiatric medication 
management, which has been shown to be a high clinical priority in LMICs (Rathod, et al., 2017). 




While there have been barriers to mental health treatment implementation PIH and ZL demonstrate 
the ability to identify and amend presented challenges at the macro and micro level. It ensures the 
delivery of quality clinical services in a global mental health setting. Rebuilding healthcare, and 
establishing the mental healthcare infrastructure has since provided a definitive example of 
overcoming barriers on a large-scale. A second example, at the micro level has been to identify 
when there were no available screening tools for depression that reflected the local culture. PIH 
and ZL then developed and validated the ZLDSI to provide an accurate measure of depression 
symptoms. Taken together, the results provide data-driven support that the established mental 
health infrastructure has been feasible, accessible, and had high levels of treatment engagement. 
Future research on the mental health infrastructure from PIH and ZL may offer guidelines for 
global mental health researchers to establish standards of care.  
Mental Health Priorities  
The data-driven results present key priorities for mental health in Haiti. In terms of the case 
identification, patient referral, and diagnosis the following considerations are provided. Case 
identification occurs at present with clinicians and community providers through care pathways. 
After patients are triaged based on the ZLDSI screening tool for depression, clinical observation, 
and expert oversight from supervisors determine the appropriate level of care. Minimal 
information was included on case identification prior to the patient’s arrival to the hospital or 
clinic. Patient referrals however, typically included community providers, clinical staff, other 
medical personnel, and traditional healers. High–volume treatment utilization areas were Hôpital 




increased trust within the community. Psychologists delivered the majority of psychosocial 
interventions (83.04%), and of the total sample 67.1% of patients received psychosocial services. 
For psychiatric medication delivery there were very few medical doctors available. Medical 
doctors (generalists) delivered .6% of psychiatric services, and medical doctors alongside 
psychologists 11.27% of psychiatric services. The treatment coverage however, for the total 
number of patients whom received psychiatric medication management was high (60.3%). 
Therefore, results suggest, that while psychiatric medication delivery was high that the direct 
access to a medical doctor (generalist) was low.  Further, the mental health treatment engagement 
with the nursing and social work teams was also very low (less than 1%). For all practitioners it is 
likely the patient caseload is incredibly high and increases the potential for provider burnout. ZL 
expert clinicians explained that coordination with nursing has been minimal and that nurses likely 
due to program budgets are not assigned to mental health service delivery on a full-time basis. ZL 
clinicians described that access to even one full-time nurse for mental health would be incredibly 
useful to increase psychiatric medication delivery. Along these lines, it is evident there is a high 
need for medical doctors (generalists), including those with a specialization in psychiatry, and 
again how this will configure into current program budgets should be addressed at the NGO level. 
Visits during the observation period ranged from 1-3 however, it was unclear whether this was due 
to attrition or clinical improvement. ZL expert clinicians described a major barrier to ongoing 
mental health treatment is transportation, and that previously clinical treatment that had better 
attendance had provided patients with travel vouchers and offered a meal. At the management and 




better understanding the barriers to ongoing mental health treatment for patients might improve 
current provider skill package delivery.  
Nevertheless, the data suggest there was high treatment engagement across mental 
disorders. The most frequent primary diagnosis included (1) major depressive disorder (60.3%) 
and generalized anxiety disorder (27.2%) for common mental disorders, (2) psychotic spectrum 
disorders (47.6%) and bipolar disorder (23.7%) for severe mental disorders, and (3) epilepsy 
(88.8%) for neurological conditions. Patients were infrequently diagnosed with co-occurring 
psychological disorders [common mental disorders (12.6%), severe mental disorders (0.03%), 
neurological conditions (0.04%)]. Common mental disorders were 2–3 times more likely to be 
female, which is consistent with previous literature (Kessler, 2003; National Collaborating Centre 
for Mental Health, 2011). As one might anticipate, common mental disorders most often received 
psychosocial interventions, whereas more often severe mental disorders and neurological 
conditions received pharmacological treatment. While common mental disorder subgroups 
frequently received psychosocial interventions [class 1a “common mental disorders–none to low 
functional impairment” (75.2%)], when we examine more severe clinical subgroups the number 
of patients who received psychosocial interventions were actually comparable [class 4b “common 
mental disorders –high functional impairment” (70.6%)]. For example, psychosocial interventions 
were still regularly received by severe mental disorders [class 2a “severe mental disorders–none 
to low functional impairment” (60%); class 5b “severe mental disorders–high functional 
impairment” (70.6%)] and neurological conditions [class 3a “neurological conditions–none to low 




(62.8%)]. Priority medications included anticonvulsants, antidepressants, antipsychotics, and 
anxiolytics. Patients were frequently prescribed Amitriptyline and Fluoxetine for common mental 
disorders, Risperidone for severe mental disorders, and Carbamazepine for neurological 
conditions. Anxiolytics were rarely prescribed for common mental disorders, severe mental 
disorders, or neurological conditions. In terms of other clinical needs, the current treatment targets 
of depressed mood, suicidality, and functional impairment were reinforced by the high rates 
observed in the total study sample. Increased needs exist for neurological conditions, in particular 
epilepsy and findings are consistent with previous research that shows an increased prevalence of 
epilepsy in Haiti (Collaborators, G. B. D. E., 2019). Moreover, neurological conditions, that were 
comprised diagnostically of epilepsy were shown to be at especially high-risk for suicidality. 
Severe mental disorders compared to common mental disorders revealed that the severe mental 
disorders subgroup also was at high-risk and 4 times as likely to be suicidal. Below how these 
results fit into the current Haitian mental health infrastructure, and suggestions for clinical practice 
are described. 
Mental Health Infrastructure  
Electronic Health Records. A major benefit to the present study was the use of electronic 
health records. In the global research literature dissemination studies do not always implement 
such data systems however, the present study strengthens the argument that EHR within primary 
care would be valuable. LMICs are often the categorization for low-resource settings, however, 
EHR provides the advantage of big data that can be used for epidemiological and public health 




produces clinical targets to ensure quality oversight in a more infrastructure specific, and country 
specific way. For example, the finding that epilepsy may be more prevalent for Haitians would not 
be readily identified by research that relies on more general categorizations of LMICs. Another 
example, includes present mental health treatment barriers to psychiatric medication management 
has likely been due to minimal collaboration with nursing, but is a result that would not generalize 
to all LMICs. At one point, the term LMICs was perhaps necessary in order to understand 
healthcare priorities globally but mental health infrastructure that includes EHR as part of the 
dissemination process again allows for individualized care, quality oversight, and ensures that 
there will be a country specific assessment.  
At present, PIH and ZL offer a model for EHR data that includes crucial information on 
(1) basic demographics such as age, gender (2) referral source (3) provider type (4) delivered 
treatment location (5) primary and secondary diagnosis with semi-structured and standardized 
protocols (6) list of current and past psychiatric medications (7) list of psychosocial interventions 
received (8) measure of  mood symptoms with a validated screening tool for depression such as 
the ZLDSI (9) ZL suicidality screening instrument as needed when indicated with a positive 
response on ZLDSI item-12 (10) assesses homicidal ideation (11) evaluates seizures (12) measure 
of functional impairment with the WHODAS and (13) measure of clinical severity (CGI-S) and 
improvement (CGI-I) with the Clinical Global Impression. EHR data therefore has provided an 
efficient way to capture patient data and since the mental health infrastructure has been built and 
established, has offered the opportunity to assess clinical needs and determine how to improve 




EHR with the following: (A) requirement that each clinical measure is scored before the clinician 
can proceed in the patient chart, (B) while clinically assessed to separate in the EHR current 
variables for suicidal and homicidal ideation, intent, and past attempt as they have implications for 
risk level (C) include patient flags when suicidal or homicidal intent and previous attempt history 
are documented in the patient chart with a prompt for the current ZL safety plan, and (D) EHR will 
prompt the clinician for suicide assessment at each appointment until the patients suicidality 
improves.  
Patient triage is determined by care pathways and procedures for risk level are already 
established however, the addition of patient flags in the EHR will inform clinicians how best to 
proceed with use of the database. Patient flags are an alert or pop-up within an EHR system to 
convey to the clinical provider next steps for clinical care, alert supervisors, and track high-risk 
patients for ongoing monitoring and follow-up. Patient flags will allow for increased accuracy in 
terms of patient care pathways and increase efficiency for high-volume clinic and hospital settings. 
At present, the EHR is completed by data managers rather than in real-time. Initially, the EHR was 
designed to be completed by the clinician while the patient was present at the appointment 
however, there were limitations based on computer access and data programming. In the future, 
computer access and data programming would be a realistic barrier to address as the direct input 
into the system would increase accuracy and ensure proper clinical documentation. Additional 
resources would need to be allocated to guarantee the continued development of EHR, and while 
providing training on how to use the EHR system for documentation and efficient clinical 




To better understand the nature of clinical services EHR data collection may provide 
further detail about case finding (E ) to describe how the patient initially was connected with 
mental health services (F) to ask if this was the patient’s first visit to the hospital or clinic (G) 
whether the patient accepted mental health services (H) and if the response was “non” or “no” to 
describe the reason why. Details like this will improve efforts with case finding, and for internal 
use allow the hospital and clinic management oversight to evaluate potential barriers to mental 
health treatment access. Provided that mental health problems are often comorbid with medical 
conditions a list of current and past medical conditions, and family medical history while collected 
information at the ZL intake, when added to the EHR will provide valuable and holistic 
information about other patient needs (e.g., HIV, tuberculosis). Along these lines, since high rates 
of functional impairment were observed it would be useful to include information about if the 
patient has (I) caregiver support for their illness and (J) the caregivers contact information. The 
ZL team already integrates family, caregivers, and community into the mental health treatment 
service delivery but these questions in EHR would further formalize into currently implemented 
procedures.  
Additionally, (K) asking about the importance of spirituality and religion for the patient 
will be clinically useful. The research suggests, spiritually informed mental health treatment is 
meaningful and helpful for Haitians (Auguste & Rasmussen, 2019; Blanc, et al., 2016). Questions 
about interest in spiritually informed mental health treatment can inform clinicians to integrate 
such perspectives into the current care pathways with the use of mental health tools. Other 




would measure patient (D) food access (E) housing stability (F) literacy (G) to add with current 
occupation patient’s work status (employed, seeking work, unemployed) (J) interpersonal and 
sexual violence (past or current) (K) transportation access for healthcare appointments (L) rural 
vs. urban resident  (M) clean water access and (N) electricity access. Again, since there were high 
rates of depressed mood symptoms and functional impairment understanding the patient’s social 
context would be important as it its likely interrelated. Importantly, demographic questions based 
on SDGs allow clinicians to further assess the difficult reality many Haitians have to face to inform 
treatment planning. It connects the bridge between mental health and SDGs. Additional data may 
solidify future partnerships with NGOs  and government agencies that utilize mental health 
treatment to target SDGs.  
To summarize, EHR data from the present study has been beneficial for internal use, offers 
information to improve the quality of clinical care, and has increased utility for research purposes. 
The use of EHR addresses a main critique of task-sharing models about the lack of clarity regarding 
quality clinical service delivery (Hoeft, et al., 2018). There has been emerging evidence that task-
sharing models are effective (Singla, et al., 2016) for low resource settings. However, prior to the 
evaluation of service quality, more task–sharing models first must be implemented. The clinical 
quality assessments are often evaluated by clinical outcomes and too often there are a lack of even 
the initial screening tools available to low resource settings. The current EHR system allows for 
the evaluation of long-term mental health treatment efficacy at–scale with the use of standardized 




Mental Health Care Pathways. Results indicate the task-sharing model followed the 
mental healthcare pathways developed by PIH and ZL. This suggests, the established mental health 
infrastructure has been adhered to by clinical providers and was accepted by patients. It provides 
a unique model of mental healthcare, as it includes severe mental disorders and neurological 
conditions with psychiatric medication management. Most collaborative care or task-sharing 
models to date, have targeted common mental disorders with psychosocial interventions (Singla, 
et al., 2016). Since common mental disorders represent the largest group of individuals who 
experience and seek treatment for mental disorders when compared to the lower population 
prevalence of severe mental disorders or neurological conditions, common mental disorders were 
a high priority to address as part of the mhGAP. At this point however, the task-sharing model 
must expand to include patients with severe mental disorders and neurological conditions and 
based on present findings are at increased risk for suicide and require pharmacological care.  
The primary psychosocial intervention delivered with the current task-sharing model was 
IPT. The World Health Organization recommends IPT as a first-line treatment for depression, that 
appears to be feasible and acceptable more broadly as a mental healthcare option for common 
mental disorders, severe mental disorders, and neurological conditions, and works well in 
conjunction with psychiatric medication management. A transdiagnostic approach with IPT for 
depression symptoms addresses a concern in previous global research literature that current 
treatment options for LMICs have had too much diagnostic specificity, where scalable and 
sustainable mental health services are necessary (Conway, Hammen, & Brennan, 2012; Murray, 




demonstrated a task-sharing model can readily expand to severe mental disorders and neurological 
conditions as part of a single mental health infrastructure, and provided transdiagnostic 
psychosocial interventions such as IPT and other common elements approaches.  
The majority of patients diagnosed with epilepsy are living with a treatable neurological 
condition, and the same potential to manage symptoms has been observed for psychotic disorders 
and bipolar disorder (Meyer, et al., 2010; Rathod, et al., 2017). To not deliver mental healthcare 
evokes unnecessary suffering and limits individual economic contribution to the community 
(McKnight & Kashdan, 2009; Whiteford, et al., 2013). By ignoring mental disorders, it only 
exacerbates societal and economic problems. For example, there is increased cost when seeking 
treatment later or when not managing psychological symptoms at all there are likely secondary 
impacts. Secondary impacts include the potential violation of human rights by denying mental 
health care or long-term confinement, unnecessary interactions with law enforcement, encounters 
with the criminal justice systems, and employment issues. In other words, it is an unnecessary 
burden economically and to societal sectors when there are evident options for mental health 
treatment that would allow people to thrive. Globally the reason mental health treatment is key, is 
that it allows citizens to fully participate in society and builds stronger ties to the community. 
Overall, these results give foundational evidence that care pathways offer a functional system for 
mental healthcare service delivery within a post-disaster setting.  
Mental Health Tools Expansion. The PIH and ZL frontline healthcare team use a 
standardized manual for the task-sharing model and care pathways “Tools for Use in an Integrated, 




manual provides detailed guidelines for triage and mental health tools for depression, psychotic 
disorders, and epilepsy (see figures 3-5). While not an aspect of the present study there are 
guidelines for child and adolescent mental health. Other clinical care pathways that have been 
developed include a post-traumatic stress disorder pathway with Cognitive Processing Therapy 
(CPT) as the delivered treatment modality and alcohol use disorder pathway. In the present study, 
the rates of alcohol use disorder and PTSD were very low. After the 2010 earthquake nearly all 
Haitians including children endorsed some symptoms of PTSD (Cerdá, at al., 2013; Cénat, & 
Derivois, 2014; Cénat, et al., 2018), although for many people PTSD improved 30-months 
following the earthquake (25.98%) (Cénat & Derivois, 2014) and our results reflect that clinical 
improvement.  
The manual “Tools for Use in an Integrated, Community-Based Mental Health System of 
Care: An Introduction and Reference Guide” provides valuable training materials that offer mental 
health tools by section. Each patient receives a semi-structured and standardized clinical intake 
interview, screening tools are specific to the mental disorder such as the ZLDSI or Abnormal 
Involuntary Movement Scale (AIMS) and examination procedures that inform triage to the 
appropriate level of clinical care (low intensity vs. high intensity), clinical symptom checklists, 
differential diagnosis, referral and follow-up forms. In terms of clinical treatment, there are 
procedures that consist of psychoeducation cards, medication evaluation forms, clinical treatment 
guidelines, stigma assessments, recommendations for family, caregiver, and community 
involvement, and when risk is indicated offers safety plans. Additionally, there are protocols for 




recommended for this already utilized and useful manual based on the latent class analysis results 
and multinomial logistic regression models include the following for mental health skill packages. 
(1) Primary Diagnosis Indicator Categories. The LCA indicators naturally fell into 
clinical subgroups of common mental disorders (100%), severe mental disorders (100%), and 
neurological conditions (100%), with two distinct care pathways that were defined by the primary 
diagnosis categorization, severity of mood symptoms, level of functional impairment, and 
suicidality (see table 17). A benefit to the present care pathways that despite specificity to 
depression, psychotic disorders, and epilepsy the patients with other mental disorders (e.g., 
generalized anxiety disorder, bipolar disorder) were not excluded from mental health service 
delivery (see tables 18–29). This increases the generalizability of results that patients were not 
excluded based on the primary diagnosis, psychiatric comorbidity, severity of depressed mood 
symptoms, or severity of functional impairment.  
(2) Depressed Mood Symptoms. Again, another definitive indicator of the LCA model was 
the severity of depressed mood symptoms. The present study compared to previous LCA models 
on depression suggests depression severity often determines clinical depression subgroups 
(Ulbricht, et al., 2018). Results suggest, common mental disorders (100%), severe mental disorders 
(100%), and neurological conditions (100%) each have two clinical pathways (figures 6–7). 
Pathway one included three classes: class 1a “common mental disorders–none to low functional 
impairment” (45%), class 2a “severe mental disorders–none to low functional impairment” (27%), 
and class 3a “neurological conditions–none to low functional impairment” (11%) where 




the other remaining three classes: class 4b “common mental disorders–high functional 
impairment” (77%), class 5b “severe mental disorders–high functional impairment” (60%), and 
class 6b “neurological conditions–high functional impairment” (25%) where percentages represent 
the “low to high” probability of depressed mood symptoms. Depressed mood symptoms were 
evaluated with the ZLDSI, and ZL expert clinicians described regular utilization of this particular 
screening tool that had been locally adapted and validated. The LCA results therefore, support the 
ZLDSI as an appropriate measurement tool for depressed mood symptoms to inform patient triage 
and to determine care pathways.  
(3) Functional Impairment. Interestingly, the most definitive LCA model clinical 
indicator was functional impairment, even more so than depressed mood symptoms. This follows 
the recommendation of previous LCA model literature to evaluate functional impairment 
especially in the context of depression  (Ulbricht, et al., 2018). As previously described, there were 
two clinical pathways each for common mental disorders (100%), severe mental disorders (100%), 
and neurological conditions (100%). In addition to depressed mood symptoms, functional 
impairment based on severity aligned with the same two clinical pathways. Pathway one included 
three classes: class 1a “common mental disorders–none to low functional impairment” (0), class 
2a “severe mental disorders–none to low functional impairment” (19%), class 3a “neurological 
conditions–none to low functional impairment” (0) where percentages represent a “none to low” 
probability of functional impairment. Pathway two included the other remaining three classes: 4b 
common mental disorders (100%), 5b severe mental disorders (100%), and 6b neurological 




While the WHODAS was coded with a simple scoring method (Andrews, et al., 2004), based on 
the total scores results offer a crude measure of functional impairment. In other words, the 
WHODAS for this particular scoring method was not specific to a domain of functioning such as 
cognition, mobility, self-care, getting along with others, life activities, and participation. 
Nevertheless, findings showed that patients self-reported to clinical providers that functional 
impairment was frequently a problem and burdensome.  
Functional impairment will potentially be useful to determine care pathways. For example, 
patient’s with psychotic symptoms or epilepsy may not endorse moderate to severe depressed 
mood symptoms despite high levels of functional impairment. High functional impairment along 
with other psychological distress would not necessarily be captured by measurement of depressed 
mood symptoms only, and consequently such patients with the ZLDSI screening tool have the 
potential to be referred for lower levels of care instead of collaborative care that would include 
high intensity treatment such as psychosocial interventions and psychiatric medication 
management. Specifically, patients in the psychotic disorder or epilepsy care pathways, with the 
inclusion of functional impairment as a screening tool at the initial intake will expand the mental 
health service coverage. For example, the most severe clinical LCA subgroups that would require 
high intensity treatment through collaborative care were class 4b “common mental disorders–high 
functional impairment,” class 5b “severe mental disorders–high functional impairment,” and class 
6b “neurological conditions–high functional impairment” with “low to high” depressed mood 
symptoms and “high” functional impairment. Looking at this more closely, LCA class 4b common 




depression (77%). By comparison class 5b severe mental disorders with high functional 
impairment (100%) and class 6b neurological conditions with high functional impairment (100%) 
had fewer depressed mood symptoms (class 5b severe mental disorders=60% depressed mood; 
class 6b neurological conditions= 25% depressed mood). Based on the depressed mood symptoms 
only,  patients who do not readily express the experience of seizures or psychotic symptoms would 
have a high likelihood of being screened to receive low intensity services, without the necessary 
high intensity services that would include psychiatric medication management. That said, class 5b 
severe mental disorders with high functional impairment and class 6b neurological conditions with 
high functional impairment, evidently are in major psychological distress but would potentially be 
screened out of collaborative care referrals. Based on the primary diagnosis for these subgroups 
that frequently included psychotic disorder, bipolar disorder, and epilepsy, high levels of 
functional impairment, and suicidality scores that were elevated with probabilities that ranged from 
12-26%––these subgroups require higher levels of care. One could argue, that patients based on 
the primary diagnosis would already be referred for psychiatric medication management however, 
including functional impairment would decrease the likelihood of clinical oversight. Nevertheless, 
of the total sample, 50% of patients endorsed moderate to severe depression symptoms and nearly 
75% endorsed functional impairment. Consequently, mental health service coverage with the 
addition of functional impairment as an initial screening tool will likely improve mental health 
service coverage for collaborative care by almost 25%. The measurement of mood and functional 




(4) Suicidality and Epilepsy. Interestingly, the suicide indicator in the LCA model was the 
highest for neurological conditions: Class 3a neurological conditions with “none to low functional 
impairment” (15%) and class 6b neurological conditions with “high functional impairment” 
(26%). More specifically,  patients had a primary diagnosis of epilepsy (class 3a neurological 
conditions=93% epilepsy and class 6b neurological conditions=87.4% epilepsy). As previously 
described, the ZLDSI for depression has been a highly beneficial screening tool for patient triage 
that determines care pathways. That said, the ZLDSI item-12, which assesses suicidality at triage 
may be especially important for neurological conditions. For example, class 3a neurological 
conditions with “none to low functional impairment” had an 11% probability of depressed mood 
symptoms, but the probability of suicidality increased to 15%. We can infer therefore, that 4% of 
patients with neurological conditions may experience suicidality without depressed mood 
symptoms. Similarly, more severe neurological conditions like class 6b with “high functional 
impairment” had a 25% probability of depressed mood symptoms and 26% probability of 
suicidality. Again, potentially 1% of patients with more severe neurological conditions had 
experienced suicidality without depressed mood symptoms.  
Reasons for this finding may be known side effects of suicidal ideation to Tegretol 
(Carbamazepine) a main psychiatric medication treatment for epilepsy, as the symptom scores may 
not have been from the patients first visit. Alternatively, morphological changes in the brain due 
to neurological symptoms like seizures may have led to disinhibition and mood dysregulation, thus 
increased the likelihood of suicidality that would not necessarily include endorsement of moderate 




have been shown to be at increased risk for suicide by 5 times and 25 times greater when there are 
complex partial seizures of temporal lobe origin (Kanner, 2006). Clinicians on the frontline mental 
healthcare team at ZL also described that patients with epilepsy present with the most severe 
psychological distress, which likely has been exacerbated in the context of social stigma given 
seizures are locally believed to be due to a hex or voodoo curse. After patients begin 
pharmacological treatment the clinicians at ZL stated many of the depressed mood symptoms and 
suicidality subside, and future research longitudinally can evaluate such clinical outcomes.  
(5) Suicidality–CMDs and SMDs. According to the LCA model common mental disorders 
rarely experienced suicidality (1-3%), and the primary diagnosis consisted of major depression, 
mild to moderate episode (50.4%) and generalized anxiety disorder (35.2%). As one might 
anticipate, class 5b severe mental disorders with high functional impairment were at elevated risk 
for suicide (12%). The primary diagnosis was usually psychotic disorder (57.8%) and bipolar 
disorder (17.8%). It should be noted that severe mental disorders included major depression with 
severe symptoms, which provides an explanation for the reduced suicidality of the common mental 
disorder’s subgroups. Overall, suicidality was present for each LCA subgroup (1a to 6b) with 
probabilities that ranged from 1-26%, or put another way 6 out 6 LCA subgroups. Implications of 
this finding emphasize the importance of initial and ongoing suicidality assessment for all mental 
disorders, especially neurological conditions and severe mental disorders that have elevated risk-
levels.  
(6) Mental Health Tools for Bipolar Disorder. Based on the data new mental health tools 




(23.7%) would be applicable to this population with consideration to the primary diagnosis rates. 
Such mental health tools for bipolar disorder might include, screening tools like the Young Mania 
Rating Scale (YMRS), with more specific information on hypomania vs. mania, and treatment 
guidelines that include psychoeducation and Lithium treatment. A challenge with including this 
psychiatric medication in the current treatment model is the potential for Lithium side effects like 
other psychotropic medications but also toxicity, and therefore require continued Lithium level 
monitoring with monthly blood samples. The majority of patients complete 1-3 visits, and such a 
commitment from the patient to receive Lithium would require assessment at the initial visit and 
local availability of the psychiatric medication. Clinical trials have shown that Lithium as a 
monotherapy in fact out performs other psychiatric medications such as Valproate, Olanzapine, or 
Risperidone and provides an effective low-cost treatment (Malhi, et al., 2013). Lastly, Family 
Focused Therapy (FFT) approaches and relapse prevent strategies for bipolar disorder are 
recommended to expand within the current ZL guidelines. FFT and relapse prevention 
interventions would be applicable to psychotic disorders, and the child and adolescent care 
pathway as well.  
(7) Mental Health Tools for Generalized Anxiety Disorder. Second, the data suggests that 
mental health tools specific to generalized anxiety disorder (27.2%) would also be useful. Again, 
this would build upon the current model with mental health tools that include a symptom checklist, 
differential diagnosis with PTSD, treatment guidelines such as relaxation strategies and CBT skills 





(8) Mental Health Tools for Women. Third, mental health tools specific to women and 
family planning would be highly valuable. The majority of patients who sought mental health 
services were women (66.7%), and based on the MLR model 1common mental disorders were 2–
3 times more likely female. This could be due to many reasons, that include increased violence 
toward women, power differentials within society, economic disparities, birth and childcare 
responsibilities, and perhaps a gender bias to pathologize women’s symptoms with consideration 
to common mental disorders globally (World Health Organization, 2013). Due to factors such as 
environmental, systemic, and household trauma that is often directed specifically toward Haitian 
women, and routinely culturally normalized there is often increased psychological distress 
provided the hostile and violent social context (Verdeli, et al., 2016). Based on what we currently 
know, common mental disorders have primarily impacted women but conclusions as to why are 
challenging to draw upon. It raises the question, are women truly impacted more by common 
mental disorders or are sociocultural  factors increasing psychological distress? While likely it is 
both, the reasons why common mental disorders like depression are much higher for women 
deserves more evaluation. Based on these results, the current care pathways might also include 
more women–centered training materials and mental health tools on topics such as interpersonal 
and sexual violence, post-partum and menopause related depression, perinatal psychosis, and 
perinatal bipolar disorder. To summarize, clinical implementation would include mental health 
programming for bipolar disorder, generalized anxiety disorder, women’s mental health, 




suicide prevention strategies for epilepsy and severe mental disorders, and the expansion of 
psychiatric medication management within collaborative care.  
Clinical Implications of Functional Impairment  
 Functional impairment as a main treatment outcome measure may be less stigmatizing 
for some patients to describe and provides a way for community mental healthcare providers to 
screen for distress with minimal clinical training and to deliver psychosocial interventions that 
target behavioral change related to functional impairment outcomes. It may be possible, that 
individuals benefit from brief psychosocial interventions that are 4–6 visits to target functional 
impairment. Goal setting and behavioral activation already has been implemented by PIH and ZL. 
Further, ZL clinicians described goal setting and behavioral activation as useful and shown 
observed benefit to patients. Building upon these mental health tools goal setting for functional 
impairment targets would include A) self-care: independently dressing, combing hair, brushing 
teeth, bathing, eating, and staying alone B) mobility: developing a standing and walking routine, 
utilizing transportation C) cognition: listening to the radio, singing a new song, or drawing a map 
of directions to improve concentration and learning D) getting along with others: meeting new 
people, practicing communication skills with a therapist E) life activities: support from family 
members to breakdown into steps household chores, therapy to practice communication skills, 
seeking work, education, or volunteer experience F) participation: engagement in the community 
or religious rituals.  
IPT importantly targets depression in four domains related to functional impairment that 




interpersonal social skills (Lewandowski, et al., 2016; Verdeli, 2016). IPT breaks the social 
isolation, gives hope, and allows the patient to develop interpersonal skills to reduce stressors that 
when within a global context often includes exposure to aggression, hostility, and violence. The 
addition of brief psychosocial interventions for functional impairment will allow clinicians to 
target the basics for the patient first. Addressing functional impairment directly, potentially will 
improve quality of life and increase treatment engagement with other mental health services. 
Alternatively, if mood and functional impairment symptoms remit with brief psychosocial 
interventions, it is a cost-effective and time efficient approach to reduce the global disease burden. 
Community mental health providers could offer brief counseling within the IPT framework. Brief 
psychosocial interventions that emphasizes skill-building could target functional impairment and 
may be useful as a pre-treatment approach. If a patient has severe symptoms, they would still be 
able to receive psychiatric medication and it would likely begin to reach the therapeutic dose (6 
weeks after pre-treatment) and increase readiness for  individual or group therapy (e.g., IPT, CBT, 
CPT) that will target psychological symptoms. Again, functional impairment with additional 
research may be useful as an indicator to inform who receives high intensity vs. low intensity 
treatments, and who will recover.  
Implementation  
Haitian’s are resilient given ongoing stressors that include the currently high 
unemployment rates, food insecurity, minimal education access, escalating political unrest that has 
led to road closures and power outages, and such dire circumstances have worsened with the 




current impact on psychological well-being due to COVID-19 has devastated this income 
restricted setting. The number of COVID-19 cases and total death toll for Haitians while low has 
further resulted in severe food insecurity and job scarcity. The majority of Haitians while young 
are experiencing malnourishment and chronic psychological distress. Civil unrest and political 
corruption have been followed by more kidnappings for ransom that live on desperate and 
vulnerable families. Gang violence has increased and kidnappings are directed toward school 
children, lawmakers, hospital staff, and foreign aid workers. A vaccine delivery under these 
extreme conditions will offer some relief, but without systemic change, medication refrigeration, 
equitable access in the supply chain, food availability, and willingness to receive the vaccine there 
will be minimal light at the end of a long road. As we reflect on this moment globally this may be 
later viewed as another moral failure.  
That said, sustainability with current mental health services therefore are of the utmost 
importance and while data-driven results provide key insights, it still raises questions about 
implementation under such circumstances of major chronic distress and overburdened systems. 
Nevertheless, PIH and ZL persist to deliver quality mental healthcare and even amidst the growing 
civil unrest. Provided the global circumstances and assessment of current needs, mental healthcare 
is essential and again can be connected further to SDGs. It is recommended travel vouchers, meals, 
and job or education support be offered in primary care alongside mental health services, and will 
potentially provide a safe place for community. Based on the data it is important to integrate 
nursing further into psychiatric medication delivery provided the high level of need for severe 




psychologists, nurses, and medical doctors  (generalists), which increases the potential for clinical 
provider burnout. Undoubtedly, nurses especially may be overwhelmed clinically and thereby 
decreases the likelihood of mental health service engagement. However, without integration with 
nursing or new additional providers it increases patient care responsibilities at excess for medical 
doctors (generalists). It may be useful in future research to assess reasons why nursing engagement 
in mental health services has been low to generate new solutions. For example, what are nurses 
individual views on mental health, assessment of current caseload and clinical burnout, mental 
health training needs, and to evaluate from the nurses’ perspective on reasons for/against increased 
collaborative mental healthcare. Again, at the systems level it may be due to the limited ability to 
assign a nurse manager full-time to mental health service delivery. Perhaps mental health seminars 
and didactics generally can build more of a training and collaborative care alliance between 
healthcare teams.  
Alternatively, other collaborators such as NGOs or government healthcare agencies may 
be willing to supervise and deliver additional psychiatric medication training. Considerations were 
also raised by mental health clinicians at ZL about utilization of the WHODAS as a main measure 
of functional impairment. Clinicians described patients may not fully understand questions from 
the WHODAS, and unlike the ZLDSI this measure was not locally adapted and validated. 
Nevertheless, the WHODAS is a measure utilized often in global settings, and the present study 
findings offers a crude measure to indicate high vs. low functional impairment. This feedback from 
ZL clinicians provides an opportunity to expand the validation of functional impairment screening 




reflect problems presented by Haitian patients. A benefit of continuing to use the WHODAS 
measure would be to compare future data longitudinally. Another possibility, would be to 
implement the Sheehan Disability Scale (SDS), an efficient measure to administer with 3-items 
about functional impairment. The SDS assesses three domains of functioning such as 1) 
work/school, 2) social life/leisure activities, and 3) family life/home responsibilities on a scale of 
0 (not at all) to 10 (extremely) with total scores that range from 0 (no functional impairment) to 30 
(high functional impairment). Adaption of the SDS measure will need to reflect that community 
or spiritual rituals are potentially more applicable rather than “leisure activities.” Moreover, 
“seeking work or education” may be another adaptation because of the currently high 
unemployment rates and limited education access. The CGI while not locally adapted or validated, 
has been described by ZL clinicians as clinically useful and due to the brevity has been applicable 
in a high-volume setting. The CGI captures the patient’s severity of illness over the past 7 days 
(CGI-S), and afterward the patient’s clinical improvement following treatment (CGI-I) and when 
applicable includes assessment of side effects to psychiatric medication management based on the 
clinician’s observation. Functional impairment is important to assess separately from the CGI-I 
and CGI-S, as the proposed functional impairment measure would be based on the patient’s self-
report rather than clinician’s observed rating, and the clinical global impression measures a 
separate construct. The CGI-I was not included in the present study as it did not evaluate clinical 
treatment outcomes. To summarize, current practices that assess depressed mood symptoms, 





Standards of Care  
 In global mental health a unified framework for best practices or standards of care does 
not exist (Hook & Vera, 2020). The manuscript by Raviola and colleagues (2020) provide details 
on the development of a comprehensive, and community–based mental healthcare system. While 
the results from the present study are preliminary, findings provide further support that the Haitian 
mental healthcare system has been feasible and acceptable for good clinical practice. The task-
sharing model framework suggests this is an inclusive mental healthcare system for common 
mental disorders, severe mental disorders, and neurological conditions that may be useful to other 
low resource settings. Electronic health records allowed for data-driven assessment to ensure 
quality clinical services that provide information to tailor and individualize patient mental health 
treatment while providing country specific, and infrastructure specific information. ZL expert 
clinicians discussed increased coordination and procedures for risk mitigation between clinicians 
and supervisors. Along these lines, ZL expert clinicians described clinical issues that have led to 
significant loss due to a lack of resources. Specifically, a lack of psychiatric medication availability 
within the supply chain has had deleterious consequences. One clinical example included a 17-
year-old child who had been stabilized with Carbamazepine (Tegretol) and shown good 
compliance, and regularly participated in psychosocial mental health services. Upon return to the 
hospital to refill her psychiatric medication the patient and clinicians learned Carbamazepine 
(Tegretol) was no longer available. After, she had a major seizure and fell to the ground hitting her 
head on a rock, and due to the impact of the fall she passed away. The clinical vignette connects 




also to alert on a supervisor-level and systemic–level when psychiatric medication supplies are 
low. Standardized procedures for psychiatric medication inventories are essential to reduce 
psychiatric medication shortages, and with increased clinical oversight from supervisors and 
hospital management teams can procure the necessary psychiatric medications through expedited 
deliveries that are shipped from abroad. Clinicians and hospitals provide life-saving psychiatric 
medications for free to patients, and without this option available patients are unable to afford or 
access their psychiatric medications. Of note, clinicians currently provide patients with one month 
to two-month psychiatric medication supplies. For patients managing seizures, mania, psychosis, 
or major depression with suicidality including clinical procedures to require at least a two-month 
back–up supply would be recommended in case of emergency shortages, unforeseen delivery 
delays, shifts or new supplier relationships, reduced production and delivery volume that may  
occur especially in the context of COVID. These factors are of increased importance for a country 
like Haiti where a Caribbean location and frequent natural disasters such as hurricanes are not 
uncommon and delivery access is mostly possible only through air or maritime routes. Another 
back-up option during psychiatric medication shortages on–site at the clinic or hospital might 
include increased coordination between primary care clinics and hospitals with the local 
pharmacies and Haitian Ministry of Health. For example, the primary care clinic or hospital would 
provide the patient with a paid voucher to receive the essential psychiatric medication(s) for free 
at the local pharmacy. At the same time, it is unnecessary to have such supply chain issues arise 
unexpectedly and the appropriate response would require increased notification of inventory 




consequences that have already arisen even within a functional community–based mental health 
system. Such incident reporting demonstrates accountability and will allow for the implementation 
of increased quality oversight to mitigate future patient and provider risk. By addressing these 
problems directly, it advocates on behalf of the patient and reduces stress for the clinician that such 
a devastating instance will occur in the future, and reduces overall liability and risk at the clinician 
level, primary care clinic and hospital level, and NGO level.  
In addition, to risk-management procedures it is recommended that increased clinical 
monitoring include a weekly report that would be sent out to the clinical supervisory teams that 
indicate patient risk-level. Patient risk-level can be assessed and incident reports would be required 
under the following circumstances: (1) endorsement of suicidal or homicidal plan and/or intent, or  
past history of a suicide attempt (2) self-harm attempts (3) injury toward others, including staff (4) 
violent or aggressive behavior toward self or staff (5) hostile/violent or unauthorized family 
members, partners, caregivers (6) restraint of patient (7) sexual harassment, intimidation, or assault 
toward others (8) damage to property or theft (9) on-site alcohol or substance related intoxication 
of the patient or clinician (10) psychiatric medication errors or major clinical issues (11) severe 
medical reactions to medication (12) acute psychosis, mania, or seizures (13) child and adolescent 
abuse (14) elderly abuse (15) patient experiences domestic assault, interpersonal violence, or 
sexual assault  (16) severely disabled patients and (17) complaints/allegations with staff or others. 
Along with risk-assessment and incident reports, patients that endorse or meet criterion that match 
these circumstances would subsequently require ongoing monitoring to assess clinical 




categorizations may benefit from flexibility with clinicians to have more frequent sessions (e.g., 
twice per week with phone calls until the patient has been stabilized), paid vouchers for travel with 
a meal for clinical appointments, paid vouchers for psychiatric medication at the local pharmacy, 
maintain psychiatric medication back-up supply (at least two-months), increased psychoeducation 
and coordination with family or caregivers, relapse prevention, and when applicable the continued 
assessment of safety planning. Moreover, when staff is involved there would be formal procedures 
to make certain that the situation has reached a resolution. To implement, there could be designated 
risk-managers to oversee these procedures for clinical adherence with supervisors and clinical 
teams, weekly reports that track incident reports completed at the clinician level, supervisory level, 
ZL clinic and hospital systemic level, and PIH NGO systemic level, to determine if the necessary 
equipment and supplies are available, document staff related injuries, and document fatalities that 
might include suicide, homicide, overdose, primary care clinic or hospital negligence, or severe 
adverse reactions to medication. Following death-related incident reports it would be appropriate 
to have a meeting with  the ZL clinical teams, ZL supervisors, ZL clinic and hospital management, 
and PIH NGO directors to discuss how to improve the quality of clinical services to reduce future 
risk. Oversight and accountability, are of the utmost importance to confirm similar incidents do 
not occur in the future and to further support clinical staff by identifying needs and offering 
additional training as necessary. Importantly, this also verifies that with ongoing documentation 
and accountability that the potential for legal representation as required and human rights abuses 
toward vulnerable patients and staff are minimized, mitigated, and responded to ethically should 




account of the patient and clinician. Ideally, risk-management oversight would include 
representatives from PIH, ZL, and an outside organization to offer perspectives that are well-
rounded, balanced, and provide a framework for implementation of an ethical response and 
solution.  
Other key priorities for implementation in Haiti include mental health tools expansion for 
epilepsy and bipolar disorder, women’s focused mental health treatment such as family planning, 
post-partum depression, interpersonal violence and sexual assault response, increased suicide 
prevention strategies, and emphasize the importance to clinically address functional impairment. 
Currently, the ZL team has been developing programming for psychosocial rehabilitation, that 
aligns with ZL clinical observation and results from the present study that functional impairment 
has been a debilitating problem for Haitians. That said, depressed mood symptoms and functional 
impairment in the future may be useful as a main screening tool for patient triage. Patients who 
indicate some level of functional impairment could receive pre-treatment or low intensity brief 
psychosocial interventions, which would address the basics of functioning and  potentially increase 
the likelihood of future treatment response when mood symptoms are targeted. The study while 
preliminary suggests that these clinical indicators are worth considering within a task-sharing 
model. Therefore, the present study provides evidence that supports clinical outcome measures for 
depression symptoms, suicidality, and functional impairment are essential. In terms of mental 
health service delivery low-intensity and high-intensity mental health services with psychiatric 
medication management were accepted by clinicians and patients for common mental disorders, 




services, efficacy, and relapse prevention strategies deserve additional consideration from an 
evaluative standpoint.  
When examining data from the present study, the results identify necessary competencies, 
and highlight areas to strengthen clinical training and allocate more resources within the current 
community-based mental health system. Overall, the present community-based mental healthcare 
system infrastructure has been supported by large-scale data and demonstrates mental health 
services are necessary to provide on behalf of the citizens whom reside in Haiti. Additionally, the 
study suggests that the present task-sharing model with the established care pathways has been 
highly beneficial. The level of collaboration, and positive action have allowed current stakeholders 
to provide a sustainable mental healthcare model. Data suggests that clinical providers offer good 
mental health service coverage for patients with common mental disorders, severe mental 
disorders, and neurological conditions but are overextended in terms of expansion. Future growth 
and development therefore will require increased funding sources and partnerships with NGOs 
and governmental agencies.  
Limitations 
Cross-Sectional Design  
Cross-sectional design limits our interpretation because it includes a single datum time 
point. Moreover, while observation at a single time point may reveal a relationship between 
variables, the causality will be challenging to determine. It would be useful for future research to 
include longitudinal data points, and especially with consideration to mental health subgroups to 




Self-Report Measures  
With self-report there is always the potential for error and recall bias. For example, the 
participant could underreport (or overstate) their psychological symptoms, and for a number of 
reasons such as social stigma or the patient’s uncertainty about how to describe their mental health 
problems. For the ZLDSI the cutoff score of 13 was determined to have a sensitivity of 85.4% and 
specificity 50.9% when other diagnoses were included (Rasmussen, et al., 2014). That said, there 
is a possibility that individuals may have been screened out who were unable to accurately self-
report their psychological symptoms, thus were excluded from the care pathways.  
Semi-Structured Clinical Interviews 
Research with community providers when using structured interviews such as the mhGAP 
materials, have shown diagnostic accuracy with 86% specificity and 46% sensitivity (Keynejad, 
Dua, Barbui, & Thornicroft, 2017). With regard to semi-structured clinical interviews there is 
always the potential to miss details regarding symptoms, and each provider may assess the patient 
somewhat differently despite having the same supervisor, clinical training, and mental health 
guidelines. At the same time, semi-structured interviews offer more flexibility and opportunity to 
assess symptoms based on clinical judgment rather than preliminary threshold criterion. For 
example, many structured interviews like the WHO WMH CIDI require that if the patient endorses 
“no” to the first few questions about the specific mental disorder then the clinician discontinues 
the evaluation for that clinical domain. For countries like Haiti where structured clinical interviews 
are not validated such examinations would not be appropriate, and descriptions of the 




Primary Diagnosis Categorization 
The primary diagnosis categorization while aligned with WHO guidelines suggests other 
practitioners may argue a preference for diagnostic specificity. The LCA results however, provide 
implications that there was no overlap with common mental disorders, severe mental disorders, 
and neurological conditions in terms of the subgroups. LCA subgroups for common mental 
disorders, severe mental disorders, and neurological conditions were distinct. We did not observe 
for example, an LCA class that included both common mental disorders and severe mental 
disorders, or common mental disorders and neurological conditions. At the same time, despite 
these transdiagnostic categorizations based on the primary diagnosis LCA results again showed 
these were distinct categories. Notwithstanding, the present study still provided information on the 
primary and secondary diagnosis within the primary diagnostic indicator category as it was 
important to determine the appropriate care pathway.  
Demographic Variables 
In Haiti there are few research studies that have included even basic demographic 
information (Wagenaar, et al., 2012). That said, one strength to this study was the inclusion of 
information such as gender, age, treatment location, number of visits during the observation period, 
and the type of treatment received. The data that was not captured by the current study included 
other demographic information such as marital status, religion and spirituality, literacy, work status 
(employed, seeking work, unemployed), food insecurity, housing stability, electricity access, 




information that might be included in future research was previously described in the “Discussion: 
Electronic Health Records” section.  
Suicidality Variable  
Suicidality while thoroughly assessed by community providers and supervised by ZL 
experts, the details about the patient’s suicidality was unclear based on the EHR data entries. 
Clinically the procedures recommend that positive endorsement of ZLDSI item-12 would prompt 
for a suicide evaluation. After the patient would be clinically evaluated for suicidal ideation to 
assess frequency, intensity, duration, plan, intent, and history of a past suicide attempt with a safety 
plan as needed. However, the EHRs did not include data entry of these suicidality details. This is 
described further in the “Discussion: Electronic Health Records” section. Regardless, this variable 
was important to include in the present analyses provided there is very limited research on 
suicidality in Haiti, and suicidality in global contexts more generally. In low resource settings the 
most that is known about suicidality includes information about suicide completion where risk-
level is elevated for ages 15-19 years-old, for individuals whom reside in rural areas, represent 
groups who experience ongoing discrimination (LGBTQIA, migrants, refugees), or have had a 
previous suicide attempt (WHO “Fact Sheet Suicide,” 2019).  
Number of Visits During the Observation Period  
There are limitations to the variable “number of visits during the observation period” since 
it was unknown when patients attended the primary care clinic or hospital. Based on clinical report 
from ZL it was not likely a patient was seen for their first visit, prior to the establishment of the 




can’t be stated with certainty. By taking this variable into account, the value of the odds ratio was 
close to 1 in the MLR model, which suggested there was not a strong relationship.   
Total Symptom Scores vs. Individual Symptom Scores  
The LCA analysis in the present study wanted to examine indicators that exceeded 
evaluation of individual symptoms for a specific mental disorder like major depression and the 
illness severity. While it would not have changed the focus of the study overall, for the post-hoc 
analyses it would have been valuable to analyze individual depression and functional impairment 
symptoms based on the mental disorder subgroups in the MLR models. For example, past LCA 
models on depression have shown individual symptoms such as hopelessness and guilt may impact 
the level of clinical severity (Li, et al., 2014), which would have been useful to include. That said, 
to our knowledge this was the first mental health study in Haiti on mental disorders at-scale and 
the symptom information was not stored after the clinicians completed the initial intake, as it was 
not necessary to determine the patient care pathway.  
Future Research 
Future research, specific to Haiti may examine clinical outcomes of the current 
community-based mental health system. A latent transition analysis, or regression model would 
provide an option for such clinical assessment. These analyses can build upon the present study 
and previous research literature, where depending on the results may suggest that the current 
framework and task-sharing model offers key information about best practices or standards of care 
for global mental health. The task-sharing model, as it includes severe mental disorders and 




continued evaluation of this model. Clinical researchers who evaluate the current care pathways 
may want to pilot a common elements approach to mental health treatment or the delivery of 
psychosocial treatments that more specifically target severe mental disorders and neurological 
conditions. Family Focused Therapy, and cognitive behavioral approaches when adapted for 
global settings may be beneficial to include as mental health service deliverables in addition to 
Interpersonal Psychotherapy that primarily targets major depression. Income restricted settings 
require adaptations to mental health service delivery that are connected to SDGs. Provisions such 
as travel vouchers, meals, clean water, and support seeking housing, jobs, or education access 
would be beneficial. Overall, Haitian primary care to date appears to provide an acceptable, 
feasible, and sustainable community-based mental healthcare treatment model, and the ongoing 
research and evaluation will determine whether there is additional evidence-based support. With 
inclusion of risk-management procedures and incident reporting, the additional oversight can be 
evaluated to also determine the quality of clinical care.  
Additionally, it is recommended research continues on the relationship between epilepsy 
and suicide. Moreover, understanding the causes of seizures might inform standards of care for 
neurological conditions, especially epilepsy. For example, globally the cause of seizures can also 
include other environmental considerations such as larva from pork tapeworms, malaria or other 
parasitic infections, viral infections, and bacterial infections (Senanayake, & Román, 1993) where 
patients would respond to antibacterial treatment. It was beyond the scope of this study but future 




always readily available and have been known to cause seizures that clinically may look like 
epilepsy.  
More generally, LCA models with the same model indicators from this study may be 
evaluated in other low resource settings and a confirmatory latent class analysis performed. Such 
modeling can clarify if task-sharing models for common mental disorders, severe mental disorders, 
and neurological conditions should include two care pathways where triage is determined by the 
assessment of depressed mood symptoms, functional impairment, and suicidality. These indicators 
may determine who will require low vs. high intensity treatment. At present, triage is often 
assessed with task-sharing models by the evaluation of depressed mood symptoms and suicidality. 
By including functional impairment this will appropriately triage patients and potentially expand 
mental health service coverage. Screening for functional impairment may improve with research 
that locally adapts and validates scales such as the WHODAS. Regardless, patients that endorse 
more functional impairment will likely benefit from pre-treatment that targets functional 
impairment to increase the likelihood of future treatment response with clinical interventions like 
CBT, IPT, and CPT that targets depressed mood or other psychological symptoms. Patients that 
are more severe and require psychiatric medication initially, would begin to reach the therapeutic 
dose following a brief psychosocial 4-6 session pre-treatment intervention that targets more severe 
functional impairment. A pilot study that examines the utility of such low intensity and pre-
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